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1 Introduction 
1.1 Integrin-mediated cell adhesion 
For cells in higher organisms it is essential to control their attachment to other cells and to the 
extracellular matrix (ECM) in order to form tissues or control cell migration. Integrins are 
heterodimeric cell surface receptors that mediate cell adhesion to the extracellular matrix and 
thereby control cell polarity, motility, proliferation, differentiation and survival. These 
molecules are ubiquitously expressed, consist of α and β subunits and require an activation 
step before they can mediate adhesion and signaling. By simultaneously binding the ECM and 
the actin cytoskeleton via adapter proteins in the cytoplasm, integrins transduce forces across 
the plasma membrane. This enables the cell to attach tightly to substrates and also to detect 
stiffness and biochemical composition of their surroundings.  
 Integrin subtypes and structures 
Integrins represent a family of 24 adhesion molecules that have specific and overlapping 
functions. Each integrin consists of one α and one β subunit, which are highly glycosylated and 
non-covalently linked. In mammals, 18 different α subunits and 8 β subunits are expressed in 
a tissue-specific manner and mediate the interaction with different ECM components. 
Integrins can be divided into four groups according to their ligand specificity for either RGD- 
(Arg-Gly-Asp) containing proteins such as Fibronectin or Vitronectin (a), for Collagens (b), for 
Laminin (c) or for LDV- (Leu-Asp-Val) containing proteins (d) (Hynes, 2002). Among the most 
closely studied integrins are the Fibronectin-binding α5β1 and the Fibrinogen-binding platelet 
integrin αIIbβ3.  
Each integrin subunit is composed of a large ectodomain of up to 1104 amino acids (AA) for α 
and up to 778 AA for β, a single span transmembrane (TM) domain of 25-29 AA and a short 
cytoplasmic tail of 13-70 AA (Arnaout et al., 2005). The crystal structure of the extracellular 
part of αVβ3 integrin was solved in 2001 and provided crucial insights into the architecture and 
the interplay of the two subunits (Xiong et al., 2001). A ligand-binding “head” structure is 
formed by the N-terminal β-propeller structure in the α subunit and the N-terminal βA domain 
of the β subunit. In 8 of the α integrin subunits, ligand binding occurs via an αA domain 
inserted into the β-propeller domain, which is homologous to the βA domain of the β-integrin 
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subunit. αV further consists of three β-sandwich domains with an immunoglobulin-like fold, 
which form so-called “thigh” and “calf” modules. In β3, the “head” domain is supported by an 
immunoglobulin-like “hybrid” domain followed by a plexin-semaphorin-integrin (PSI) domain, 
four domains with an epidermal growth factor (EGF)-like fold and a β-tail domain (Xiong et al., 
2001). Integrins can adopt three different conformations, a compact, bent-closed (BC) state, 
in which the α and β extracellular domains are folded back onto themselves, an extended-
closed (EC) state, where the two subunits are no longer bent but display low affinity towards 
their ligand, and an extended-open (EO) conformation, where the α and β cytoplasmic, 
transmembrane and ectodomains are separated and the ligand binding pocket within the β 
headpiece is opened up (Moser et al., 2009, Chen et al., 2010, Nishida et al., 2006).  
 
Figure 1: Structural model of an αIIbβ3 heterodimer in bent-closed (left) and extended-open (right) 
conformation (Shattil et al., 2010). The model shows the domain structure of integrins as well as the spheroid 
“head” piece formed by the N-terminal domains of the α and β subunit, which mediates ligand binding. The bent 
conformation is the state observed in crystal structures of integrin extracellular domains (PDB ID: 4G1M), while 
the model of the extended-open conformation was derived by separating and rearranging the domains of the 
crystal structure. Both conformations were fused to structures of the integrin transmembrane domains resolved 
by NMR spectroscopy (PDB ID: 2K9J) and to unstructured integrin tail peptides.  
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 Integrin activation and clustering 
The shift from the BC to the EO conformation is referred to as integrin activation. It can be 
induced by numerous external cues, which lead to the binding of intracellular activators such 
as talin and kindlin to the β-tail (Shattil et al., 2010, Vicente-Manzanares and Horwitz, 2011). 
This “inside-out” signaling controls ligand binding and is followed by the assembly of diverse 
signaling hubs that associate with the F-actin cytoskeleton and signal into the interior of the 
cell (“outside-in” signaling). Signal propagation inside the cell is achieved via the 
phosphorylation of specific substrates, the generation of phosphatidylinositol (3,4,5)-
trisphosphate (PI(3,4,5)P3) by phosphoinositide 3-kinase (PI3K) at the plasma membrane, and 
by rearrangements of the actin cytoskeleton (Qu et al., 2011, Pasquali et al., 2007).  
In two recent studies, the three different activation states of integrins and the transitions 
between these conformations were characterized thermodynamically (Li et al., 2017b, Li and 
Springer, 2017). These studies revelaed that K562 cell expressing α5β1 integrins have a 
4,000-fold higher affinity towards fibronectin in the EO conformation than in the BC or EC 
states and the energetically limiting step in integrin activation is the extension of the 
extracellular domains, as it requires a free energy of about 4 kcal/mol (Li et al., 2017b). 
Due to this energy barrier, the three activation states are distributed on the cell surface in 
a thermodynamic equilibrium where 99.75 % of the integrins are in the BC, 0.10 % in the 
EC and 0.15 % in the EO state. The high-affinity EO state is stabilized by the binding of 
adapter proteins such as talin and kindlin to the cytoplasmic tail and the application of 
relatively weak pulling forces (0-4 pN) from the actin cytoskeleton (Li and Springer, 
2017).  
Since the adhesive force generated by a single integrin is insufficient to firmly link a region of 
the cell membrane to the ECM, several integrins need to assemble into micro- or even macro-
clusters and thus provide stronger adhesion (van Kooyk and Figdor, 2000). Although the exact 
mechanisms for integrin clustering have not been resolved, there are two hypotheses how 
these assemblies could be initiated (Carman and Springer, 2003). The presence of multivalent 
ligand has been shown to recruit integrin clusters, thereby increasing adhesion strength by 6-
fold (Roca-Cusachs et al., 2009). This indicates that integrin clustering can be induced by 
extracellular cues such as high ligand density. Another hypothesis focuses on intracellular 
adaptor proteins such as talin and kindlin as potential mediators of integrin clustering. Talin is 
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able to form dimers via its C-terminal dimerization domain and a recent study demonstrated 
that kindlin-2 dimerizes via the N- and C-terminal halves of its F2 domain (Goult et al., 2013, 
Li et al., 2017a). It could be imagined that both mechanisms play a role and potentiate each 
other, especially considering the aforementioned distribution of integrin activation states. 
One integrin in the EO state could bind to its ligand, become stabilized in this conformation by 
talin or kindlin binding to its cytoplasmic domain, who then in turn increase their respective 
local concentrations by forming homodimers. This increase in local concentration leads to a 
higher probability of kindlin or talin binding to another integrin, stabilizing it in the EO state as 
well. The accumulation of several active integrins and adaptor proteins could trigger the 
recruitment of other adhesome proteins and the formation of mature focal adhesions. Finally, 
it is alos possible that transmembrane domaine association of integrin subunits contributes to 
clustering. 
 The integrin transmembrane domain and cytoplasmic tail 
Once activated, integrins assemble into small clusters and recruit adaptor and signaling 
proteins, the entirety of which has been termed the integrin adhesome (Zaidel-Bar and Geiger, 
2010). Nucleation of adhesome assembly occurs at the short cytoplasmic tails of integrins. Of 
particular importance are the integrin β-subunits, which control the activation of integrins. 
The tail sequences of the different β subunits show a high degree of similarity, especially in 
the membrane proximal region (Moser et al., 2009). Most integrin β-tails contain two 
canonical NxxY-motifs, which serve as binding sites for phosphotyrosine binding (PTB) 
domains including the integrin activators, talin and kindlin (Calderwood et al., 2003). While 
the membrane-proximal NPxY motif has been shown to bind the FERM domain of talin 
(Calderwood et al., 1999), the membrane-distal NxxY motif binds the FERM domain of kindlin 
(Moser et al., 2008, Nikolopoulos and Turner, 2000b).  
The canonical model for integrin activation, established mainly through studies on αIIbβ3 
dimers, states that in the inactive, low-affinity conformation, the transmembrane domains of 
integrin α and β subunits are tightly associated through GxxxG dimerization motifs (termed 
the outer membrane clasp), and through a salt bridge in the region closer to the cytoplasm 
(inner membrane clasp). In this state, the αIIb helix is aligned with the plasma membrane, 
while the β3 helix is tilted in a 25° angle relative to the α helix (Yang et al., 2009, Lau et al., 
2009).  
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It has been proposed that, upon binding of activating molecules like talin, the tilt is reduced, 
destabilizing the inner membrane clasp and leading to a separation of the helices, which 
converts the integrin extracellular domain into an active state and probably promotes 
clustering (Ye et al., 2014). However, it remains unclear how universally applicable this 
mechanism is to other types of integrins, since it has lately been shown that in β1-containing 
integrins,  lysine-752, which appears to be conserved in β1 and β3, displays opposite roles (Lu 
et al., 2016). Despite their high sequence homology, β1 and β3 transmembrane and 
cytoplasmic domains (TMCyto) display differences in biological functions and potentially in 
the structures they form.  
 
 
Figure 2: Sequences and structures of β1 and β3 transmembrane and cytosolic domains (TMCyto) (A,B (Lu et 
al., 2016), C (Lau et al., 2009)). (A) Within the amino acid sequences, the NxxY motifs (blue boxes) and the helical 
parts of the structures (red boxes) are highlighted, as well as the conserved lysine residue(red) and the residue 
at which the structure depicted in (C) ends (blue). NMR structures of the monomeric β TMCyto domains (B) 
reveal that the helical parts span the plasma membrane (blue) and extend well into the cytosol (red), while the 
remainders of the cytoplasmic tails are unstructured. An NMR structure of the transmembrane domains of an 
αIIbβ3 dimer (C) shows the orientations and interactions of the two subunits. Notably, the β3 helix is tilted in a 
25° angle relative to the αIIb helix PDB 2K9J).  
 
1.2 The integrin-proximal adhesome complex 
Integrin tails lack enzymatic and actin-binding activities and hence rely on the recruitment of 
adhesome components acting as adaptor and signaling molecules for signal propagation. 
Initially, these signaling hubs (termed the adhesome) are small (<0.25 µm) and short-lived (<1 
min). They are called nascent adhesions (NA) and can eventually mature into larger and 
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longer-lived focal adhesions (FAs) (Vicente-Manzanares et al., 2009). While most NAs dissolve, 
a few associate with the F-actin cytoskeleton and recruit further adhesion proteins like tensin 
or α-actinin, EPLIN and other LIM domain containing proteins, which reinforce their 
attachment to the actin fibers. High-resolution quantitative mass spectrometry has revealed 
that a set of core proteins leads to the formation of NAs and the tension-dependent 
recruitment of further proteins including 24 LIM domain-containing proteins. This recruitment 
finally results in the maturation of NAs into FAs (Schiller et al., 2011, Kuo et al., 2011). To date, 
a minimum of 245 proteins are recruited to integrin adhesion sites (Schiller et al., 2013). They 
form an intricate protein network necessary for signaling, cytoskeletal organization and 
mechanotransduction, thereby inducing downstream functions such as cell migration, 
differentiation, proliferation and survival (Engler et al., 2006, Wozniak and Chen, 2009).  
 
Figure 3: Overview of central integrin adhesome components and their reported interactions. THD (only the 
head domain is depicted for simplicity) and kindlin interact directly with the integrin β cytoplasmic domain and 
recruit other proteins to the adhesion site. Among these are paxillin, focal adhesion kinase (FAK), the IPP complex 
(ILK, PINCH, parvin), EPLIN (epithelial protein lost in neoplasm) and RSU-1 (ras-suppressor protein). The dashed 
lines represent reported interactions between individual components, the green letters indicate the references. 
a (Anthis et al., 2009), b (Lawson et al., 2012), c (Hoellerer et al., 2003), d (Moser et al., 2009), e (Theodosiou et 
al., 2016), f (Fukuda et al., 2009), g (Huet-Calderwood et al., 2014, Fukuda et al., 2014), h (Wang et al., 2008, 
Lorenz et al., 2008), i (Karakose et al., 2015), j (Dougherty et al., 2005), k (Stiegler et al., 2013) 
Due to the high complexity, dynamics, size and co-existence of various adhesion sites, it is 
difficult to determine and characterize the protein-protein interactions in NAs and FAs using 
conventional means such as microscopy of fluorescently tagged FA components or pull-down 
experiments. Therefore, most attempts at structural analysis have been conducted on a set of 
proteins identified as “key components” for integrin activation and signaling. Among these 
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are talin, kindlin, paxillin, focal adhesion kinase (FAK), the IPP (integrin-linked kinase (ILK), 
PINCH, parvin) complex, EPLIN, RSU1, vinculin, zyxin, CAS, α-actinin and tensin (Hoffmann et 
al., 2014).  
 Talin and kindlin activate integrins through interactions with the integrin 
cytoplasmic tail 
Among the proteins composing the integrin adhesome, talin and kindlin are the two 
components most crucial for integrin activation by directly interacting with the cytoplasmic 
tail. Talin acts not only as an integrin activator, which has been shown in knockout and 
knockdown experiments, but also connects the integrin with the actin cytoskeleton and 
mediates force transduction (Priddle et al., 1998). In vertebrates, there are two talin isoforms, 
the ubiquitously expressed talin1, and talin2, which is the prevailing form in muscle cells 
(Debrand et al., 2009). The kindlin protein family comprises three members in mammals, 
kindlin-1 which is mainly expressed in epithelial cells of skin, intestine and kidney, kindlin-2, 
which is ubiquitously expressed, and kindlin-3, which is only found in cells of hematopoietic 
lineages (Ussar et al., 2006). Like talin, kindlin binds directly to integrin tails, but neither is 
sufficient to activate fibronectin-binding integrins on its own (Theodosiou et al., 2016). 
Furthermore, integrins which where “forced” into the EO state by the addition of Mn2+ ions 
did not display full adhesive capacity when either talin or kindlin were depleted, indicating 
that the aforementioned stabilization of the EO state by the two adaptor proteins is essential 
for integrin activation. Therefore, it can be assumed that kindlin and talin act synergistically 
for maintaining the high-affinity EO state of integrins and thus form the “inner core” of the 
adhesome. 
 Talin structure and interactions with the integrin tail  
Talin is a large (~270 kDa) protein comprised of a C-terminal rod domain of about 220 kDa and an N-
terminal head domain (THD) of about 47 kDa, which are connected via a long and probably 
unstructured linker (Rees et al., 1990). THD consists of a FERM (4.1, ezrin, radixin, moesin) domain that 
contains three subdomains (F1, F2, F3) and an additional F0 subdomain, which has a ubiquitin-like 
structure. The large rod domain encompasses 13 R-domains composed of 4-5 α-helices each and an 
actin binding and dimerization domain (DD) at the C-terminus.    
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Figure 4: Crystal structure of the tain-1 head domain (PDB 3IVF) and model of full-length talin (Elliott et al., 
2010, Calderwood et al., 2013). The talin head domain comprises an elongated FERM domain (F1, F2, F3) and an 
N-terminal F0 domain. A flexible, unstructured loop in the F1 domain was deleted for crystallization and is missing 
in the structure. THD is connected via a long, unstructured linker with the rod consisting of 13 helical bundle 
domains (R1-13) and the C-terminal dimerization domain (DD). There are two integrin binding sites in the F3 
domain and in R11-R12, three actin binding sites in the FERM domain, in R4-R8 and in R13-DD.  
Binding to β-integrin tails is accomplished via the F3 subdomain, which forms a PTB domain, 
and via a proposed second integrin binding site within the rod domain (Calderwood et al., 
2003). When talin function is not required, it is believed to be in an autoinhibited state where 
its C-terminus interacts with the PTB domain, preventing β-tail binding by the FERM domain 
(Goksoy et al., 2008). The second integrin binding site, however, should still be accessible in 
this conformation. Talin connects to F-actin via three proposed binding sites in the FERM 
domain, in the rod domains R4-R8 and in the actin binding and dimerization domain 
(Calderwood et al., 2013). Further reinforcement of actin binding is accomplished through 
interaction with actin-binding adapter molecules such as vinculin, for which there are several 
binding sites in the rod domain (Schiller and Fässler, 2013). Most vinculin binding sites are 
cryptic and only become exposed when talin is extended and under force (del Rio et al., 2009). 
Furthermore, talin F3 domain has been shown to interact with the focal adhesion targeting 
(FAT) domain of FAK. The FAK binding site largely overlaps with the integrin binding surface in 
F3, probably excluding the binding of both partners at the same time (Lawson et al., 2012).  
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Due to the size of full-length talin and the 
corresponding difficulties in its 
recombinant production, the much smaller 
THD domain is used in most experiments 
that study integrin functions. After deletion 
of an unstructured loop in the F1 domain, 
the head domain of talin-1 was successfully 
crystallized and structurally characterized 
(Wegener et al., 2007, Elliott et al., 2010). 
Furthermore, the structure of the talin-2 
F2F3 domains in complex with β1D integrin 
tail has been solved, shedding light on the 
binding mode and important residues for 
interactions (Anthis et al., 2009). The 
reason for choosing the talin-2/β1D pair for 
crystallization is that at a KD of 36 µM it 
displays the highest affinity and thus the 
most stable complexes of all the talin-1/-
2 and β1A, β1D, β3 combinations (see Fig. 
5). The talin-1/β1A interaction in solution 
is extremely weak with a KD of 490 µM, 
which is surprising, since this talin-integrin pair is prevailing in most cell types. Talin F3 forms 
a narrow groove, which binds to the membrane-proximal NPxY motif, and additionally forms 
a salt bridge with the N-terminus of the cytoplasmic tail, close to the plasma membrane 
(Anthis et al., 2009).  
In β1A and β1D, the NPxY motif displays different conformations, resulting in higher binding 
affinity in the talin-2/β1D pair, which appears to be required in muscle tissue (Anthis et al., 
2010). Yet even this highest affinity indicates a surprisingly weak bond (36 µM), considering 
that it must withstand the traction forces from the actin cytoskeleton via the integrin tail.  
 
Figure 5: Crystal structure of the talin-2 F2 and F3 domains 
in complex with the β1D tail peptide (PDB 3G9W) (Anthis 
et al., 2009). Talin-2 and β1D are the prevailing variants in 
muscle tissue and display higher affinities than other talin-
integrin tail pairs. The sequence variations between β1A, 
β1D and β3 are displayed, as well as the binding affinities 
for the different variants. The crystal structure shows the 
binding pocket of talin-2 F3 (blue) with β1D peptide (red). 
The membrane-proximal NPxY motif essential for the 
interaction is highlighted in yellow. 
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 Kindlin structure and functions 
The kindlin family encompasses three different members, kindlin-1, -2 and -3. While kindlin-1 
is mainly expressed in epithelial cells and kindlin-3 in hematopoietic cells, kindlin-2 is almost 
ubiquitously expressed (Meves et al., 2009). Despite the high degree of similarity, the three 
kindlins also fulfill non-redundant functions, indicated by the observations that in the absence 
of one isoform, the other two cannot compensate for the loss (Karakose et al., 2010).  
 
Figure 6: Crystal structure of a kindlin-2 dimer in complex with the integrin β cytoplasmic tail (Li et al., 2017a). 
(A) For crystallization, a kindlin-2 construct was chosed in which the flexible loop inserted into the F1 domain as 
well as the PH domain were deleted. (B) Unlike talin, which displays an unusual, elongated structure of the FERM 
domain, kindlin adopts a classical, cloverleaf-like conformation. In the crystal structure, as well as in solution, 
kindlin-2 forms homodimers through the N- and C-terminal parts of the F2 domains. The cartoon in the upper 
right corner depicts the orientation of the domains as well as the potential position of the PH domain. (C) Similar 
to talin, kindlin-2 binds the membrane-distal NPxY motiv of the integrin β1 tail through a narrow groove in the 
F3 domain. Additionally, the TTV-motif directly upstream of the NxxY motif and the C-terminal EGK-motif are 
essential for kindlin-2 binding to the tail. (orange: integrin β1 cytoplasmic domain, blue: kindlin-2 F3 domain) 
Structurally, the kindlins are closely related to THD, sharing the 3-subunit FERM domain and 
the F0-subdomain, yet lack a rod domain. Like THD, kindlin also has a large unstructured region 
within the F1 domain. The most striking difference in comparison to THD is the pleckstrin 
homology (PH) domain, which is inserted into the F2 subdomain and binds 
phosphatidylinosotides in the plasma membrane. Like talin, kindlin interacts directly with β-
tails via the PTB fold in their F3 domains (Bottcher et al., 2009). Besides the membrane-distal 
NxxY motif, a TTV (β1) or STF (β3) motif upstream of it  are crucial for kindlin binding. 
Furthermore, it has been shown that the β1 tail’s COOH terminus is essential for kindlin 
binding and that the deletion of these residues reduces the affinity (Harburger et al., 2009). 
Recently, the crystal structure of kindlin-2 has been solved, using a construct in which the 
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flexible F1 linker and the PH domain had been deleted (Li et al., 2017a). This structure shows 
that in kindlin-2, as opposed to the elongated THD, the F0-F3 domains are arranged in a 
classical cloverleaf-like shape. Binding to the TTV or STF motif as well as to the membrane-
distal NxxY motif occurs in a narrow groove within the F3 domain and the Glu-796 residue of 
the C-terminal EGK motif in β1 is bound through backbone-backbone interactions (Figure 6C). 
Furthermore, the crystal structure as well as biophysical studies showed that kindlin-2 forms 
dimers through the N- and C-terminal parts of the F2 domain (Figure 6B). The formation of these 
dimers in solution is slow and occurs over several days, therefore the proposed function of 
the dimers in integrin clustering will have to be assessed in future studies. 
It has been shown that reduced levels of kindlin-2 cause disruption of the actin cytoskeleton 
and that, like talin, kindlin not only associates with F-actin indirectly through adapter proteins 
like α-actinin and migfilin, but also binds actin directly through its F0 domain (Tu et al., 2003, 
Has et al., 2009, Bledzka et al., 2016). Furthermore, kindlin-2 binding to ILK has been 
intensively studied, mapping the interaction surface with the ILK pseudokinase domain to a 
38-AA linker sequence between the N-terminus of the F2 domain and the PH domain in 
kindlin-2. It has been proposed that the interaction with ILK might be crucial for recruiting 
kindlin to focal adhesions and for enhancing kindlin-mediated integrin activation (Fukuda et 
al., 2014, Huet-Calderwood et al., 2014). Recently, direct interaction of kindlin-2 and paxillin 
has been demonstrated, revealing a mechanism through which paxillin is recruited to focal 
adhesions by kindlin (Theodosiou et al., 2016). 
 Importance of the plasma membrane for talin- and kindlin-mediated integrin 
activation 
The plasma membrane plays an important role in focal adhesion assembly, as several 
adhesome proteins, including talin, kindlin, ILK and FAK interact with phosphatidylinositol-
phosphates (PIPs) in the inner leaflet of the plasma membrane. These interactions are thought 
to recruit the proteins to the membrane and to ensure their correct orientation towards the 
integrin tail and each other. For talin-mediated integrin αIIbβ3 activation, the mechanism has 
been determined in great detail and demonstrates the importance of interactions with the 
membrane. Talin in its autoinhibited form, where positively charged residues in the F3 domain 
are bound to a negatively charged surface in the R9 domain, is located in the cytoplasm. The 
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same residues can bind to negatively charged phosphatidylinositol-4,5-bisphosphate (PIP2) in 
the plasma membrane, which probably disrupts its autoinhibition and orients talin towards 
the plasma membrane and the integrin tail (Legate et al., 2011, Goksoy et al., 2008). 
Mutations, which disrupt the F3-R9 interaction, have been shown to increase the rate of focal 
adhesion assembly (Kopp et al., 2010). Furthermore, experiments using β3-tails coupled to 
large unilamellar vesicles (LUVs) showed that PIP2 as well as the presence of negatively 
charged membrane lipids enhances talin affinity towards the tail (Moore et al., 2012). After 
disruption of the autoinhibited state, most likely mediated by interactions of the talin FERM 
domain with PIP2, talin F3 binds to the first NPxY motif and to the membrane-proximal region 
of the β tail, extending its transmembrane helix (Ye et al., 2016). Through the formation of a 
salt bridge with a conserved Asp residue, F3 domain binding reduces the tilt angle of the β3 
TM helix by 20° and disrupts the interaction of the integrin α and β TM domains (Anthis et al., 
2009, Ye et al., 2014).  
 
Figure 7: Mechanism of talin-mediated integrin activation (Anthis et al., 2009). (A) By interacting with 
negatively charged phosphatidylinositol-phosphates in the plasma membrane via positively charged residues in 
F2 and F3 (blue), THD is recruited and correctly oriented towards the integrin tail. Through the formation of a 
salt bridge with the β tail, talin reduces its tilt by 20° (C) and unclasps the α and β TM domains (B). The model is 
based on the NMR structure of the TM domains of αIIbβ3 (PDB 2K9J) overlaid with the x-ray structure of the 
talin-2 F2F3-β1D fusion construct (PDB 3G9W). 
Kindlins recognize PIP2 and phosphatidylinositol-3,4,5-trisphosphate (PIP3) via their F0 and PH 
domains and via an unstructured loop in the F1 domain. Moreover, there are indications of a 
conformational change in the PH domain following PIP3 binding which might be important for 
anchoring kindlin to the plasma membrane (Liu et al., 2011, Liu et al., 2012, Yates et al., 2012, 
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Bouaouina et al., 2012). These interactions with the plasma membrane have been shown to 
be essential for full co-activation of integrins by kindlin. NMR data suggests that, unlike talin, 
kindlin alone is not sufficient to unclasp αIIbβ3 TM domains.  Instead, it enhances activation 
by talin, however neither by increasing talin binding to the tail nor by facilitating talin 
localization to the membrane (Kahner et al., 2012). Also, no direct interaction of kindlin and 
talin has been reported so far, therefore the co-activating effect of kindlin might be derived 
from events occurring after talin binding to the integrin tail. It has been proposed that kindlin 
might also be involved in integrin clustering and to increase focal adhesion assembly via 
avidity effects. This might be achieved through kindlin dimerization, which bind to two integrin 
tails and thus initiate cluster formation, or through the recruitment of other adhesome 
components such as paxillin, ILK or migfilin (Das et al., 2013, Li et al., 2017a). 
 FAK 
FAK, a highly conserved non-receptor tyrosine kinase, plays a pivotal role in focal adhesions 
as a signaling switch and as a scaffolding molecule. It is ubiquitously expressed and essential 
for embryonic development (Ilic et al., 1995). FAK is composed of an N-terminal FERM domain, 
a 40 AA linker, a kinase domain, a long proline-rich low-complexity region and a C-terminal 
focal adhesion targeting (FAT) domain (Lietha et al., 2007). In its autoinhibited conformation, 
the FERM domain and the catalytic domain interact, keeping FAK inactive. Recent studies have 
shed some light on the proposed mechanism of FAK activation (Goni et al., 2014, Brami-
Cherrier et al., 2014).  
A patch of basic amino acids (KAKTLR) in the FERM F2 domain has been shown to bind PIP2 in 
the plasma membrane, inducing a “relaxed” conformation as well as transient FAK 
dimerization. Formation of dimers occurs via FERM:FERM as well as FERM:FAT or FAT:FAT 
contacts and facilitates phosphorylation of Y397 in the linker region between the FERM and 
kinase domain in trans. Together with three nearby PxxP motifs, phosphorylated Y397 leads 
to Src recruitment and activation by binding to its Src homology (SH2 and SH3) domains. Src 
in turn phosphorylates the Y576 and Y577 residues in the activation loop of the FAK kinase 
domain, which leads to further activation of FAK (Calalb et al., 1995). This FAK-Src complex 
then phosphorylates substrates such as paxillin and induces structural changes in the actin 
cytoskeleton (Schaller et al., 1995, Mitra et al., 2005).  
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The FAT domain is composed of a four-helix bundle and has been shown to bind to the LD 
(Leu-Asp-rich) motifs in paxillin (Hayashi et al., 2002). Of these five LD motifs at the N-terminus 
of paxillin, characterized by the consensus sequence LDXLLXXL, LD2 and LD4 have been shown 
to bind the FAT domain, which contains two paxillin binding sites (Scheswohl et al., 2008). 
NMR structures show that paxillin LD2 and LD4 peptides can bind simultaneously to the FAT 
domain (as displayed in Figure 8B), yet it is not clear whether this is a mechanism to recruit two 
paxillin molecules or whether one paxillin molecule binds both sites. 
 
Figure 8: Structure and proposed mechanism of activation of FAK (Lietha et al., 2007, Kleinschmidt and 
Schlaepfer, 2017). (A) FAK is composed of a FERM domain, a kinase domain and a FAT domain, which are 
connected via long linker regions. The C-terminal FAT domain contains two binding sites for the LD2 and LD4 
motifs of paxillin. Phosphorylation of Y925 creates a binding site for Grb2, which activates the MAPK pathway (B, 
PDB 2L6F). In its inactive, autoinhibited state, FERM and kinase domains are bound (C, PDB 2J0K). (D) Upon 
binding to PIP2 in the plasma membrane, FAK adopts a relaxed conformation and forms transient dimers through 
FERM:FERM and FAT:FAT contacts. This allows for Y397 autophosporylation in trans and a FERM:FAT interaction 
can be stabilized by paxillin. Phosphorylation of Phosphorylation of 397 creates a binding site for Src, which 
attaches via its SH2 and SH3 domains to phosphor-Y397 and three neighboring PxxP motifs. Src phosphorylates 
Y576 and Y577, which leads to full activity of FAK.  
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For the latter case, a model has been proposed that suggests paxillin bending around the FAT 
domain to occupy both binding sites (Bertolucci et al., 2005). Both paxillin binding sites are 
necessary for full activity of FAK, yet one site is sufficient for FA localization and even mutation 
of both sites still allows for FA targeting at 10 % efficiency compared to the wild type 
(Scheswohl et al., 2008). It appears that FAK is recruited to FA sites in part through complexes 
of integrin tails, kindlin and paxillin (Theodosiou et al., 2016). Paxillin facilitates recruitment 
of FAK to focal adhesions, yet it is not sufficient, since the deletion of other FAT binding 
partners prevents FAK recruitment to FAs (Miller et al., 2013). Therefore, the exact mechanism 
of FAK recruitment to FAs has yet to be resolved. It has further been proposed that the 
application of force induces detachment of the FERM and kinase domains and increases Y397 
phosphorylation (Zhou et al., 2015). 
 Paxillin 
Paxillin is an essential component of focal adhesions and functions as an adaptor or scaffold 
protein for focal adhesion components. Its N-terminus is composed of five Leu-Asp rich 
regions, referred to as LD1-5, which are heavily phosphorylated upon integrin activation and 
which mediate binding to kindlin, vinculin, ILK, FAK and parvin at defined and non-overlapping 
binding sites (Turner, 2000, Deakin and Turner, 2008). These LD motifs form amphipathic 
helices, as was shown in NMR structures (see Fig. 8B). Phosphorylation on Y31 and Y118 
enhances binding of FAK to the nearby LD2 and LD4 domains in an indirect manner and seems 
to play a role in focal adhesion maturation (Zaidel-Bar et al., 2007).   
NMR structures of the paxillin LD1, LD2 and LD4 motifs each in complex with the CH2 domain 
of α-parvin have been solved (Wang et al., 2008), showing that the CH2 domain displays the 
canonical CH fold with the unusual variation of the N- and C-terminal helices packing together 
to form a hydrophobic surface which allows LD1 binding. Through this interaction, paxillin 
recruits parvin to early focal adhesions (Nikolopoulos and Turner, 2000a). Due to large linker 
regions in between the LD motifs, the N-terminal half of paxillin appears to be largely 
unstructured, making the determination of a crystal structure difficult. It stands to reason that 
paxillin undergoes conformational changes upon binding to its interactors, resulting in a more 
defined structure. 
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Figure 9: Domain structure of paxillin and NMR structure of paxillin LD1 domain in complex with α-parvin CH2 
domain (PDB 2K2R) (Brown and Turner, 2004). Paxillin is composed of 5 LD-motifs at its N-terminus and of four 
Zn2+-binding LIM domains at its C-terminus, which mediate binding to many different adhesome components. 
There is no crystal structure yet of full-length paxillin, but the structures of different LD motifs have been 
determined in complex with interaction partners, like parvin CH2 domain.  
The C-terminal half of paxillin contains four LIM domains, which are each composed of two 
zinc-finger domains and a tight turn and which mediate protein-protein interactions 
(Schmeichel and Beckerle, 1994). The LIM2 and LIM3 domains play an important role in focal 
adhesion targeting, which can be regulated through their phosphorylation (Brown et al., 
1998). It has recently been demonstrated that the LIM3 domain of paxillin binds to kindlin-2 
in a Zn2+-dependent manner (Theodosiou et al., 2016). This binding poses a mechanism for 
paxillin recruitment to integrin tails, where it then carries out its role as central focal adhesion 
adapter molecule. 
 The IPP complex 
The heterotrimeric ILK/PINCH/parvin (IPP) complex has been shown to be pre-assembled in 
the cytoplasm of mammalian cells and is recruited to focal adhesions after integrin activation 
by talin and kindlin (Zhang et al., 2002, Hoffmann et al., 2014). The chief component of the 
IPP complex is Integrin-linked kinase (ILK), which, contrary to its name, contains a 
pseudoactive site and is incapable of catalyzing phosphorylation (Wickstrom et al., 2010). 
Instead, it plays an important role as scaffolding protein in a heterotrimeric complex with 
PINCH and parvin (IPP complex) and links integrins to the actin cytoskeleton and to adaptor 
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and signaling molecules (Qin and Wu, 2012). Of ILK, there is only one isoform in vertebrates, 
while there are two members of the PINCH family (PINCH-1 and -2) and three parvin isoforms 
(α-, β-, γ-parvin). PINCH-1 and -2 are equally expressed in adult tissues, as well as α- and β-
parvin, while γ-parvin is the predominant form in hematopoietic cells (Korenbaum et al., 2001, 
Legate et al., 2006). ILK can form complexes with different PINCH and parvin isoforms, which 
mediate varying downstream signaling effects.  
 
Figure 10: Structural properties of the IPP complex (Stiegler et al., 2013, Chiswell et al., 2008). (A) The 
heterotrimeric IPP complex is composed of ILK, PINCH and parvin. ILK Ankyrin repeat domain (ARD) binds to 
PINCH LIM1 domain, while the pseudokinase domain associates with the parvin CH2 domain. (B) The crystal 
structure of ILK-ARD/PINCH-LIM1 (PDB 4HI8) reveals that the five Ankyrin repeats in ILK are almost identically 
folded (C) and stack via α-helix contacts, leading to a concave, superhelical structure. The inside of this structure 
is termed “Ankyrin groove” and interacts with the Zn2+ binding side of PINCH LIM1, which is composed of a 
tandem-Zn-finger motif. (D) A SAXS analysis of a minimal IPP complex composed of full-length ILK, PINCH LIM1 
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domain and α-parvin CH2 domain revealed and envelope into which the two partial structures of ILK-ARD/PINCH-
LIM1 and ILK-PKD/parvin CH2 (determined by crystallization) were modeled, suggesting a compact structure. 
The 52 kDa protein ILK is composed of five N-terminal Ankyrin repeats (ANK), a short linker 
sequence and a C-terminal pseudokinase domain (PKD). The Ankyrin repeat domain binds to 
the first LIM domain of PINCH, which has been characterized by crystallization (Chiswell et al., 
2008). Ankyrin repeats consist of 33 AA stretches, which fold into hairpin-helix-turn-helix 
structures and which pack against each other through their α-helices, stacked in an antiparallel 
manner. In the overall structure, this leads to the formation of helical bundles arranged in a 
left-handed superhelical spiral, which resembles a cupped hand with the so-called “Ankyrin 
groove” on the concave side (Mosavi et al., 2004, Sedgwick and Smerdon, 1999). This groove 
contains the binding surface through which ILK attaches to PINCH (Chiswell et al., 2008). 
PINCH comprises five LIM domains, each composed of 55 AA tandem-Zn-fingers, which bind 
Zn2+ ions for stabilization. The Zn2+ binding sites in PINCH LIM1 are on the side that is facing 
the Ankyrin groove, allowing both zinc fingers to bind to ILK, while the C-terminal one has 
been shown in mutagenesis studies to be the more important one for binding (Velyvis et al., 
2001). In ILK, the Ankyrin repeats 2-5 directly interact with LIM1, with ANK4 providing the 
most important interactions. ANK1 is not directly binding to LIM1, yet mutagenesis studies 
showed it to be important for PINCH binding, suggesting that it might associate with LIM2 
domain, which is absent in the crystal structure. NMR structures of PINCH LIM1-4 have been 
determined (PDB: 1G47 (LIM1), 2D8X (LIM2), 2COR (LIM3), 1NYP/1U5S (LIM4)).  
Parvin consists of an N-terminal polypeptide stretch followed by two calponin-homology (CH) 
domains, of which the second binds the pseudokinase domain (PKD) of ILK. The ILK-PKD/α-
parvin-CH2 crystal structure (PDB 3KMW) not only revealed the structural basis for the 
interaction but also helped resolve the strongly debated question whether ILK is a real kinase 
or a pseudokinase (Fukuda et al., 2009). While the ILK PKD shows the conserved kinase domain 
fold with an ATP bound at the expected location, the catalytic loop is severely degraded and 
the key Asp and catalytic Lys and Asn residues are missing. Furthermore, the topologies of ATP 
and Mg2+ are altered and the activation segment is unusually short and lacks a conserved 
phosphorylation site. Finally, the fact that the crystal structure contains non-hydrolyzed ATP 
strongly indicates catalytic inactivity (Qin and Wu, 2012). In vitro, using the purified ILK 
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variants, no catalytic activity was observed, neither could a previously proposed interaction 
with PIP3 be verified (Fukuda et al., 2009).  
The binding site for α-parvin CH2 domain is formed by two conserved helices (αEF and αG) 
and part of the P+1 loop, which is the substrate binding site in active kinases (Fukuda et al., 
2011). The binding interface between ILK-PKD and parvin CH2 is large, which is typical for high-
affinity complexes (Lo Conte et al., 1999).  
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The binding interface for paxillin in the CH2 domain is not compromised by ILK binding 
suggesting that simultaneous binding of ILK and paxillin is possible (Wang et al., 2008). 
Furthermore, the ILK-PKD/α-
parvin CH2 complex was shown to 
interact with integrin β1 and β3 
tails in pull-down experiments, 
indicating that the integrin 
binding site on ILK is also non-
overlapping with the parvin 
binding site (Fukuda et al., 2009, 
Hannigan et al., 1996). Besides 
binding to ILK, α-parvin has been 
shown to interact with paxillin and 
F-actin simultaneously 
(Nikolopoulos and Turner, 2000a).  
The structure of the full-length 
heterotrimeric complex has not 
been solved yet due to problems 
in producing the components 
recombinantly. Even the 
pseudokinase domain of ILK, if 
produced alone in E. coli, is largely 
insoluble, while co-expression of 
the second parvin CH domain 
leads to soluble complexes 
(Fukuda et al., 2009). Stiegler et al. 
reported the successful 
production of a “minimal IPP complex” in E. coli, composed of full-length ILK, the α-parvin CH2 
domain and the LIM1 domain of PINCH1, facilitating SAXS analysis (Stiegler et al., 2013). 
Modeling of the two existing structures determined by X-ray crystallography (PDB 3F6Q, 
Figure 11: Crystal structure of the ILK pseudokinase domain in 
complex with α-parvin CH2 domain (Fukuda et al., 2009). (A) The ILK 
kinase domain displays a classical kinase structure, yet it has no 
catalytic activity. (B) The activation segment (displayed in green) is 
shorter and the conformation of the non-hydrolyzed ATP in the crystal 
structure is unusual, compared to the catalytically active protein 
kinase A (PKA). (C) The parvin CH2 domain binds to the helices αEF and 
αG and to part of the activation loop.  
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3KMU) into the obtained envelope suggests a compact conformation of the complex, with 
dimensions of 120x60x40 Å.  
A possible mechanism for the recruitment of the IPP complex to integrin tails is through 
binding to kindlin-2. In cells lacking kindlin-2, ILK and PINCH do not localize to adhesion sites 
(Montanez et al., 2008). This indicates that the direct interaction of ILK with the integrin tail 
might not be enough to recruit ILK from the cytoplasm, yet it is possible that IPP, which has 
been recruited to the focal adhesion through kindlin-2 or paxillin or a complex of both, might 
interact with the tail during later stages of adhesion maturation (Wickstrom et al., 2010).  
 The IPP-binding proteins EPLIN and RSU-1  
Epithelial protein lost in neoplasm (EPLIN) and ras suppressor protein 1 (RSU-1) has been 
identified as interaction partners of PINCH and also localize to FAs (Karakose et al., 2015). 
EPLIN was first found to be of interest in a screen for proteins downregulated in human cancer 
cells, as its name implies (Maul and Chang, 1999). It is composed of a central LIM domain and 
two actin-binding domains (ABD) at the N- and C-termini and exists in two splice variants, the 
90 kDa EPLIN-α and the 110 kDa EPLIN-β. EPLIN has been shown to bundle F-actin fibers via 
its two ABDs and also to influence nucleation of G-actin (Maul et al., 2003).  
Extracellular signal-regulated kinase (ERK) phosphorylates EPLIN at S362 and S604, thereby 
inhibiting F-actin binding and relocating EPLIN to the cell periphery (Han et al., 2007). There, 
it has been shown to co-localize with paxillin and to potentially stabilize FAs (Tsurumi et al., 
2014). The localization to adhesome complexes is probably mediated through interaction with 
PINCH, which was identified by interactome studies on PINCH as well as in assays with cells 
depleted of PINCH, where EPLIN did not localize to FAs any more (Karakose et al., 2015). 
Furthermore, depletion of EPLIN significantly reduces cell adhesion, spreading and migration. 
Recently, the phosphatase CDC14A has been shown to de-phosphorylate EPLIN, thereby 
controlling the actin-bundling effect of EPLIN (Chen et al., 2017).  
Ras suppressor protein 1 (RSU-1) was originally identified as a protein, which can inhibit 
transformation by Ras (Cutler et al., 1992). It is highly conserved, expressed in various 
mammalian cells and comprises 7 leucine-rich repeats (LRR) (Ito et al., 2010). These LRR motifs 
can be found in various proteins and have been shown to mediate protein-protein interactions 
(Kobe and Kajava, 2001). RSU-1 interacts with the LIM5 domain and the short C-terminal part 
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of PINCH-1, which are both required for binding (Dougherty et al., 2005). Since the short C-
terminal region is only present in PINCH-1 but not PINCH-2, the interaction of RSU-1 is 
restricted to PINCH-1.  
Studies on cells depleted of 
either RSU-1 or PINCH-1 
indicated that RSU-1 
localization to focal 
adhesions is dependent on 
PINCH-1 while depletion of 
RSU-1 had no effect on 
PINCH-1 recruitment (Ito 
et al., 2010). Therefore, the 
LIM1 domain of PINCH 
appears to be crucial for 
localization to focal 
adhesions through binding 
to ILK and for cell 
attachment, while LIM5 
through binding of RSU-1 is 
required for cell spreading. 
Furthermore, RSU-1 has 
been reported to regulate 
PINCH-1 levels and 
stability, which thereby 
affects and regulates the 
stability of the IPP complex 
as well (Gonzalez-Nieves et 
al., 2013).  
 
Figure 12: Structural details of EPLIN and RSU-1. (A) EPLIN consists of a 
central LIM domain and two actin binding domains at the N- and C-terminus. 
So far, only a solution structure of the Zn2+-binding LIM domain has been 
resolved (PDB 2D8Y), the remaining parts of the molecule are probably 
intrinsically disordered when not bound to a ligand. (B) RSU-1 has been shown 
to bind to PINCH-1 and contains 7 leucine-rich repeat (LRR) motifs of the 
consensus sequence LxxLxLxxN/CxL, where x can be any amino acid and L can 
also be replaced by I, F or V (LRR motif indicated in green). (C) Of RSU-1 there 
is no crystal structure known so far, but it can be expected to assume a similar 
fold as other LRR motif-containing proteins, like the internalin b leucine rich 
repeat domain (PDB 1D0B). Each LRR consists of one α helix and one β strand, 
which are each stacking to form a bent, arc-like structure. 
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1.3 Experimental approaches for studying protein-protein interactions in vitro 
Assembly of the integrin adhesome is based on various protein-protein interactions, with 
individual components exerting catalytical or scaffolding functions, or both, as is the case for 
FAK. Therefore, understanding which proteins interact with each other to form the large multi-
protein adhesome complexes or smaller subcomplexes is essential for reconstructing the 
events that lead to FA assembly and function. There are several well-established methods to 
study protein-protein interactions in vitro using recombinant proteins. Which of these 
methods is best suited for studying an interaction depends on the characteristics of the 
recombinantly produced proteins. As a first indication whether two proteins interact, pull-
down assays are used in which one potential binding partner is immobilized on a surface (e.g. 
beads) and incubated with the potential binding protein. If there is an interaction, both 
proteins can later be co-eluted. Although this method is very crude and prone to non-specific 
interactions with the bead material, it is a good screening tool to find interactions which merit 
further study. Classical biophysical methods for detecting and quantifying protein-protein 
interactions are surface plasmon resonance spectroscopy (SPR), isothermal titration 
calorimetry (ITC), microscale thermophoresis (MST) or analytical ultracentrifugation (AUC). 
These approaches allow not only the detection of an interaction but also the determination 
of biniding affinities and in some cases also stoichiometry and kinetic parameters such as on- 
and off-rates. All of these methods possess advantages and caveats, such as the high sample 
consumption in ITC or the occurrence of non-specific interactions with the chip surface in SPR. 
Therefore, it is difficult to predict which method will be best suited for measuring a specific 
protein-protein interaction and ideally, several orthogonal methods should be applied to 
identify potential artifacts.  
The aforementioned methods are well suited for studying the binding modes and affinities of 
protein-protein interactions, however they do not provide structural information, like 
interfaces involved in the interaction, orientation of the proteins in the complex or 
conformational changes. These questions are classically answered through X-ray 
crystallography, NMR spectroscopy or Cryo-electron microscopy (Cryo-EM). Recently, another 
approach to gain information on the native structure of protein complexes by chemical 
crosslinking and subsequent mass spectrometric analysis has been developed (Herzog et al., 
2012, Leitner et al., 2010). After assembly or isolation of protein complexes with several 
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components, the structures are fixed by chemically crosslinking lysine residues, which are a 
specific distance (25-30 Å, dependent on the crosslinker) apart from each other. The 
crosslinked sample is proteolytically cleaved into peptides, which retain the crosslinks and can 
thus be identified by mass spectrometric analysis. This allows the identification of protein 
surfaces, which are located in close proximity within the complex, as well as conformational 
changes in single components, induced by binding to other proteins. The crosslinks can be 
displayed in existing partial structures of the proteins in the complex and allow the generation 
of a model.  
 
1.4 Aims of the thesis 
The integrin adhesome is a highly complex and versatile assembly of proteins with signaling, 
scaffolding and force-transducing properties. The innermost components, whose deletion 
causes severe defects in cell adhesion and migration, have been identified in numerous 
studies, yet little is known regarding the architecture of the complex. Due the high amount of 
different proteins in focal adhesions in cells it is difficult to pinpoint which components 
interact directly and in which sequence and stoichiometry. One way to investigate direct 
binding can be done by reconstructing adhesome complexes in vitro using recombinant 
proteins.  
The first aim of my thesis was the recombinant production and purification of the innermost 
components of the integrin adhesome. I established protocols for obtaining purified and 
active full-length FAK, EPLIN and the heterotrimeric IPP complex at >90 % purity. Recombinant 
THD, kindlin-2 and paxillin were purified according to already established protocols. 
The second aim was the detection and characterization of protein-protein interactions among 
these adhesome components and towards the integrin tail. Furthermore, I assembled 
complexes of adhesome proteins in order to gain structural information via chemical 
crosslinking and LC-MS/MS analysis.  
For the third aim of my thesis I established a platform for studying the interactions of 
adhesome components with integrin tails embedded into a lipid bilayer. For this, I 
incorporated integrin transmembrane and cytoplasmic domains, which can be selectively 
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inserted into Nanodiscs composed of varying lipid compositions. This system can be used to 
test the binding of individual components as well as complex assembly around integrin tails 
by pull-down experiments as well as single-molecule microscopy. 
The fourth aim was to express and purify talin-integrin fusion constructs, which can be used 
in optical tweezer experiments. This set-up simulates the traction force on the talin-integrin 
bond as it is inside the cell, including a so-far neglected element of integrin dynamics. 
Furthermore, it can be used to study and characterize the bond in presence of kindlin-2 and a 
lipid bilayer. 
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2 Material and Methods 
2.1 Materials 
 Buffers and gels 
Buffers for recombinant protein purification 
Kindlin, talin, PINCH, paxillin, EPLIN  
A1 20 mM Tris, 500 mM NaCl, 1 mM TCEP, pH 7.5 
A2 20 mM Tris, 500 mM NaCl, 500 mM imidazole, 1 mM TCEP, pH 7.5 
A3 20 mM Tris, 200 mM NaCl, 1 mM TCEP, pH 7.5 
IPP complex 
B1 50 mM HEPES, 150 mM NaCl, 10 µM ZnCl2, 0.1 % Tween-20, 1 mM TCEP, 1 mM PMSF, 
pH 7.5 
B2 50 mM HEPES, 150 mM NaCl, 10 µM ZnCl2, 0.05 % Tween-20, 1 mM TCEP, pH 7.5 
B3 50 mM HEPES, 150 mM NaCl, 500 mM imidazole, 10 µM ZnCl2, 0.05 % Tween-20,  
1 mM TCEP, pH 7.5 
B4 50 mM HEPES, 150 mM NaCl, 1 µM ZnCl2, 0.05 % Tween-20, 1 mM TCEP, pH 8.5 
B5 50 mM HEPES, 150 mM NaCl, 500 mM imidazole, 1 µM ZnCl2, 0.05 % Tween-20,  
1 mM TCEP, pH 8.5 
FAK 
C1 50 mM Na-phosphate, 350 mM NaCl, 5 % glycine, 5 % mannitol, 1 mM TCEP, pH 7.5 
C2 50 mM Na-phosphate, 350 mM NaCl, 500 mM imidazole, 5 % glycine, 5 % mannitol,  
1 mM TCEP,  pH 7.5 
TMCyto constructs 
D1 50 mM HEPES, 150 mM NaCl, 0.1 % Triton-X100, pH 7.5 
D2 50 mM HEPES, 150 mM NaCl, 3 % EMPIGEN, 1 mM TCEP, pH 7.5 
D3 50 mM HEPES, 150 mM NaCl, 1.5 % EMPIGEN, 1 mM TCEP, pH 7.5 
D4 50 mM HEPES, 150 mM NaCl, 500 mM imidazole, 1.5 % EMPIGEN, 1 mM TCEP, pH 7.5 
D5 20 mM MES, 60 mM NaCl, 1.5 % EMPIGEN, 1 mM TCEP, pH 5.5 
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D6 20 mM MES, 1 M NaCl, 1.5 % EMPIGEN, 1 mM TCEP, pH 5.5 
Nanodiscs 
Cholate buffer 20 mM Tris, 100 mM NaCl, 100 mM Cholate, pH 7.5 
Nanodisc buffer 20 mM HEPES, 150 mM NaCl, 0.5 mM EDTA, pH 7.5 
Cytobuffer 139 mM K2HPO4, 8.8 mM NaH2PO4, 0.4 mM MgCl2, 3.2 mM NaCl,  
pH 7.5 
PBS   10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4 
NHS labeling buffer 20 parts PBS + 1 part 200 mM NaHCO3, pH 9.0 
 
Agarose Gel electrophoresis 
1x TAE buffer            40 mM Tris, 20 mM acetic acid, 1 mM EDTA 
6x DNA sample buffer 0.2 % (w/v) Orange G, 60 % (w/v) glycerol, 60 mM EDTA 
Agarose gel   1 % (w/v) agarose in 1x TAE buffer, 1 µl ethidium bromide per 
     10 ml gel volume  
 
SDS-PAGE 
1x SDS running buffer 25 mM Tris, 192 mM Glycine, 0.1 % (w/v) SDS 
1x Tricine running buffer 25 mM Tris, 25 mM Tricine, 0.05 % (w/v) SDS 
5x SDS sample buffer  250 mM Tris/HCl, pH 8.0, 7.5 % (w/v) SDS, 25 % (v/v) glycerol, 
(reducing)   0.25 mg/ml bromophenol blue, 12.5 % (v/v) 2-mercaptoethanol 
4x Lower Tris    1.5 M Tris/HCl, pH 8.8 
4x Upper Tris    0.5 M Tris/HCl, pH 6.8 
Tricine Tris    2.5 M Tris-HCl, pH 8.8 
Coomassie staining solution 10 % (v/v) acetic acid, 25 % (v/v) isopropanol,  
0.1 % (w/v) Coomassie Brilliant Blue R-250 
Coomassie destaining solution I 10 % (v/v) acetic acid, 25 % (v/v) isopropanol 
Coomassie destaining solution II 10 % (v/v) acetic acid 
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Table 1: Composition of gels used for SDS-PAGE. The amounts given are sufficient for 2 separating gels (10 ml 
total) and 2 stacking gels (5 ml).  
SDS gels  
 
Separating 
gel 
ddH2O 
(ml) 
30 % Acrylamide/Bis 
(ml) 
Lower Tris 
(ml) 
20 % SDS 
(µl) 
10 % APS 
(µl) 
TEMED 
(µl) 
10 % 4.15 3.3 2.5 50 50 5 
12 % 3.45 4.0 2.5 50 50 5 
15 % 2.45 5.0 2.5 50 50 5 
 
Stacking gel ddH2O 
(ml) 
30 % Acrylamide/Bis 
(ml) 
Upper Tris 
(ml) 
20 % SDS 
(µl) 
10 % APS 
(µl) 
TEMED 
(µl) 
4 % 3.1 0.65 1.25 50 37 7.5 
 
Tricine gels 
 
% gel ddH2O 
(ml) 
30 % Acrylamide/Bis 
(ml) 
Tricine Tris 
(ml) 
- 10 % APS 
(µl) 
TEMED 
(µl) 
16 % 0.22 5.33 4.3  50 6 
4 % 3.42 0.66 0.76  50 6 
 
Silver staining  
Fixing solution   13.5 % (v/v) formalin, 40 % (v/v) methanol 
Na2S2O3 solution   0.02 % (w/v) Na2S2O3 in H2O 
AgNO3 solution   0.1 % (w/v) AgNO3 in H2O 
Developing solution 3 % (w/v) Na2CO3, 0.05 % (v/v) formalin,  
0.000016 % (w/v) Na2S2O3 
Stop solution    50 % (v/v) ethanol, 15 % (v/v) acetic acid 
100 % TCA solution   1 g/ml TCA in ddH2O 
 
Western Blotting 
Western Blot transfer Buffer  25 mM Tris, 192 mM Glycine, 10 % (v/v) methanol 
PBS     4 mM KH2PO4, 16 mM Na2HPO4, 115 mM NaCl, pH7.4 
PBS-T     PBS, 0.1 % (v/v) Tween-20 
Blocking solution   4 % (w/v) non-fat dried milk powder in PBS-T 
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 Media and cell culture materials 
DMEM, 4.5 g/l Glucose, GlutaMax   Gibco, 31966-021 
Fetal bovine serum     Gibco, 10270-106 
FreeStyle 293 Expression Medium    Thermo Fisher, 12338001 
(HEK293E suspension culture)   
EX-CELL 405 Serum-Free Medium    Sigma-Aldrich, 14405C 
(High Five Insect cells)    
LB medium  1 % (w/v) tryptone/peptone, 1 % (w/v) 
NaCl, 0.5 % (w/v) yeast extract 
LB-agar plates      LB medium with 5 g/l agar 
5ml Costar Stripette     Corning, 4487 
15ml Costar Stripette     Corning, 4488 
25ml Costar Stripette     Corning, 4489 
15ml tube      Corning, CLS430791 
50 ml tube      Corning, CLS430829 
75 cm2 Falcon Tissue Culture Treated Flask  Corning, 10-126-11  
175 cm2 Falcon Tissue Culture Treated Flask Corning, 10-126-13  
Cellfectin II      Invitrogen, 10362100 
Geneticin (G418 Sulfate, 50 mg/mL)   Gibco, 10131027  
Penicillin/ Streptomycin (100x)   PAA, P11-010 
PEI (linear, 1 mg/ml in ddH2O)   Polysciences, 23966  
PEI MAX 40000 (Polyethylenimine HCl MAX, Polysciences, 24765-2 
Linear, Mw 40,000)   
Pluronic F-68 Non-ionic Surfactant (100X)  Gibco, 24040032   
Trypsin / EDTA (10x)     Gibco, 15400-054 
Vi-CELL XR      Beckman Coulter, 383556 
 
 Antibodies 
All antibodies used (except anti-His6and anti-GST) were directed against the focal adhesion 
components from mouse.  
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Table 2: Antibodies used for detection of recombinant focal adhesion components in Western Blot 
Protein detected Host Dilution for WB Source 
FAK rabbit 1 : 1000 Cell signaling, 3285S 
GST mouse 1 : 2500 Novagen, 71097-3 
ILK mouse 1 : 5000 Transduction laboratories, 611803 
kindlin 2 mouse 1 : 1000 Merck Millipore, MAB2617 
α-parvin rabbit 1 : 1000 Cell signaling, 8190 
paxillin mouse 1 : 1000 Transduction laboratories, 610051 
PINCH mouse 1 : 1000 Transduction laboratories, 612710 
RSU-1 rabbit 1 : 1000 “self-made” by Fässler department 
THD rabbit 1 : 1000 “self-made” by Fässler department 
phospho-Tyr mouse 1 : 1000 Merck Millipore, 4G10, 05-321 
phospho-pax-Y31 rabbit 1 : 1000 Thermo Fisher, 44-720G 
phospho-pax-Y118 rabbit 1 : 1000 Thermo Fisher, 44-722G 
Src (pan) rabbit 1 : 1000 Thermo Fisher, 44-656G 
 
 Instruments 
Avanti J-25 centrifuge    Beckman Coulter  
Avanti J-26S XP centrifuge    Beckman Coulter  
CD spectrometer Jasco J-715    Jasco 
Dynamic Light Scattering (DLS)    Wyatt 
DynaPro Nanostar  
EasyPure II LF ultrapure water system  Barnstead 
Eppendorf 5424R centrifuge    Eppendorf 
Eppendorf 5804R centrifuge    Eppendorf 
Epson Perfection V550 Photo scanner  Epson 
ImageQuant LAS4000 Luminescent    GE Healthcare 
image analyzer   
Infors HT Minitron incubator    Infors 
JA-10 fixed-angle rotor    Beckman Coulter 
JA-25.50 fixed-angle rotor    Beckman Coulter 
microTOF mass spectrometer   Bruker 
Mini-PROTEAN Tetra      BioRad, 1658004 
Vertical Electrophoresis Cell  
Mini Trans-Blot Cell     BioRad, 1703930 
Monolith NT.115 Instrument, red-blue  Nanotemper, MO-G007  
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NGC Quest 10 Plus Chromatography system BioRad, #7880003 
Nanodrop 1000     Thermo Fisher 
Optima XL-100K ultracentrifuge   Beckman Coulter 
Prometheus NT.48 NanoDSF device   Nanotemper, PR001 
Sonopuls HD 2070 Sonicator    Bandelin 
with MS 73 Microtip   
SW 41 Ti Rotor, Swinging Bucket   Beckman Coulter, 331362 
T3 Thermocycler (PCR cycler)   Biometra 
 
 Organisms 
E. coli One Shot® ccdB Survival™ 2 T1R cells  Thermo Fisher, A10460 
E. coli DH10EmBacY     MultiBacTurbo kit, A. Craig & I. Berger 
E. coli Rosetta Bl21 (DE3) (F- ompT hsdSB   Merck Millipore, 70954-3 
(rB- mB-) gal dcm (DE3) pRARE (CamR))   
HEK293E-EBNA1  Obtained from Y. Durocher, 
Biotechnology Research Institute, 
National Research Council Canada, 
Montréal 
High Five insect cells     Thermo Fisher, B85502 
OmniMax cells  One Shot OmniMAX™ 2 T1R Chemically 
Competent E. coli, Thermo Fisher 
pirHC cells  pir+ cells, high copy number, MultiBacTurbo 
kit, A. Craig & I. Berger 
SF9 insect cells     Merck Millipore, 71104-3 
 
 Enzymes and commercial proteins 
(All restriction enzymes used for cloning were acquired from New England Biolabs) 
Benzonase Nuclease    Merck Millipore, 71205-3 
Calf intestinal alkaline phosphatase  NEB, M0290S 
Cre recombinase    NEB, M0298S 
Fast-Link DNA ligation kit   Lucigen, LK6201H 
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His-PreScission protease   GE Healthcare, 27-0843-01 
His-SenP2 (Sumo-protease)  MPIB Microchemistry Core Facility,  
(Reverter and Lima, 2004) 
His-TEV protease  MPIB Microchemistry Core Facility,  
(Kapust et al., 2001) 
LysC      Wako, LAL3933 
MSP1E3D1     Cube Biotech, 26156 
MSP2N2     Cube Biotech, 26176 
PfuUltra II Fusion HS DNA Polymerase Agilent, 600670 
RecA      NEB, M0249S  
SUMOstar Protease    Life Sensors, 4110 
T4-DNA polymerase    NEB, M0203S 
Trypsin     Promega, V5111 
 
 Columns for purification 
DextraSEC PRO2 desalting columns  AppliChem, A8710,0050 
ENrich SEC70     BioRad, 780-1070 
ENrich SEC650    BioRad, 780-1650 
HiLoad 16/600 Superdex 200 pg  GE Healthcare, 28989335 
HisTrap FF, 1 ml    GE Healthcare, 17-5319-01 
HisTrap HP, 5ml     GE Healthcare, 17-5248-02 
HiTrap Q HP, 1 ml    GE Healthcare, 17-1153-01 
HiTrap SP HP, 1 ml    GE Healthcare, 17115101 
 
 Fluorophores 
Alexa 488 NHS ester    Thermo Fisher, A20000 
Alexa 647 NHS ester    Thermo Fisher, A37573 
Alexa 647 Maleimide    Thermo Fisher, A20347 
Atto 565 NHS ester    Atto tec, AD 565-31 
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NT647 labeling kit    Nanotemper, L001 
 
 Miscellaneous 
1 kb plus DNA ladder    Thermo Fisher, 10787018 
BS3-H12/D12 crosslinker   Creative Molecules Inc., 001SS 
Cell scrapers     Sarstedt, 83.1830  
Dounce tissue grinder, 25 ml   Blaessig Glas 
Gel Filtration Standard   BioRad, 151-1901 
Immobilon P, PVDF membrane  Merck Millipore, IPVH00010 
MST capillaries, premium coated   Nanotemper, MO-K005 
(hydrophilic)     
nanoDSF Grade Standard capillaries  Nanotemper, PR-C002 
Ni-NTA Agarose beads   Qiagen, 30210 
Ni-NTA Sepharose High Performance GE Healthcare, 17-5268-01 
Precision plus protein standard   BioRad, 1610375 
Kaleidoscope    
Whatman Chromatography paper  GE Healthcare, 3030917 
Concentrators 
Amicon Ultra 4, 10 K    Merck Millipore, UFC801024 
Amicon Ultra 15, 10 K   Merck Millipore, UFC901024 
Amicon Ultra 15, 30 K   Merck Millipore, UFC903024 
Amicon Ultra 0.5 ml, 10 K   Merck Millipore, UFC501096 
Sterile filters 
Ultrafree-MC-GV, PVDF, 0.22 µm    Merck Millipore, UFC30GV00 
Millex GV, 0.22 µm PVDF     Merck Millipore, SLGV033RS 
Millex HA, 0.45 µm MCE     Merck Millipore, SLHA033SS 
Stericup and Steritop, 0.22 µm, GP    Merck Millipore, SCGPT05RE 
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Dialysis devices 
SnakeSkin Dialysis membranes, 10.000 MWCO  Thermo Fisher, 68100 
SnakeSkin Dialysis membranes, 3.500 MWCO  Thermo Fisher, 68035 
Slide-A-Lyzer Mini dialysis devices, 10K MWCO, 0.5 ml Thermo Fisher, 88401 
DNA purification 
QIAquick Gel Extraction Kit     Qiagen, 28706 
QIAprep Spin Miniprep Kit     Qiagen, 27106  
QIAquick PCR Purification Kit     Qiagen, 28106 
NucleoBond BAC 100      Macherey-Nagel, 740579 
NucleoBond Xtra Midi Plus     Macherey-Nagel, 740412.50 
Lipids and detergents  
DDM (n-Dodecyl-β-Dmaltopyranoside)   Anatrace, D310-25GM 
DMPC lipid (1,2-dimyristoyl-      Corden Pharma, LP-R4-B58 
sn-glycero-3-phosphocholine)     
DMPG lipid (1,2-dimyristoyl-     Avanti Polar Lipids, 240796 
sn-glycero-3-phospho-(1'-rac-glycerol)    
EMPIGEN BB (30.3 %)      Sorachim, EMP-100 
PI(4,5)P2 (1,2-dioctanoyl-sn-glycero-3-    Avanti polar lipids, 850185P 
phospho-(1'-myo-inositol-4',5'-bisphosphate))    
POPS (1-palmitoyl-2-oleoyl-      Avanti polar lipids, 840034P 
sn-glycero-3-phospho-L-serine)     
 
 Chemicals 
Acetic acid     Sigma-Aldrich, 33209 
Acetonitrile     Fluka, 34967 
Agarose, Ultra pure    Invitrogen, 16500-500 
AgNO3      Riedel-de Haen, 31630 
Ammonium bicarbonate   Fluka, 40867-50G-F 
Ammonium peroxodisulfate (APS)  Merck Millipore, 1.01201.0500 
Ampicilin     Sigma-Aldrich, A9518 
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Brilliant Blue R    Sigma-Aldrich, B0149 
Chloramphenicol    Sigma-Aldrich, C0378 
Chloroform     Merck Millipore, 1.02445.1000 
Chromosulfuric acid     Sigma-Aldrich, 27174 
(2-5% Na2Cr2O7 in 90% H2SO4)  
Ethanol     Sigma-Aldrich, 32205 
Ethidium bromide    Roth, 2218.2 
Formaldehyde, 37 %     Merck Millipore, 1.04003.1000 
Formic acid (FA)    Fluka, 56302 
Gentamicin solution (50 mg/ml)  Sigma-Aldrich, G1397   
Glycerol, 86 %     Roth, 4043.1 
Glycine     Sigma-Aldrich, 33226 
HCl, 37 %     VWR Chemicals, 20252.335 
HEPES      Biomol, 05288.100 
Imidazole     Merck Millipore, 1.04716.0250 
Immobilon Western     Merck Millipore, WBKLS0500 
chemiluminescent HRP substrate  
Iodoacetamide    Sigma-Aldrich; I6125-5G 
IPTG   
(Isopropyl β-D-1-thiogalactopyranoside) Thermo Fisher, R0392  
Isopropanol     Sigma-Aldrich, 33539 
Kanamycin     Sigma-Aldrich, K1876 
K2HPO4 * 3 H2O    Roth, 6878.1 
D-Mannitol     Sigma-Aldrich, M4125 
2-Mercaptoethanol    Merck Millipore, 805740 
MES      Merck Millipore, 1.06126.0025 
Methanol     Sigma-Aldrich, 32213 
MgCl2 * 6 H2O     Merck Millipore, 1.05833.1000 
NaCl      Roth, 3957.2 
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Na2CO3     Merck Millipore, 1.06392.1000 
NaHCO3     Merck Millipore, 6329.1000 
NaH2PO4 * H2O    Merck Millipore, 1.06346.1000  
NaOH      VWR Chemicals, 28245.298 
Na2S2O3* 5 H2O    Merck Millipore, 0077695 
NiSO4 * 6 H2O     Sigma-Aldrich, 31483 
Non-fat dried milk    AppliChem, A0830,0500 
Orange G     Roth, 0318.1   
PMSF       Sigma-Aldrich, P7626 
Rotiphorese Gel 30    Roth, 3029.1 
SDS pellets     Roth, CN30.3 
Sodium azide     Merck Millipore, 1.06688.0100 
Sodium cholate hydrate   Sigma-Aldrich, C6445 
Spectinomycin    Sigma-Aldrich, S2647 
Sucrose     Sigma-Aldrich, S7903 
TCEP      Roth, HN95.2 
TCEP (for crosslinking)   Perbio Science Germany; 0020490 
Trifluoro acetic acid    Thermo Scientific, 28904 
Titriplex III (EDTA)    Merck Millipore, 1.08418.1000 
Trichloroacetic acid TCA)   Merck Millipore, 1.00807.1000 
Tricine      Sigma-Aldrich, T0377 
Triton-X100     Roth, 3051 
Trizma base (Tris)    Sigma-Aldrich, T1503 
Tryptone/peptone    Roth, 8952.2 
Tween-20     Serva, 37470.01 
Urea      Sigma-Aldrich, U6504 
Yeast extract     Roth, 2363.3 
ZnCl2       Merck Millipore, 8816.0250 
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 Expression vectors and primers 
Table 3: List of expression vectors used, indicating expression system, resistance markers and purification 
tags.  
Name System Resistance Tag/Protease site 
pCoofy17-EPLIN E. coli Kanamycin N-His10-SUMO3 
pCoofy17-Kindlin2 E. coli Kanamycin N-His10-SUMO3 
pCoofy17-Paxillin E. coli Kanamycin N-His10-SUMO3 
pCoofy17-THD E. coli Kanamycin N-His10-SUMO3 
pCoofy55-FAK HEK293 Ampicillin N-His10-SUMOstar 
pET15b-TMCyto-b1-wt E. coli Ampicillin N-His6 
pET15b-TMCyto-b1-NPIA E. coli Ampicillin N-His6 
pET15b-TMCyto-b1-NPKA-TTAA E. coli Ampicillin N-His6 
pET15b-TMCyto-a5-wt E. coli Ampicillin N-His6 
pACEBac1-IPP Insect cells Gentamycin N-His6-PreScission 
pACEBac1-IPP-dLIM5 Insect cells Gentamycin N-His6-PreScission 
pIDS-K2-IntBeta-Pax Insect cells Spectinomycin N-GST-PreScission 
pIDK-RSU-EPLIN Insect cells Kanamycin / 
pIDC-FAK-Talin Insect cells Chloramphenicol / 
pCoofy17-Talin1-F3-b1A_long_link E. coli Kanamycin N-His10-SUMO3 
pCoofy17-Talin2-F3-b1D_long_link E. coli Kanamycin N-His10-SUMO3 
pCoofy17-Talin2-Head-b1D-
2ybbR-N-link 
E. coli Kanamycin N-His10-SUMO3 
pCoofy17-Talin2-Head-b1D-
2ybbR-F3-link 
E. coli Kanamycin N-His10-SUMO3 
 
Table 4: List of primers used for the construction of expression vectors  
Name Sequence Purpose 
PaKa53_SLIC_ 
FAK_rev 
5’- CCCCAGAACATCAGGTTAATGGCGTCAGTG 
TGGCCGTGTCTG -3’ 
Amplification of FAK from 
pCoofy18-mFAK 
PaKa135_SLIC_ 
FAK_pCoofy55_fwd 
5'- CTCATCGCGAACAGATTGGAGGAATGGCAG 
CTGCTTATCTTGACC -3’ 
Amplification of FAK from 
pCoofy18-mFAK 
PaKa81_LP2_ 
ccdB_fwd 
5’- CGCCATTAACCTGATGTTCTG -3’ 
Amplification of the pCoofy55 
backbone 
PaKa136_SLIC_ 
SUMOstar_rev 
5'- TCCTCCAATCTGTTCGCGATGAG -3’ 
Amplification of the pCoofy55 
backbone 
PaKa137_EPLIN_ 
planB_fwd 
5'- GGGATCCATGGAAAACTGTCTGGGAGATTCC -3’ 
Amplification of EPLIN from 
pET15b-EPLIN 
PaKa138_EPLIN_ 
PlanB_rev 
5’- CCCTCGAGTCATTCTTCATCCTCGTCCTC -3’ 
Amplification of EPLIN from 
pET15b-EPLIN 
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PaKa182_Insert_ 
TMCyto_pGEX_fwd 
5'- CCTGGGATCCGGTGGCGGTAGCGGCGG 
TGGCAGCCATGACAGAAGGGAATTTGCTA -3’ 
MultiBAC cloning 
PaKa183_Insert_ 
TMCyto_pGEX_rev 
5'- CAGCCTCGAGCTCATTTTCCCTCATACTTC -3’ MultiBAC cloning 
PaKa184_IPP_ 
Insect_PINCH_fwd 
5’- CACCGTCGACGTGTTCCAGCAGCAG -3’ MultiBAC cloning 
PaKa185_IPP_ 
Insect_PINCH_rev 
5’- TCGGCGGCCGCTCATTTCTCGAACTGCGGGTGGC 
TCCAACCGCTGCCTTCCTTCCTAAGGTCTCAGATAG -3’ 
MultiBAC cloning 
PaKa187_ 
ILK_pIDK_fwd 
5’- CTGTTCTCGAGGCCCATGGACGACATTTTCAC -3’ MultiBAC cloning 
PaKa188_ 
ILK_pIDK_rev 
5’- TCAGGCTAGCGGCGTTACTTGTCCTGCATC -3’ MultiBAC cloning 
PaKa189_Parva_ 
pIDK_fwd 
5’- GTGCCCTCGAGCGCCCCCATGGGATCCC -3’ MultiBAC cloning 
PaKa190_Parva_ 
pIDK_rev 
5’- TGATGCTAGCGCTCTTATATTCCCCAGAAC 
ATCAG -3’ 
MultiBAC cloning 
PaKa191_K2_ 
pIDK_fwd 
5’- GCAGCTCGAGGGAATGGCTCTGGACGGG -3’ MultiBAC cloning 
PaKa192_K2_ 
pIDK_rev 
5’- CAGGGCTAGCGCGTCACACCCAACCACTG -3’ MultiBAC cloning 
PaKa193_PAX_ 
pIDC_fwd 
5’- GTTCAGGCCTCCCATGGACGACCTCGATG -3’ MultiBAC cloning 
PaKa194_PAX_ 
pIDC_rev 
5’- TCAGTCTAGAGGCGTTAGCAGAAGAGCTTC -3’ MultiBAC cloning 
PaKa195_pIDK_ 
EPLIN_fwd 
5’- GTTCCTCGAGCAGACCGGTGGATCCATG -3’ MultiBAC cloning 
PaKa196_pIDK_ 
EPLIN_rev 
5’- GGTGGCTAGCTGCGAGTCATTCTTCATCCTCG -3’ MultiBAC cloning 
PaKa197_pIDK_ 
RSU_fwd 
5’- GGAGGCTAGCGACGAGGACACCATCGAC -3’ MultiBAC cloning 
PaKa198_pIDK_ 
RSU_rev 
5’- AGCTATGCATCCCCAGAACATCAGGTTAATGG -3’ MultiBAC cloning 
PaKa199_pIDC_ 
Talin_fwd 
5’- CAGCAGCGCTCCGGTGGAATGGTTGCGC -3’ MultiBAC cloning 
PaKa200_pIDC_ 
Talin_rev 
5’- TGGTTCTAGACGAGTGCGGCCGCTCAGC -3’ MultiBAC cloning 
PaKa201_pIDC_ 
FAK_fwd 
5’- GTTCGGATCCCCCATGGCAGCTGCTTATC -3’ MultiBAC cloning 
PaKa202_pIDC_ 
FAK_rev 
5’- GGTTTCTAGAGTCAGTGTGGCCGTGTCTG -3’ MultiBAC cloning 
PaKa203_pIDK_ 
IntBeta_fwd 
5’- GGAACTCGAGTTCATGTCCCCTATAC -3’ MultiBAC cloning 
PaKa204_pIDK_ 
IntBeta_rev 
5‘- TGCGCCATGGCGAGCTCATTTTCCCTCATAC -3’ MultiBAC cloning 
PaKa242_Mut_ 
LIM5_fwd 
5’- CTGTTTGGTGATGTTTGATTCCATTGCAACCGTG -3‘ Deletion of PINCH-LIM5 
PaKa243_Mut_ 
LIM5_rev 
5’- CACGGTTGCAATGGAATCAAACATCACCAAAC 
AG -3‘ 
Deletion of PINCH-LIM5 
PaKa231_SLIC_ 
linker1_Talinforce_fwd 
5’- GCTAGCGGTGGTGGTAGTGCCGGTG -3‘ 
Amplification of longer linker 
sequence for talin-integrin fusions 
PaKa232_SLIC_ 
linker1_Talinforce_rev 
5’- GCTACCTCCGCCAGATCC -3‘ 
Amplification of longer linker 
sequence for talin-integrin fusions 
PaKa233_SLIC_ 
Talin2_247_fwd 
5’- GGTGGTGGATCTGGCGGAGGTAGCTGTGG 
CCATGATCGTCGCG -3‘ 
Amplification talin2-integrin fusion 
backbone 
PaKa234_SLIC_ 
Talin2_247_rev 
5’- CACCGGCACTACCACCACCGCTAGCGCTTT 
GTTTCTTCTTAAGGATG -3‘ 
Amplification talin2-integrin fusion 
backbone 
PaKa235_SLIC_ 
Talin1_239_rev 
5’- CACCGGCACTACCACCACCGCTAGCGCTTT 
TTTTCTTCTTAAGGATG -3‘ 
Amplification talin1-integrin fusion 
backbone 
PaKa236_Insert_ 
ybbR_N_AgeI_fwd 
5’-  CCGGTGGAGACTCTCTGGAATTCATCGCTT 
CTAAACTGG -3‘ 
Cloning of talin-intergin fusion 
construct 
PaKa237_Insert_ 
ybbR_N_AgeI_rev 
5’-  CCGGCCAGTTTAGAAGCGATGAATTCCAGA 
GAGTCTCCA -3‘ 
Cloning of talin-intergin fusion 
construct 
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PaKa238_Insert_ 
ybbR_tail_MscI_fwd 
5‘- CGACTCTCTGGAATTCATCGCTTCTAAACTG 
GCTGG -3‘ 
Cloning of talin-intergin fusion 
construct 
PaKa239_Insert_ 
ybbR_tail_MscI_rev 
5‘- CCAGCCAGTTTAGAAGCGATGAATTCCAGAG 
AGTCG -3‘ 
Cloning of talin-intergin fusion 
construct 
PaKa240_SLIC_Talin_ 
ybbR_fwd 
5’- GGTGGTGGATCTGGCGGAGGTAGCGACTCTC 
TGGAATTCATCGC -3‘ 
Cloning of talin-intergin fusion 
construct 
 
 Software 
Bruker Compass DataAnalysis 4.2  Bruker 
Dynamics 7     Wyatt Technology 
Inkscape 0.92     https://inkscape.org/en/ 
ChromLab 4.0     BioRad 
MO-S001A MO.Affinity Analysis  Nanotemper 
MO-S001C MO.Control   Nanotemper 
PR-S01 PR.ThermControl   Nanotemper 
ProtParam tool    http://web.expasy.org/protparam/ 
Serial Cloner 2-6-1    SerialBasics 
Spectra Manager II    Jasco 
UCSF Chimera 1.10.2    http://www.cgl.ucsf.edu/chimera/ 
  
 
2.2 Methods 
 Molecular Biology Methods 
 Generation of chemically competent E. coli cells (OmniMax™, Rosetta™, pirHC) 
50 ml of LB medium were inoculated with an overnight culture of E. coli cells at a ratio of  
1:100 (v/v) and incubated at 37 °C while shaking, until an OD600 nm of 0.5 was reached. Then, 
the culture was centrifuged (4,000 x g, 4 °C, 10 min) and the pellet was resuspended in 40 ml  
0.1 M MgCl2 solution. After another centrifugation step, the pellet was resuspended in 20 ml 
50 mM CaCl2 solution and incubated on ice for 30 min. After centrifugation, the cells were 
resuspended in 2 ml 50 mM CaCl2, 15 % (v/v) glycerol and 100 µl aliquots were flash-frozen in 
liquid nitrogen. All reagents were passed through a 0.22 µm sterile filter prior to use.  
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 Transformation of chemically competent E. coli cells 
Either 1 µl of purified plasmid DNA or 10 µl of a ligation, SLIC, or mutagenesis reaction were 
added to one 100 µl aliquot of competent cells. After 25 min incubation on ice, the cells were 
subjected to a 45 sec “heat shock” at 42 °C, then cooled down again on ice. 500 µl of LB 
medium were added and the bacteria were incubated for 45 min at 37 °C and 650 rpm shaking 
in a heat block. Afterwards, the cells were pelleted (3 min, 4000 x g), resuspended in 50 µl LB 
and plated on LB-agar plates with the desired antibiotics for selection. The plates were 
incubated over night at 37 °C.  
 Analytical and preparative agarose gel electrophoresis 
1 % (w/v) agarose in 150 ml TAE buffer was heated in a microwave, until the agarose had been 
completely dissolved. The homogeneous solution was cooled down to 50-60 °C under running 
tap water, then mixed with 15 µl ethidium bromide and cast into a casting platform with a 
comb for either narrow or broad pockets (10 µl vs. 30 µl sample volume). After cooling down, 
the solid gel was placed in a running chamber filled with TAE buffer and loaded with the DNA 
samples. Prior to application on the gel, the DNA was mixed with 6x DNA sample buffer. The 
gel run was conducted at 150 V for approximately 1 h and the bands visualized on a UV light 
transilluminator at 366 nm.  
When a preparative gel electrophoresis was conducted, the desired bands were cut out of the 
gel using a scalpel and extracted from the agarose using a QIAquick PCR purification kit, 
according to the manual. This method is based on the immobilization of the desired DNA 
fragments on an ion exchange column, removal of unbound contaminants and elution of the 
purified DNA. 
 Preparation of plasmid DNA from bacterial cultures 
For small-scale preparation of plasmid DNA from 5 ml culture volume, the QIAprep Spin 
Miniprep kit was used. It combines alkaline lysis of the bacteria cells with ion exchange 
chromatography on spin columns, where only the DNA is bound. Contaminating proteins or 
RNA pass through the column, the DNA is washed and eluted in buffer of alkaline pH. 
For transient transfection of HEK293 cells, high amounts of plasmid DNA are necessary. 
Therefore, DNA was extracted from 500 ml cultures using the NucleoBond Xtra Midi Plus kit. 
The underlying purification principle is the same as for the Miniprep kit. 
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 Restriction digest of dsDNA 
For the insertion of DNA fragments into expression vectors, PCR products or vector DNA were 
digested with restriction endonucleases. These enzymes recognize specific DNA sequences 
and cut both strands, creating either blunt or cohesive ends, which can then be specifically 
joined with the desired complementary fragment. For a preparative digest, 2-3 µg of DNA 
were mixed with 10-20 units of restriction enzyme (or enzymes) and 10x reaction buffer (as 
recommended by the supplier). The samples were the incubated at the optimal reaction 
temperature (usually 37 °C) for 1-2 h and the desired fragments separated by agarose gel 
electrophoresis. These fragments were the extracted, purified and used for ligation. For 
analytical digests, 300-500 ng of DNA were digested with 5 units of restriction enzyme(s).  
 Polymerase chain reaction (PCR) 
For amplifying DNA fragments while optionally manipulating the flanking regions (inserting 
restriction sites, creating homologous regions for SLIC cloning etc.), PCRs were conducted.  
PCR reaction (50 µl): 
50 ng   Template-DNA 
5 µl              Pfu Ultra II reaction buffer  (10x) 
1 µl  Pfu Ultra II DNA Polymerase  (2.5 U/µl) 
1 µl   Primer fwd      (10 µM)  
1 µl   Primer rev      (10 µM)  
1 µl   dNTPs      (10 mM)  
x µl   ddH2O 
Program thermo-cycler: 
      95 °C  2 min 
      95 °C   20 s 
50-55 °C   20 s                     30 x 
      72 °C   20 s per 1 kb 
      72 °C  3 min 
        4 °C   hold 
The PCR reactions were analyzed by agarose gel electrophoresis and the desired bands were 
cut out and purified. 
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 Site-directed mutagenesis using QuikChange mutagenesis 
In order to introduce point mutations or to delete gene fragments, mutagenesis PCR was used. 
For this reaction, primers were designed with the desired mutation in the middle of the 
oligonucleotide, flanked by 15-20 bp complementary sequences on both sides.  
PCR reaction (50 µl): 
70 ng   Template-DNA 
5 µl              Pfu Ultra II reaction buffer  (10x) 
1 µl  Pfu Ultra II DNA Polymerase  (2.5 U/µl)  
1 µl   Primer fwd      (10 µM)  
1 µl   Primer rev      (10 µM)  
1 µl   dNTPs      (10 mM)  
x µl   ddH2O 
 
Program thermo-cycler: 
      95 °C  2 min 
      95 °C   20 s 
50-55 °C   20 s        18 x 
      72 °C  60 s per 1 kb 
      72 °C   10 min 
        4 °C    Hold 
The PCR reaction was digested with DpnI for 1 h at 37 °C. This enzyme cleaves only the 
methylated template DNA, but not the newly synthesized, mutated DNA strands, reducing the 
number of negative clones in the following transformation and selection process. 10 µl of the 
digested PCR reaction were added to one aliquot of chemically competent OmniMax cells.  
 DNA sequencing 
In order to confirm the successful generation of the desired expression constructs and to 
check for unwanted point mutations, the plasmid DNA was sequenced using one or more 
specific sequencing primers. The sequencing reaction and evaluation was carried out by the 
Microchemistry Core Facility of the MPI for Biochemistry or by Eurofins Genomics. The 
sequences were aligned using the Serial Cloner software.  
 DNA ligation 
DNA fragments were joined using Fast-Link DNA ligase. 100 ng of vector backbone DNA were 
mixed with a three-fold excess of insert DNA, calculated by formula (1).  
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m insert [ng] = 3 * m backbone [ng] * 
𝐿𝑒𝑛𝑔𝑡ℎ 𝑖𝑛𝑠𝑒𝑟𝑡 [𝑏𝑝]
𝐿𝑒𝑛𝑔𝑡ℎ 𝑏𝑎𝑐𝑘𝑏𝑜𝑛𝑒 [𝑏𝑝]
  (1) 
After addition of 2 µl 10x reaction buffer, 1 µl ATP (10 mM), 1 µl Fast-Link Ligase (2 U) and 
ddH2O to a final volume of 20 µl, the sample was incubated at RT for 20 min. 10 µl of the 
ligation reaction were added to 1 aliquot of chemically competent cells. 
 SLIC (Sequence- and ligation-independent cloning) (Li and Elledge, 2012) 
For insertion of DNA fragments into expression vectors with no suitable restriction sites at the 
desired location, SLIC cloning was used. The underlying principle of this method is the 
generation of identical sequences at the ends of two DNA fragments, followed by a 
homologous recombination event, which fuses the two fragments into one vector. The 
identical sequences that mediate the homologous recombination reaction have to be 
between 15-25 bp long.  
The desired DNA fragments or vector backbones were amplified by a PCR reaction using 
primers with the identical sequences at the termini. The bands of the correct sizes were 
excised from agarose gels, and then the SLIC reaction was carried out.  
100 ng  Backbone DNA 
x µl   Insert DNA (calculated using formula (1)) 
1 µl  RecA buffer (10X) 
1 µl  RecA  
y  µl  ddH2O (fill up to 10 µl) 
The reaction was incubated for 30 min at 37 °C and then the 10 µl were added to one aliquot 
of competent OmniMax cells. 
 De-phosphorylation of DNA 
In order to reduce re-ligation of vector backbones, the DNA was de-phosphorylated using calf 
intestinal alkaline phosphatase (CIP). 
30 µl  Vector DNA (after gel extraction) 
4 µl  CutSmart buffer (10X) 
1 µl  CIP (10 U) 
5 µl  ddH2O 
40 µl 
After 30 min incubation at 37 °C, the DNA was used for ligation. 
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 T4-DNA polymerase fill-in reaction 
For ligation of DNA fragments with non-compatible ends, i.e. blunt ends and 5’- overhangs, a 
fill-in reaction with T4-DNA polymerase was carried out. This enzyme recognizes 5’- overhangs 
and synthesizes the recessed strand in 5’ -> 3’ direction to form double stranded DNA with 
blunt ends.  
50 µl   digested sample (5’- overhang) 
1 µl  NEB Buffer (CutSmart or 3.1) 
2.4 µl  dNTPs (10 mM) 
1 µl   T4 DNA Polymerase (3U) 
5.6 µl  dH2O 
 60 µl 
The reaction was incubated for 20 min at 12 °C, followed by a heat inactivation step at 75 °C 
for 20 min. The remaining enzyme and excess dNTPs were removed using a PCR purification 
kit according to manufacturer’s protocol. 
 Vector fusion using Cre recombinase 
The enzyme Cre recombinase recognizes loxP sites in dsDNA and mediates site-specific 
recombination between two of these elements. Therefore, two vectors containing one single 
loxP site each can be fused into one large vector by Cre-mediated recombination. This method 
can be used for the fusion of up to four vectors simultaneously.  
1.5 µg  Vector A 
1.5 µg   Vector B 
(1.5 µg Vector C) optional 
(1.5 µg Vector D) optional 
2 µl  Cre recombinase Buffer 
1.5 µl   Cre recombinase (1.5 U) 
20 µl 
The reaction mix was incubated at 37 °C for 1 h and then used for the transformation of  
200 µl OmniMax cells. Clones carrying vector fusions were selected using a combination of the 
antibiotic resistance markers on the vectors used. 
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 Cell biology methods 
 Adherent cell culture 
Adherent HEK293T cells were maintained in DMEM, supplemented with 10 % (v/v) FBS and  
1 % (v/v) Penicillin/Streptomycin in a humidified atmosphere at 37 °C and 5 % CO2. For 
passaging, the cells were washed once with PBS, then incubated for 5 min at 37 °C with 
trypsinization solution (1x Trypsin/EDTA solution in PBS). The cells were detached by tapping 
on the culture flask, mixed with 3 parts culture medium, centrifuged at 300 x g, 5 min, 20 °C 
and resuspended in culture medium. The desired amount of cells was transferred to a new 
culture vessel and supplemented with culture medium.  
 Transient transfection of adherent HEK293T cells 
Cells were cultured to ~90 % confluence. 3 h prior to transfection (Tom et al., 2008a), the 
medium was changed to DMEM + 1 % FBS. For every 1 cm2 of growth area, 0.3 µg vector DNA 
was mixed with 17 µl PBS and 0.4 µl PEI solution (1 mg/ml), resulting in a DNA : PEI ratio of 1.5 
: 2. After 15 min incubation at RT, the transfection mixture was distributed dropwise across 
the growth area and the cells incubated for up to 7 days at 37 °C. Recombinant protein 
production was monitored by SDS-PAGE or western blotting after 3, 5 and 7 days.  
 Suspension culture of cells 
Protein production in suspension cells was carried out by Judith Scholz from the 
Microchemistry Core facility of the Max-Planck Institute for Biochemistry. 
For large-scale protein production, suspension-adapted HEK293E-EBNA1 (Durocher et al., 
2002) cells were used. These cells stably express the Epstein-Barr virus nuclear antigen 1 
(EBNA1), which amplifies episomal DNA containing an Epstein-Barr virus origin of replication. 
Plasmid DNA is thus retained throughout the production phase, increasing the yield of 
recombinant proteins. 
The HEK293E cells were cultivated in serum-free Freestyle medium, supplemented with 1 % 
(v/v) Pluronic and 50 µg/ml G-418, in shaker flasks at 37 °C, 5 % CO2 and 110 rpm. Cell number 
and vitality was determined using a Vi-CELL XR analyzer. For maintenance and expansion, the 
cells were grown to a density of 1.5 * 106 cells/ml and diluted with fresh medium to a density 
of 2-2.5 * 105 cells/ml.  
58   Material and Methods 
 
 Recombinant protein production 
 Transient transfection of HEK293E cells in suspension 
For recombinant protein production, HEK293E cells were grown to a density of  
1.0 * 106 cells/ml and then transiently transfected using PEI MAX (Tom et al., 2008b). 1 µg 
vector DNA per ml culture volume was mixed with PBS (1/10 to 1/100 of the culture volume) 
and 2 µg PEI MAX per ml culture volume, yielding a DNA : PEI ratio of 1 : 2. After 15 min at RT, 
the transfection mix was added drop-wise to the HEK293E cells. Recombinant protein 
production was maintained for 72 h post transfection and then the cells were harvested (200 
x g, 5 min). The pellet was flash-frozen in liquid nitrogen and stored at -80 °C until protein 
purification was performed. 
 Recombinant protein production in High Five insect cells 
Multi-protein complexes were produced in High Five insect cells using the MultiBACTurbo 
expression system (Bieniossek et al., 2012). Chemically competent E.coli DH10EmBacY cells 
were transformed with a single pACEBAC1 vector containing expression cassettes for all 
desired proteins. The transformation was carried out as usual, with an extended incubation 
phase at 37 °C after the heat-shock (over night instead of 45 min). The bacteria were then 
plated on an LB agar plate containing kanamycin (50 µg/ml), gentamycin (7 µg/ml), tetracyclin 
(10 µg/ml), BluoGal (100 µg/ml) and IPTG (40 µg/ml). If the vector DNA has been inserted 
correctly into the mini-attTn7 site via T7 transposition, the LacZ gene in the baculoviral DNA 
is disrupted and BluoGal is no longer degraded to the blue product. Colonies containing the 
desired Bacmids thus remain white after 48 h incubation at 37 °C and are selected for Bacmid 
preparation.  
Two positive colonies were used for a 2 ml pre-culture and incubated at 37 °C and 250 rpm 
until cells started growing. 50 – 200 ml medium were then inoculated in a ratio of 1:100 with 
the pre-culture and incubated at 37 °C, 250 rpm for up to 24 h. The cells were harvested by 
centrifugation (2800 x g, 15 min) and the Bacmid DNA was isolated using the Nucleobond 
BAC100 kit according to manufacturer’s protocol.  
For production of sufficient amounts of baculovirus for liter-scale production of recombinant 
protein complexes, Sf9 insect cells were transfected with Bacmid DNA. For 1 ml culture 
volume, 1 µg Bacmid DNA was mixed with 100 µl PBS and 2 µg PEI MAX and vortexed 3 x 3 s. 
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The cell density was adjusted to 0.8 * 106 
cells/ml and the transfection mixture was 
added dropwise to the culture. After 5 d at 26 
°C and 150 rpm, cell vitality and shape was 
assessed using a ViCell counter and 
microscopical fluorescence control. In case of 
successful transfection, the cells are larger 
than the non-transfected control and show 
green fluorescence signal in more than 90 % 
of the cells, due to a GFP reporter gene on the 
EmBacY Bacmid DNA. Successfully transfected 
cultures were harvested by centrifugation 
(2800 x g, 15 min), the supernatant was 
cleared by sterile filtration (0.22 µm) and used 
either directly for recombinant protein 
production or for further virus amplification. 
In order to generate larger amounts of 
baculovirus particles, the supernatant 
generated by transfection was used for 
infection of a larger culture of SF9 cells. For 
this purpose, cell density was adjusted to  
0.5 * 106 cells/ml and transfection supernatant was added in dilutions ranging from 1:1000 to 
1:5000, depending on the transfection efficience (determined in small-scale cultures 
beforehand). 48 h post infection, the cell number had doubled approximately and the cells 
had grown in size, indicating virus production. The culture was then diluted to 1 * 106 cells/ml, 
incubated at 26 °C for 48 h and then the supernatant was harvested as before. 
For large-scale protein production, High Five insect cells were adjusted to a density of  
1 * 106 cells/ml and infected with supernatant from either transfection or P1 amplification. 
Again, the optimal virus titer for infection, as well as its influence on the production of the 
desired recombinant proteins was determined using small-scale production and then 
Figure 13: Workflow for the expression of multi-
protein complexes in insect cells using the 
MultiBACTurbo system. All expression cassettes for the 
individual proteins are combined into one large 
acceptor vector, which is then transformed into 
DH10EmBacY cells. After Tn7 transposition, the 
expression cassettes are integrated into a baculovirus 
shuttle vector (Bacmid), which can be isolated from 
the bacteria and used for transfection of insect cells. 
These cells will then start producing baculovirus, 
which is used for large-scale infection of insect cells 
and recombinant protein production. Image from 
(Berger, 2012) 
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expanded to 1-5 l cultures. When the transfection supernatant was used, 10 ml of supernatant 
were added to 1 l culture volume. 72 h post-transfection, cells were harvested (2800 x g,  
15 min). The pellet was flash frozen in liquid N2 and stored at -80 °C until protein purification 
was performed. 
 Recombinant protein production in E. coli Rosetta BL21 (DE3) 
One day prior to recombinant protein production, expression vectors were transformed into 
chemically competent E. coli Rosetta BL21 (DE3). Positive clones were selected on LB agar 
plates containing the vector’s selection marker as well as chloramphenicol (34 µg/ml), to 
retain the Rosetta cells’ pRARE plasmid. For production, 1.5 l LB medium containing the 
respective selection antibiotics were inoculated with all the colonies on the LB agar plate. For 
this purpose, the plate was covered with 2 ml LB medium and the colonies were harvested 
using a cell scraper. This rather unusual inoculation method was chosen especially for pCoofy-
vectors since in overnight cultures, a high percentage of cells were dead or dying and took 4-
5 hours after inoculation to recover and start dividing. Cultures inoculated with the colonies 
on the agar plate recovered much more quickly and yielded higher amounts of protein. 
Cells were grown at 37 °C to an OD550 nm of 0.6, then cooled down to 18 °C for overnight 
production or to 12 °C for 72 h production. For LIM-domain proteins like PINCH or paxillin, 
ZnCl2 was added to a final concentration of 0.466 mM. Gene expression was then induced by 
addition of IPTG to a final concentration of 0.2 mM. Cells were harvested the following day or 
after 72 h by centrifugation (5000 x g, 10 min) and resuspended in 30 ml Buffer A1. The cells 
were flash-frozen in liquid N2 and stored at -80 °C until protein purification.  
 Recombinant protein purification 
All buffers, ddH2O and 20 % ethanol used for purification were prepared freshly (maximum 
one week prior to purification) and passed through a 0.22 µm bottle-top filter to remove 
particles or microorganisms. Buffers used on the FPLC system were additionally degassed by 
stirring them under vacuum for 1-2 h. The detergents were added after filtration and 
degassing to avoid foaming. TCEP was added freshly on the day of usage. All purification steps 
were carried out at 4 °C on the FPLC system or on ice for batch purification to avoid 
temperature-dependent protein degradation or aggregation.  
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 Cell disruption and preparation of lysates for purification 
The E. coli cell pellets were thawed slowly in a water bath at RT and supplemented with 1 mM 
TCEP, 1 mM PMSF (optional) and 1 µl per 1 ml pellet volume Benzonase. After addition of 10 
µl Lysozyme (10 mg/ml) per 1 ml pellet volume, cells were incubated for 10 min on ice and 
then sonicated using 1 s pulses for 10 min at 50 % amplitude. After 10 min incubation on ice, 
the cell debris was removed by centrifugation (58,000 x g, 20 min, 4 °C) and the supernatant 
was cleared by passing through a 0.45 µm membrane filter.  
HEK293 cell pellets were thawed slowly on ice, then resuspended in 5-6 ml Buffer C1 per 1 ml 
pellet volume and supplemented with 1 mM TCEP, 1 mM PMSF. After addition of 1 µl 
Benzonase per 1 ml cell suspension, cells were disrupted using a Dounce tissue grinder. The 
grinder was immersed in ice to prevent warming up the suspension through friction heat. Cells 
were homogenized by slowly moving the piston up and down 20 times. After 10 min 
incubation on ice to allow the Benzonase to cleave cellular DNA, cell debris was removed by 
centrifugation (58,000 x g, 20 min, 4 °C) and the supernatant was cleared by passing through 
a 0.45 µm membrane filter. 
High five insect cells were disrupted analogously to HEK293 cells, with the exception that the 
pellet was resuspended in 10 ml Buffer B1 and 4 µl Benzonase per 1 ml cell suspension was 
added. In order to reduce plasma membrane contamination of the samples, 0.1 % (v/v) 
Tween-20 was added to the lysis buffer.  
 Immobilized metal ion affinity chromatography (IMAC) 
Recombinant proteins with a hexa-histidine (His6) fusion tag were purified by immobilization 
on an agarose matrix functionalized with nitrilotriacetic acid (NTA) groups. NTA is a potent 
chelating agent, which coordinates metal ions such as Ni2+ and creates a surface that binds 
poly-histidine stretches in proteins with high affinity. Elution of the target protein is achieved 
by addition of excess imidazole, which competes with the His-residues for the binding sites on 
the Ni-NTA resin. The recombinant proteins were purified using either HisTrap HP columns on 
the FPLC system or Ni-NTA beads for batch purification.  
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Ni-NTA column purification 
Prior to sample application, the column was washed with 5 column volumes (CV) of ddH2O, 
followed by 3 CV of elution buffer (500 mM imidazole) to remove potential contaminants. The 
column was then equilibrated with 3 CV running buffer (0 mM Imidazole). The cleared cell 
lysates were loaded using a sample pump, passing the sample over the column 2-3 times. The 
elution was performed in steps of 3-6 CV of increasing imidazole concentration. Typically, the 
steps used were 0 mM, 20 mM, 50 mM, 100 mM, 250 mM and 500 mM imidazole. The elution 
profile was adapted for each protein to achieve highest purity. Fractions of 0.5 – 14 ml were 
collected during the elution phase, depending on column size and expected behavior (“wash” 
fractions vs. target protein elution fractions). The chromatography was monitored using a 
multi-wavelength detector at 215 nm (peptide bond), 260 nm (DNA), 280 nm (protein) and 
optionally 650 nm (647-labeled proteins). The protein composition of the peak fractions was 
determined using SDS-PAGE and the fractions containing the target protein were pooled and 
concentrated for following purification steps. After completion of the protein purification, the 
column was washed again with 5 CV ddH2O, followed by 2-3 CV 20 % ethanol. The column was 
stored under 20 % ethanol at 4 °C and re-used until a decrease in purification performance 
was observed.  
Ni-NTA batch purification 
For batch purification, an appropriate amount of Ni-NTA beads was used, depending on the 
expected protein amount produced. (1 ml of Ni Sepharose High Performance beads can 
immobilize 40 mg protein under optimal conditions). The beads are delivered as “slurry”, 
meaning a suspension in storage solution. This slurry is composed of ~ 50 % (Qiagen) or  
~ 80 % (GE) beads, which has to be taken into consideration when estimating the amount of 
beads needed. The slurry was centrifuged at 600 x g, 2 min, 4 °C to sediment the beads, then 
the supernatant was removed and discarded. The beads were then equilibrated by adding  
5-10 bead volumes of the respective buffer used for purification and then centrifuged again, 
followed by removal of the supernatant. This step was carried out twice, then the cell lysate 
was applied on the beads at 4 °C on a rotating wheel for 2 h or over night. The suspension was 
then centrifuged and the supernatant removed. The beads were washed afterwards with ≥10 
bead volumes of buffer containing increasing concentrations of imidazole (0, 20, 50, 100, 250, 
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500 mM) and the supernatants analyzed by SDS-PAGE. At the expected elution volumes (250 
and 500 mM in most cases), the suspension was incubated for 10 min on ice before 
centrifugation. The fractions containing the target protein were pooled and concentrated for 
further use.  
Affinity tag removal and “reverse” Ni-NTA chromatography 
All recombinant proteins were produced with removable affinity tags. For the removal of poly-
histidine tags, the fusion protein was cleaved with the appropriate protease, which carried a 
poly-histidine tag itself. Proteins with His10-SUMO3 tag were treated with 1 U His6-SenP2 
protease per 100 µg recombinant protein and incubated at 4 °C over night. For the production 
in HEK293E cells a modified (non-cleavable by the mammalian SUMO-protease) His10-
SUMOstar tag and His6-SUMOstar protease (1U per 100 µg protein, 4 °C, over night) were 
employed. For tags flanked by TEV or PreScission sites, His6-TEV protease (1 U per 3 µg protein, 
4 °C, over night) and His6-PreScission protease (1 U per 100 µg protein, 4 °C, over night) were 
used. After cleaving was completed, the samples were incubated on Ni-NTA beads 
equilibrated with the respective buffer (see batch purification) for 1-2 h at 4 °C on a rotating 
wheel to immobilize the affinity tag as well as the protease, leaving the tagless recombinant 
protein in the supernatant. The beads were centrifuged (600 x g, 2 min, 4 °C) and the 
supernatant was removed carefully for further use. If the samples were obtained from Ni-NTA 
purification, they still contained high amounts of imidazole, which had to be removed to 
enable binding to the beads. For this purpose, the sample was concentrated using a centrifugal 
concentrator, diluted 5- to 10-fold to reach an imidazole concentration of 50-70 mM and 
concentrated again if SEC was performed afterwards.  
 Cation exchange chromatography (CIEX) 
The underlying principle of ion exchange chromatography is the interaction of charged protein 
side chains with column material carrying opposite charges. For CIEX, the target protein is 
transferred into a buffer with low salt concentration and a pH value that is at least 1 unit below 
the theoretical pI of the protein. The theoretical pI can be calculated using the ProtParam tool 
on the ExPASy website. Since most adhesome proteins do not tolerate dialysis, the buffer 
exchange was achieved by concentrating the target protein and then diluting it 15 – 20 x with 
CIEX running buffer,. Elution of the target protein is achieved by increasing the NaCl 
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concentration of the buffer, since free ions interact with the column material and “shield” it 
from the charged protein side chains. 
For the purification, the column was washed with 5 CV of ddH2O, followed by 5 CV of elution 
buffer containing 1 M NaCl to remove potential contaminants. The column was then 
equilibrated with 3 CV of running buffer and the sample was loaded passing it 3 x over the 
column using a sample pump. Elution was performed using a stepwise increase of the NaCl 
concentration, from 0 mM to 1 M. The chromatography was monitored using a multi-
wavelength detector and the protein-containing fractions were analyzed by SDS-PAGE. The 
fractions containing the target protein were pooled and concentrated. After purification, the 
column was washed with 5 CV ddH2O and 3 CV 20 % Ethanol for storage. 
 Size exclusion chromatography (SEC) 
Size exclusion chromatography separates proteins by their hydrodynamic volumes. Small, 
globular proteins can easily enter the porous column material and are held back for some 
time, whereas large particles pass through the column much more quickly. Therefore, 
aggregates elute first, followed by large proteins or protein complexes and finally small 
proteins.  
Preparative size exclusion chromatography was used as a final “polishing” step in protein 
purification to remove aggregates and small contaminants and to achieve buffer exchange. 
Analytical size exclusion chromatography was performed to test for protein-protein 
interactions or protein complex formation. Columns with a bed volume of 24 ml were used 
for analytical SEC, while preparative SEC was performed on a 120 ml Superdex200 HiLoad 
column. The columns were washed with 1.2 CV ddH2O and equilibrated with 1.2 CV of running 
buffer.  
Table 4: Overview of SEC columns and properties 
Column Bed volume Separation range Flowrate 
HiLoad 16/600 Superdex200 pg 120 ml 10 - 600 kDa 1 ml/min 
SEC70 24 ml 0.5 - 70 kDa 0.7 ml/min 
SEC650 24 ml 0.5 - 650 kDa 0.7 ml/min 
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Samples were concentrated to a final volume of 250 µl for analytical SEC and 3 ml for 
preparative SEC and passed through a 0.22 µm centrifugal filter prior to application on the 
columns. The samples were injected into sample loops with 500 µl or 5 ml capacity. For sample 
application, the loops were emptied with 2 x loop volumes and the chromatography was 
performed by passing 1.2 CV of running buffer over the column at flow rates of 0.7 (analytical 
SEC) or 1.0 ml/min (preparative SEC). The fractions containing protein were analyzed by SDS-
PAGE and the desired fractions (not the aggregate peak) were pooled and concentrated. The 
columns were washed with 1.2 CV of ddH2O and 1.2 CV of 20 % ethanol for storage. 
In order to calculate the hydrodynamic volumes of proteins from their retention time on the 
column, calibration runs using a protein standard were performed. Using the molecular 
weights and the peak elution volumes of the proteins in the standard, a calibration curve is 
generated (formula (2)). 
𝑘𝑎𝑣 =  
(𝑣𝑒− 𝑣0)
(𝑣𝑡− 𝑣0)
    (2) 
 
kav: specific partition coefficient of a protein  
ve: elution volume  
v0: dead volume of the column 
vt: bed volume  
 
 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
For analytical separation of a protein mixture, SDS-PAGE was performed. The protein sample 
was denatured by mixing with reducing sample buffer containing sodium dodecyl sulfate (SDS) 
and applied on a gel. The denatured proteins bind negatively charged SDS molecules, which 
mask charges in the amino acid side chains, leading to a separation by molecular weight alone. 
Depending on the size of the protein of interest, gels containing different percentages of 
acrylamide were used. A higher percentage of acrylamide yields a more densely crosslinked 
gel, through which proteins need longer to pass leading to a better resolution in the lower 
molecular weight range and vice versa. The gels used for discontinuous gel electrophoresis 
consisted of a weakly crosslinked 4 % stacking gel on top of a 10 or 12 % separating gel. 
Proteins pass quickly through the stacking gel and are concentrated at the top of the 
separating gel, in which the actual separation according to molecular weight is achieved. 
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The vertical gel electrophoresis was performed in mini-gel format using the Mini-Protean 
Tetra cell system. Protein marker and denatured protein samples were applied into the gel 
pockets and a constant voltage of 100 V in the beginning and 300 V after a few minutes was 
applied. Electrophoresis was performed until the blue loading dye running front had almost 
reached the lower end of the gel.  
For most samples containing ample amounts of protein, Coomassie staining was used to 
visualize protein bands. The gels were covered with 0.1 % (w/v) Coomassie staining solution, 
boiled for 30 s in a microwave at 800 W and incubated at RT on a rocking platform for  
20 – 25 min. For destaining, the gels were covered with destaining solution I, boiled shortly in 
a microwave and incubated for 10 min on a rocking platform. After analogous treatment with 
destaining solution II and 30 min incubation, gels were covered with deionized H2O and 
scanned.  
 Silver staining of SDS gels 
For visualization of protein bands in samples of low protein concentration (down to low 
nanogram levels) a more sensitive staining method was necessary. Silver staining is based on 
the principle that silver ions bind to proteins and can be reduced under certain conditions to 
form a visible image of the protein bands. The gels were covered in Fixing solution and 
incubated at RT for 10 min on a rocking platform (like all following steps), then washed 2x for 
5 min with deionized H2O. Afterwards, the gels were incubated in Na2S2O3 solution for 1 min, 
then washed 2x for 20 s with deionized H2O. The freshly prepared, cold silver nitrate solution 
was added then and incubated for 10 min in the dark. After rinsing the gel shortly with 
deionized H2O and a small volume of developing solution, the rest of the developing solution 
was added and the gels were incubated under constant shaking until brownish bands started 
appearing. As soon as the desired grade of staining was reached, the stop solution was poured 
onto the gel and mixed briefly. The stained gels were then imaged using a scanner. 
 Tricine SDS-PAGE (Haider et al., 2012) 
In order to better resolve proteins in the low molecular weight range (≤ 20 kDa), 16 % tricine 
gels were used, according to the protocol by Haider et al. The discontinuous polyacrylamide 
gels are cast analogously to the “classical” SDS gels, with the exception that the gels do not 
contain any SDS. The running buffer used for these gels contains SDS as well as tricine as a 
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carrier molecule, instead of glycine. Electrophoresis and Coomassie staining were performed 
analogously to the classical gels. 
 Trichloroacetic acid (TCA) precipitation of proteins 
Samples containing low amounts of protein can be concentrated prior to SDS-PAGE by 
precipitating the proteins with trichloroacetic acid (TCA). This method can also be applied for 
samples containing high amounts of detergents or other molecules which interfere with gel 
electrophoresis. The proteins are precipitated by addition of TCA to a final concentration of 
20 % (w/v) and 10 min incubation on ice. After centrifugation (5 min, 21,000 x g, 4 °C), the 
supernatant was removed and the pellet washed twice with 1 ml cold acetone and centrifuged 
again. After the second washing step, the pellet was dried in a heating block at 50 °C until the 
remaining acetone had evaporated. The pellet was then resuspended in a small volume of 1x 
sample buffer and applied onto an SDS or tricine gel.  
 Detection of proteins by Western Blot 
The detection of proteins immobilized on a membrane by specific mono- or polyclonal 
antibodies is referred to as Western Blotting. This method is suitable for the identification of 
a certain target protein in purified samples as well as cell lysates at much higher sensitivity 
than Coomassie or silver staining.  
Proteins were first separated via SDS-PAGE and then transferred onto a PVDF membrane by 
electroblotting. The stacking gel was removed and the separating gel was placed onto a 
slightly larger slip of PVDF membrane, which was activated in 100 % methanol for 5 min prior 
to assembly. The membrane itself rested on 4 sheets of Whatman paper soaked in transfer 
buffer and another 4 sheets were placed on top of the SDS gel. Great care was taken at each 
assembly step to remove any air bubbles trapped between the layers and to properly soak 
every component in transfer buffer. The assembly was then inserted into the blotting chamber 
filled with transfer buffer and cooled by an ice block. The transfer was performed at 300 V for 
1.5 h. Afterwards, the membrane was incubated for 1 h in blocking buffer containing 4 % (w/v) 
non-fat dry milk to saturate unspecific binding sites. The membrane was then rinsed with PBS-
T and incubated with the primary antibody (usually 1:1000 dilution in PBS with 5 % (w/v) BSA) 
over night at 4 °C and shaking. The primary antibody was removed and could be re-used for a 
few weeks. The membrane was washed 3-4 times in PBS-T for 5 min and the secondary 
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antibody, coupled to horseradish peroxidase (HRP), was added in 1:3000 dilution in PBS-T for 
1 h at RT. The membrane was washed again 3-4x in PBS-T and then imaged using a 
chemiluminescence-based detection kit.  
 Determination of protein concentration 
The concentration of a purified protein sample was determined by measuring the absorbance 
at 280 nm (A280) using a NanoDrop spectrophotometer. By applying the Lambert-Beer law 
(formula 3), the protein concentration was calculated from the A280 value and the protein’s 
molar extinction coefficient εprot. The latter was determined using the ProtParam tool on the 
ExPASy website.  
A280 = εprot * c * d    (3) 
A280 : absorbance at 280 nm   
εprot : molar extinction coefficient of the protein, [M-1cm-1] 
c: protein concentration, [mol/l]  
d: path length, 1 cm for NanoDrop  
From the protein concentration, the total amount of protein in a certain sample volume could 
be determined using formula 4. 
m = c * M * V     (4) 
m: protein amount [g]  
M: molar weight of the protein [g/mol]  
V: volume of the sample [l] 
For proteins labeled with fluorescent dyes, the degree of labeling (DOL) was determined by 
measuring the absorbance at 280 nm and at the emission maximum of the respective dye. A 
DOL of 1 corresponds to 100 % labeling of the protein, or a theoretical one dye molecule on 
each protein molecule. For the DOL calculation, formula 5 was used.  
𝐷𝑂𝐿 =
𝐴𝑚𝑎𝑥∗𝜀𝑝𝑟𝑜𝑡
(𝐴280−𝐴𝑚𝑎𝑥∗𝐶𝐹280)∗𝜀𝑚𝑎𝑥
  (5) 
Amax : absorbance at absorption maximum of dye 
εprot : molar extinction coefficient of the protein, [M-1cm-1] 
A280 : absorbance at 280 nm 
CF280 : correction factor of the dye 
εmax : molar extinction coefficient at absorption maximum of dye, [M-1cm-1] 
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Table 5: Molar extinction coefficients and molecular weights of the proteins and dyes used in this study 
Protein/dye MW (g/mol) ε [M-1cm-1] CF280 (dyes only) 
α5 TMCyto 14,073.2 8,480  
β1 TMCyto wt 16,304.0 13,980  
β1 TMCyto NPIA 16,211.9 12,490  
β1 TMCyto NPKA TT/AA 16,151.8 12,490  
β1D TMCyto DTQ/V 16,527.3 13,980  
EPLIN 66,134.8 69,900  
FAK 119,242.9 133,620  
ILK 51,313.1 70,930  
kindlin 2 77,800.0 124,790  
His6- α-parvin 46,058.7 21,430  
paxillin 60,811.0 47,330  
PINCH 37,240.3 32,890  
PINCH-strep 38,481.6 36,900  
PINCH dLIM5 28,707.0 24,410  
RSU-1 31,461.1 15,930  
THD 46,891.0 42,860  
IPP complex 135,877.5 129,260  
    
Alexa-488 NHS 643.4 73,000 0.11 
Alexa-647 Maleimide 1250 265,000 0.03 
Alexa-647 NHS 1250 270,000 0.03 
Atto-565 NHS 708 120,000 0.12 
NT-647 unknown 250,000 unknown 
 
 Concentrating of protein samples using centrifugal concentrators 
Centrifugal concentrator units are simple and efficient tools for reducing the volume of a 
protein sample and thereby increasing its concentration. Depending on the volume of the 
sample, concentrators with capacities of 0.5, 4 or 15 ml were used. Concentrators with 
molecular weight cut-off (MWCO) of 10,000 or 30,000 Da were selected according to the sizes 
of the proteins to be concentrated. The concentrators were equilibrated with buffer prior to 
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use and centrifuged at 4000 x g, 10 min, 4 °C (4 and 15 ml) or 9500 x g, 5 min, 4 °C (0.5 ml). 
The flow-through and remaining concentrate were discarded and the protein sample was 
added and centrifuged. After each round of centrifugation, the concentrate was pipetted up 
and down several times to keep it homogeneous and to check for the formation of aggregates. 
This procedure was repeated until the desired final volume of the sample was achieved or the 
protein started to aggregate. The concentrate was then flushed a few times over the 
membrane to remove residual bound protein and removed by pipetting.  
 Chemical labeling of proteins with fluorescent dyes 
Proteins were labeled using either thiol-reactive maleimide-conjugated dyes for attachment 
of fluorophores to cysteine residues, or amine-reactive NHS-ester conjugates for labeling of 
primary amine groups, predominantly in lysine side chains. 1 mg of fluorescent dye was 
dissolved in 200 µl water-free DMSO and stored in 10 µl aliquots at -20 °C.  
Prior to labeling, the proteins were transferred into a buffer suitable for the intended labeling 
reaction using desalting columns. For maleimide dyes, all types of buffer (Tris, HEPES, MES, 
phosphate) can be used, as long as the pH value is between 7.0 and 7.5. In order to ensure 
that the cysteines to be labeled were in their reduced form, TCEP was added to a final 
concentration of 2 mM prior to the labeling reaction. Then, the thiol reactive dye was added 
in 10-20x molar excess, and the reaction carried out at RT for 2 h in the dark. For amino-
reactive dyes, the protein was first transferred to NHS labeling buffer (PBS, 10 mM NaHCO3, 
pH 9.0) and then mixed with 2.5x molar excess of dye. The labeling reaction was carried out 
for 1 h at 4 °C in the dark. 
For removal of excess dye, the samples were either passed through desalting columns or, if 
carrying a His-tag, bound to Ni-NTA beads, washed with buffer until the supernatant was 
colorless and then eluted with 500 mM imidazole. 
 Buffer exchange using desalting columns 
DextraSEC PRO2 desalting columns were used for buffer exchange at low sample volumes or 
for removal of free dye after labeling reactions. The columns were equilibrated by letting first 
the storage fluid and then 5 ml of the desired buffer pass through the column by gravity flow. 
Then, 200 µl sample were applied to the column, followed by 200 µl buffer. Elution was 
performed with 350 µl buffer. For removal of unbound dye, separation of two fluorescent 
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species could be seen on the column. The eluate was collected before the second species 
reached the bottom of the column and residual eluate was discarded. For applications, which 
are highly sensitive to perfectly matched buffers, the samples were passed through a column 
a second time. 
 
 Biophysical methods  
 Dynamic light scattering (DLS) 
DLS is used for characterization of protein solutions with respect to particle size and 
polydispersity. By measuring fluctuations in the intensity of scattered laser light, the 
translational diffusion coefficients of the particles in solution can be determined. Using the 
diffusion coefficient, the hydrodynamic radius of a particle can be calculated, provided that 
the sample is monodisperse, i.e. it contains only one species of molecules. This makes DLS a 
suitable method for detecting and monitoring protein aggregation and thus allows for quality 
control of protein preparations.  
Before conducting a DLS measurement, the sample was centrifuged for 5 min at 21,000 x g 
and 4 °C to remove dust particles and very large aggregates, which could interfere with the 
measurement. The DLS instrument was cooled to 4 °C before starting a measurement to avoid 
temperature-dependent aggregation of the proteins. 6 µl of buffer were pipetted into a 
disposable DLS cuvette and placed into the sample holder. If the cuvette was not clean or if 
the buffer contained large particles, a decay curve was visible and the count rate exceeded a 
value of 80,000. In this case, the cuvette was cleaned thoroughly with ddH2O and dried with 
compressed air and the buffer filtered. If the buffer sample was clear, the actual protein 
sample was loaded into the cuvette and the DLS measurement carried out. The laser power 
was set to auto-attenuation, the temperature to 4 °C, the acquisition time to 5 s, the number 
of acquisitions to 15 and the measurement was carried out 3 times. The Dynamics software 
was used to calculate the hydrodynamic radius of the particles in the sample.  
 Circular dichroism (CD) spectroscopy 
Circular dichroism spectroscopy is a valuable tool for rapid determination of protein secondary 
structures. When circularly polarized light at wavelengths in the far-UV (< 250 nm) spectrum 
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hits protein secondary structures, the left- and right-handed circularly polarized components 
of the light are absorbed to a different extent. Thus, the plane of the light wave is rotated, 
resulting in a shift of the circularly polarized light to an elliptically polarized form. CD is 
reported in degrees ellipticity at different wavelengths. Secondary structure elements of 
proteins render distinct CD traces. Proteins with predominantly α-helical structures display 
negative ellipticity at 222 nm and 208 nm and positive values at 193 nm. Proteins containing 
mostly antiparallel β-sheets render negative ellipticity at 218 nm and positive values at 195 
nm. Disordered proteins display almost no ellipticity at wavelengths ≥ 210 nm and negative 
values around 195 nm. Since most proteins are composed of a mixture of these secondary 
structure elements, each protein renders a distinct CD spectrum in the near-UV range. This 
spectrum can be used to estimate the percentage of each structure element and to determine 
whether the protein is correctly folded or not. CD spectroscopy can also be used to monitor 
changes in the secondary structures of a protein, induced by conformational change when 
binding a ligand or by unfolding of the protein. 
CD spectra were acquired using a quartz cuvette with 1 mm path length and a sample volume 
of 300 µl in a Jasco J-715 spectropolarimeter. Prior to the measurements, a buffer reference 
was prepared by mixing 30 µl of the protein buffer with 270 µl ddH2O. Likewise, the sample 
(protein concentration ≥ 1 mg/ml) was diluted with ddH2O. First, a CD spectrum of the buffer 
sample was acquired from 190 nm to 250 nm at 10 °C with 4 repetitions. Afterwards, the 
buffer was removed from the cuvette and the protein sample was added and measured using 
the same parameters. The buffer reference spectrum was later subtracted from the protein 
spectrum to eliminate effects caused by the buffer. The secondary structure estimation on the 
corrected spectrum was performed with the Spectra Manager II software.  
Protein stability was determined by thermal denaturation. From the protein spectrum 
acquired as described above, the wavelength at which the spectrum displays the lowest 
ellipticity was selected (usually near 206 nm). At this wavelength, ellipticity was continuously 
measured while raising the temperature from 10 °C to 90 °C at a rate of 1 °C/min. When the 
protein unfolds, the secondary structures become disrupted and change the CD spectrum of 
the protein to a disordered curve. The ellipticity values were plotted against the temperature, 
rendering a transition temperature around which the protein unfolds. This transition 
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temperature is an indicator of protein stability and indicates the quality of the protein 
preparation. 
After the measurements, the quartz cuvette was cleaned by incubation with chromosulfuric 
acid over night and rinsing with methanol, followed by drying with compressed air. 
 Interaction studies on recombinant proteins using pull-down assays on Ni-NTA 
beads 
Pull-down assays on Ni-NTA beads were used as a first indication of proteins binding to each 
other or as a means to assemble multi-protein complexes for crosslinking studies. Ni-NTA 
beads were equilibrated with the buffer of the bait protein and then incubated with the His-
tagged bait protein on a spinning wheel at 4 °C for 1-2 h or over night. The supernatant was 
removed and the beads were washed once with buffer. Then the prey protein or proteins 
were added at a higher amount than the bait protein in order to detect binding also at low 
affinities. The interaction partners were added to the beads and, if necessary, diluted with 
buffer to a volume that allows for an adequate suspension of the beads. The mixture was 
incubated on a rotating wheel at 4 °C for 1 h, then the supernatant was removed and the 
beads were washed twice with buffer containing 50 mM imidazole to remove non-specifically 
bound protein. If the beads were subsequently used for crosslinking, the second washing step 
was carried out with buffer without imidazole to avoid losing the amine-reactive crosslinker 
to imidazole. The protein complexes bound to the beads were then eluted with 500 mM 
imidazole and analyzed by SDS-PAGE or Western Blot. As a control to check for non-specific 
interaction of the prey proteins with the Ni-NTA beads, “empty” beads were incubated with 
the same amounts of prey proteins as the sample and treated in the same way.  
 Chemical crosslinking of focal adhesion complexes and analysis by LC-MS  
Complexes of recombinant focal adhesion proteins were assembled on Ni-NTA beads, 
crosslinked, enzymatically digested and analyzed by LC-MS/MS to identify protein surfaces, 
which had been close to each other in the complex. In one approach, the complexes were 
assembled on beads and eluted with 500 mM imidazole. Afterwards, the sample was passed 
through a desalting column to reduce the imidazole concentration far enough to not impede 
the crosslinking reaction. A titration series with increasing concentrations of an equimolar 
mixture of isotopically light (d0) and heavy (d12) labeled BS3 crosslinker was conducted on 
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small volumes of the sample in order to find the optimal concentration. The concentration of 
the eluate was determined via NanoDrop and aliquots of 5 µl were mixed with 2.5x, 2x, 1x, 
0.5x, 0.4x or 0.2x molar amount of BS3. An aliquot of BS3 powder was dissolved directly before 
crosslinking in 35 µl ddH2O and diluted to the desired concentrations with buffer. As a control, 
one aliquot was mixed with buffer instead of BS3. The samples were crosslinked on ice for 1 h 
and then analyzed by SDS-PAGE. The optimal amount of BS3 was selected, where the protein 
bands started disappearing but were still visible, while larger species at the upper part of the 
gel started to form.  
In another approach, the complexes were not eluted but instead directly crosslinked while still 
bound to the beads. The pelleted beads were mixed with approximately their volume of buffer 
to obtain a 1:1 slurry. A titration series following the same principle as described above was 
conducted on 5 µl aliquots (corresponding to 2.5 µl beads) to determine optimal crosslinker 
concentration. 1 µl of BS3 dilution was added to the sample and the crosslinking reaction 
carried out at 35 °C and 1200 rpm for 30 min in a heating block. For SDS-PAGE, 5 µl sample 
buffer were added to the beads, incubated at 95 °C for 5 min and the entire sample was 
applied on a gel. 
In both approaches, the optimal crosslinker concentration was selected and scaled-up to  
170 µl eluate or 100 µl bead-slurry and the crosslinking reaction was carried out analogously 
to the test samples using a freshly dissolved BS3 aliquot. The crosslinking reaction was 
quenched by addition of 1 M ammonium bicarbonate solution to a final concentration of  
100 mM. After 10 min incubation at 35 °C, 2 sample volumes of 8 M urea (340/200 µl) and  
50 mM TCEP to a final concentration of 5 mM were added and incubated at 35 °C and 800 rpm 
for 30 min. Afterwards, 100 mM iodoacetamide solution was added to a final concentration 
of 10 mM and incubated at RT in the dark for 35 min. The proteins were digested by adding 
LysC protease in a ratio of 50:1 (mproteins : mLysC) and incubating at 35 °C and 1300 rpm for 2 h. 
Afterwards, 14 sample volumes (2380/1400 µl) of a 50 mM ammonium bicarbonate solution 
was added, as well as Trypsin at the same amount as LysC before. The samples were incubated 
at 35 °C and 1300 rpm over night and then mixed with 100 % acetonitrile to a final 
concentration of 3 % and 10 % trifluoroacetic acid to a final concentration of 1 %.  
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The samples were then subjected to peptide clean-up using Sep-Pak columns. After activation 
with 1 ml 100 % acetonitrile and washing with 2x 1 ml 2 % acetonitrile, 0.2 % formic acid, the 
sample was loaded onto the column. The flow-through was collected and re-applied to the 
column to increase binding. Afterwards, the column was washed twice with 2 % acetonitrile, 
0.2 % formic acid, letting it run dry after the second wash. The sample was eluted twice with 
400 µl 60 % acetonitrile, 0.2 % formic acid and lyophilized using a Speed-vac for storage at -20 
°C. For mass-spectrometric analysis, the sample was dissolved in 20 µl 25 % acetonitrile, 0.1 
% trifluoroacetic acid while shaking for 20 min at 35 °C and maximum rpm. Crosslinked 
peptides were enriched on a Superdex Peptide PC 3.2/30 column and the fractions analyzed 
by LC-MS on an LTQ Orbitrap Elite instrument. The analysis was carried out using the xQuest 
software. 
 Assembly of Nanodiscs by dialysis 
Nanodiscs consist of lipid bilayers encircled by membrane scaffold proteins (MSPs) and have 
a disc-like shape and a uniform diameter that depends on the MSP variant used. Once 
assembled, these discs are stable and homogeneous, can be diluted or concentrated and are 
used for applications such as electron microscopy. During assembly, transmembrane proteins 
can be added to the mixture and thus be incorporated into the disc, allowing for reconstitution 
of the membrane protein in a plasma membrane-like environment and removal of the 
detergent necessary for solubilization.  
TMcyto-α5 wt, -β1 wt or -β1 mutant constructs were produced intracellularly in E. coli, leading 
to the formation of inclusion bodies due to the hydrophobic transmembrane domain. The cells 
were disrupted, the supernatant containing the soluble proteins was discarded and the pellet 
was washed once in buffer D1, followed by centrifugation (58,000 x g, 20 min, 4 °C). The pellet 
was resuspended in buffer D2, which contained 3 % (v/v) EMPIGEN BB detergent for 
solubilization of the TMcyto constructs from the inclusion bodies. The sample was incubated 
over night on a rotating wheel at 4 °C. Afterwards, the solution should have become more 
transparent, indicating successful solubilization. If this was not the case, more buffer D2 was 
added and the EMPIGEN concentration increased to 4 % (v/v), followed by another 1-2 h 
incubation. The sample was centrifuged again and the supernatant was passed through a 0.45 
µm sterile filter and purified by IMAC and CIEX chromatography. If the sample was intended 
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for single-molecule microscopy, the TMcyto constructs were fluorescently labeled with 
maleimide-coupled dyes, immobilized on Ni-NTA beads and eluted, maintaining the EMPIGEN 
concentration at 1.5 % (v/v) to avoid precipitation.  
As scaffold proteins, MSP1E3D1 and MSP2N2 were used producing discs with 13 and 17 nm 
diameter, respectively. Both MSP proteins carry His6 tags, which are cleavable by TEV 
protease. If empty Nanodiscs were used for microscopy, the scaffold protein was labeled with 
amine-reactive dyes prior to Nanodisc assembly.  
The lipids used were DMPC, a mixture of DMPC and PIP2 (9:1 molar ratio) or DMPC with 10 % 
PIP3. The lipid powder was dissolved in 100 % chloroform (DMPC, POPC) or a 20:9:1 mixture 
of chloroform:methanol:H2O and (PIP2, PIP3) to a final concentration of 50 mg/ml. The desired 
volume of lipid solutions was then transferred to a clean glass tube using a Hamilton glass 
syringe and dried under N2-stream. The tube was then incubated in a vacuum desiccator over 
night and the lipids were solubilized in cholate buffer, rendering a 50 mM lipid stock solution.  
For Nanodisc assembly, the TMcyto protein, the scaffold protein and the lipids were mixed in 
the correct molar ratio to obtain theoretically one TMcyto tail in one Nanodisc. The mixing 
ratios depended on the type of MSP used. For smaller, MSP1E3D1 discs, a ratio of 1 (TMcyto) 
: 2 (MSP1E3D1) : 150 (lipid) was used, due to the fact that 2 molecules of MSP1E3D1 form one 
disc encircling 150 lipid molecules. For larger MSP2N2 discs, a ratio of 1 (TMcyto) : 1 (MSP2N2) 
: 330 (lipid) was used. Before adding lipids to the mixture, cholate buffer was added to keep 
the final cholate concentration between 10 and 20 mM to avoid precipitation of the lipids. 
The samples were then dialyzed three times against 1 l of Nanodisc buffer in dialysis cups 
(MWCO 10,000), allowing the dialysis to reach equilibrium for 4 h or more per step. The 
samples were then passed through 0.22 µm centrifugal filters and applied on an analytical 
SEC650 column to separate assembled Nanodiscs from individual components. The fractions 
were then analyzed by SDS-PAGE and silver staining.  
 Analytical ultracentrifugation (AUC) 
Analytical ultracentrifugation is a versatile method for determining shape, molecular mass and 
complex formation of proteins in solution. The sample is being centrifuged at up to  
250,000 x g while simultaneously being monitored through an optical detection system using 
light absorbance at a specific wavelength. Using this set-up, the process of sedimentation of 
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the different components in the sample relative to the axis of rotation can be followed and 
plotted. From these intensity plots, the sedimentation coefficients and molecular masses of 
the different particle species can be obtained. These data give hints to protein complex 
formation, multimerization of proteins and of aggregation.  
AUC measurements were performed using either unlabeled proteins and detection at 280 nm, 
allowing for the simultaneous monitoring of all components in the mixture, or labeling one 
protein with an amine-reactive fluorescent dye and detection at the absorbance maximum of 
the dye. The latter approach shows complex formation more clearly, since the sedimentation 
of only one protein is monitored and every peak appearing in addition to the monomer peak 
of the labeled protein indicates an interaction with one of the unlabeled components. For one 
measurement, up to 3 cells could be used simultaneously. Therefore, when using unlabeled 
proteins, the components expected to form a complex were each sedimented alone in two 
cells and mixed together in the third. This approach allows for the clear assignment of 
monomer peaks in the mixed sample and the detection of additional “new” peaks, which 
indicate complex formation of the two proteins. For measurements with unlabeled proteins, 
a sample volume of 300 µl was used, while for labeled samples, cells with 130 µl sample 
volume were used. For calculation of the sedimentation coefficients and the molecular 
weights, the viscosity of the buffer was determined before the measurement. The AUC runs 
were performed at 250000 x g for 18 h at 16 °C and the data evaluation was performed using 
the Sedterp software.   
 Determination of binding constants using microscale thermophoresis (MST) 
Microscale thermophoresis (MST) is a method for monitoring and quantifying biomolecular 
interactions in solution by applying a temperature gradient. One of the interaction partners is 
labeled using a fluorescent dye (e.g. Alexa 488 or NT-647), making it traceable by exciting the 
sample with blue or red laser light. Inside thin glass capillaries containing constant amounts 
of the labeled interaction partner in a titration series of the unlabeled component, a 
microscopic temperature gradient spanning 2-6 °C is induced by an infrared (IR) laser. 
Application of the temperature gradient usually leads to a depletion of labeled molecules in 
this region, which can be quantified by the change in fluorescence intensity. The velocity of 
movement along the gradient is influenced by the size, charge and hydration shell of a protein. 
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These attributes usually change when an interaction partner is bound to the protein, altering 
the MST trace of the labeled molecule. Using the thermophoresis readouts from the titration 
series, an equilibrium binding constant for the interaction can be calculated.  
For interaction studies on 
adhesome components 
using MST, capillaries with 
hydrophilic coating 
(“premium coated”) were 
used to reduce non-specific 
interaction of the proteins 
with the glass surface. The 
interaction partner (ligand) 
and the fluorescently 
labeled protein were 
transferred into the same 
buffer to avoid artifacts 
derived from non-matching 
buffers. The ligand was 
concentrated to ~10x the 
expected KD of the 
interaction, or as highly as 
possible and centrifuged at 
21,000 x g and 4 °C for 5 min 
to remove large aggregates. 
The interaction partner was labeled and loaded into capillaries in varying dilutions to test for 
the optimal concentration to be used in the actual experiment. The capillaries were scanned 
using standard settings (20 % LED power, red or blue laser, depending on the fluorophore) 
and a concentration was selected which yielded 800-900 fluorescence counts. Then the 
titration series of the ligand was performed by mixing 10 µl of the concentrated protein with 
10 µl buffer, then 10 µl of the first dilution with another 10 µl buffer and so on. From the last 
dilution, 10 µl was removed and discarded, while the first tube contained 10 µl of undiluted 
Figure 14: Schematic representation of MST principle (Jerabek-Willemsen et 
al., 2014). (A) Fluorescently labeled molecules are excited and detected by 
the same objective in a temperature gradient induced by an infrared laser. 
At the beginning of the measurement, fluorescent molecules are evenly 
distributed, resulting in a constant initial fluorescence. When the infrared 
laser is switched on, a temperature gradient forms and leads to a 
“temperature jump” caused by a change of the properties of the 
fluorophore. During the following thermophoresis phase, labeled molecules 
move out of the heated area until an equilibrium is reached. After the laser 
is switched off, an “inverse temperature jump” occurs where the 
fluorescently labeled molecules diffuse back into the heated area. (B) The 
shape of the MST trace is dependent on the size, charge and hydration shell 
of the fluorescently labeled molecule and changes upon binding of an 
interaction partner. (C) Typically, a titration series of 16 different 
concentrations of the interaction partner is used to determine an 
equilibrium binding constant. For this purpose, the change in normalized 
fluorescence (∆Fnorm = Fhot/Fcold) is plotted against the ligand concentration, 
yielding a binding curve, which can be fitted to obtain a binding constant.  
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protein. Great care was taken to pipet exactly 10 µl in each step and low-binding pipet tips 
were used to reduce sample loss. Each dilution was then mixed with 10 µl fluorescent protein 
(or 2 µl, if very high ligand concentrations were desired) and loaded into capillaries. Then, a 
capillary scan was performed and the measurements carried out at 20 % LED power and once 
20 % and once 40 % MST power. The binding curves were fitted using the NT Analysis software. 
 Determination of protein stability using differential scanning fluorimetry (Nano-
DSF) 
Differential scanning fluorimetry is a label-free method for determining thermal and chemical 
stability of a protein. The underlying principle of this method is the measurement of 
tryptophan and tyrosine fluorescence of a protein over a temperature gradient or in increasing 
concentrations of denaturing agents (e.g. urea or guanidinium chloride). When a protein 
unfolds due to temperature or denaturants, Trp and Tyr residues, which are normally hidden 
inside the hydrophobic core of the protein, become exposed to the solvent. This leads to a 
change in fluorescence intensity and emission wavelength, which is determined by measuring 
the fluorescence emission at 330 and 350 nm. By plotting the F350/F330 ratio versus the 
temperature, protein denaturing curves are derived. Usually, the thermal unfolding process 
occurs over a narrow temperature range and the mid-point of the transition from folded to 
unfolded protein is referred to as the melting temperature, Tm. This value can be used as a 
measure for protein stability, the higher the Tm, the more stable the protein. Due to the 
measurement of 48 samples at the same time, Nano-DSF is used for buffer screening to 
determine optimal pH, salt and additives like detergents, which help stabilize the protein.  
For conducting a Nano-DSF measurement, the purified protein was concentrated and 
centrifuged at 21,000 x g and 4 °C for 5 min. The minimal sample concentration should provide 
500 nM Trp residues, but in order to ensure high enough signal strength, the protein 
concentration was adjusted so that at least 5 µM Trp concentration was reached. The protein 
was mixed in a 1:10 ratio with the 10x concentrated buffer solutions to be tested, in a final 
volume of 15 µl. The samples were then loaded into glass capillaries, making sure that the 
whole capillary was filled by tapping on it carefully in order to avoid unwanted effects caused 
by evaporation. Up to 48 capillaries were placed into the sample holder and fixated by a 
magnetic clamp. The excitation intensity was adjusted by performing capillary scans at 
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different laser intensities and choosing a value that gave sufficient fluorescence counts for all 
capillaries while not exceeding the detection maximum. The thermal unfolding was performed 
from 15 °C to 95 °C at a rate of 1 °C/min and optionally, a refolding curve from 95 °C to 15 °C 
at 1 °C/min was measured. The PR.ThermControl software was used to determine the Tm 
values for the different buffer conditions were determined using.  
 Preparation of complexes using rate-zonal centrifugation 
For the preparation of large protein complexes, rate-zonal centrifugation using a sucrose 
gradient can be used, avoiding high pressures, which occur during column-based purifications. 
A density gradient of 5-20 % sucrose in buffer B2 at a total volume of 13 ml was mixed using 
a gradient station. 300 µl of sample was carefully layered as a narrow zone on top of the 
gradient and centrifuged at 260,000 x g at 4 °C for 16 h. Afterwards, the gradient was 
fractionated into 500 µl fractions using the gradient station, beginning at the top. The gradient 
provides a medium of increasing density and velocity, separating the particles in the sample 
by size and mass. The fractions were then analyzed by SDS-PAGE and Western Blot. 
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3 Results 
3.1 Focal adhesion kinase (FAK) 
 Production and purification of recombinant FAK 
The DNA sequence coding for full-length murine FAK was inserted into the pCoofy55 
expression vector (obtained from the Microchemistry Core Facility), optimized for intracellular 
production in HEK293E cells. This vector contains a His10-SUMOstar tag under the control of a 
CMV promoter and an EBV origin of replication for enhanced copy number and retention 
inside the cell. The coding sequence for FAK was amplified from the bacterial expression 
vector pCoofy18-mFAK (cloned by D. Moik, Fässler department) using the primers PaKa53 and 
PaKa135 (see Table 4) and inserted into the pCoofy55 backbone, amplified using primers 
PaKa81/136, by SLIC cloning. This allowed for the insertion of the FAK gene at the C-terminus 
of the SUMOstar sequence without any additional amino acids. The correct insertion and 
absence of unwanted 
mutations was verified 
by sequencing the 
entire coding sequence 
for His-SUMO-FAK on 
the vector pCoofy55-
FAK.  
Expression of the 
construct was first 
tested in small-scale 
production in adherent 
HEK293T cells and then 
expanded to liter-scale 
production in 
suspension - growing 
HEK293E cells. For first 
trials, His-SUMO-FAK 
Figure 15: Test purification of His-SUMO-FAK from HEK293T cells. (A) Adherent 
cells from three T-175 flasks were homogenized in buffer (20 mM Tris, 200 mM 
NaCl, 1 mM TCEP, 1 mM PMSF, pH 7.5) and recombinant His-SUMO-FAK was 
enriched by Ni-NTA batch purification (SN B1: unbound protein, El: 500 mM 
imidazole eluate). The eluate was cleaved with SUMOstar protease and the 
protease and affinity tag were removed by reverse Ni-NTA chromatography (El+P: 
eluate after cleaving, SN B2: supernatant after removal of protease and tag). (B) 
Cleaved FAK was applied to a SEC650 gel filtration column fur further purification 
and removal of aggregates (lanes 1-10: fractions as indicated in chromatogram; 
buffer: 20 mM Tris, 200 mM NaCl, 1 mM TCEP, pH 7.5). The elution volume of the 
FAK-containing peak (6, 7) is 11.6 ml, corresponding to a molecular weight of 267 
kDa. 
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was produced by transient transfection of three T-175 flasks of HEK293T cells, which were 
harvested after 72 h. The protein was then subjected to Ni-NTA batch purification, followed 
by removing of the His-SUMO tag with SUMOstar protease and “reverse” Ni-NTA 
chromatography. The affinity tag was removed with ≥ 90 % efficiency, assessed by SDS-PAGE, 
where the FAK band was shifted from 132 kDa (His-SUMO-FAK) to 119 kDa (FAK cleaved). The 
cleaved protein was concentrated and applied to an SEC650 analytical gel-filtration column 
for further purification (Figure 15). The elution volume of FAK is 11.6 ml, which corresponds to 
a size of 267 kDa. This might indicate a dimeric state of FAK or be due to an elongated 
conformation of the molecule.  
 
 
 
 
During purification problems concerning the stability of FAK became apparent. Concentrating 
the protein in centrifugal concentrators and also dialysis into low-salt buffer led to severe 
aggregation. Furthermore, considerable amounts of protein were lost on the SEC column, 
either in filters or on the column itself. The losses during SEC were independent of the column 
material used (S200, Superose-6, SEC650). In order to reduce these effects, the thermal 
unfolding of FAK was assessed using Nano-DSF and a buffer screen obtained from the 
Microchemistry Core Facility (Figure 16). FAK was diluted 10-fold with each of the 48 different 
buffers with varying pH, salt concentrations and additives to a final concentration of 50 µg/ml 
and the transition temperatures for the different conditions were compared. The best 
conditions showed a clear shift of the transition temperatures from 51.8 °C (Tris buffer, pH 
pH 5.5 pH 6.5 pH 7.5 pH 5.5 pH 6.5 pH 7.5 pH 5.5 pH 6.5 pH 7.5 pH 5.5 pH 6.5 pH 7.5 
48.1°C 49.2°C 52.3°C 50.1°C 51.7°C 52.6°C 51.1°C 52.6°C  54.5°C 56.4°C 59.1°C 
49.2°C 51.4°C 52.4°C 49.1°C 52.3°C 51.8°C  53.4°C 54.7°C 53.5°C 56.0°C 58.0°C 
53.9°C 53.8°C 58.6°C 50.3°C 51.3°C 56.4°C 50.0°C  55.2°C 45.4°C 44.7°C 47.3°C 
53.1°C 52.5°C 55.3°C 46.9°C 51.4°C 54.4°C 47.0°C 51.8°C 52.7°C 47.8°C  49.3°C 
Figure 16: Buffer optimization of recombinant FAK produced in HEK293T cells using Nano-DSF. FAK was mixed 
with each buffer indicated in the upper matrix to a final concentration of 50 µg/ml and the transition 
temperatures during thermal unfolding were compared (lower table). The condition most similar to the buffer 
FAK was purified in is highlighted in blue, while the conditions with the highest transition temperatures are 
highlighted in red.  
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7.5) to 58.0 °C and 59.1 °C (50 mM Na-Phosphate, 0/350 mM NaCl, 5 % Glycine, 5 % Mannitol, 
pH 7.5). Therefore, the high-salt variant of the buffer with 1 mM TCEP (C1/C2) was used for 
larger-scale purifications from HEK293E cells.  
Purification of His-
SUMO-FAK from one 
liter of HEK293E 
suspension culture in 
buffers C1/2 typically 
yielded 10 mg of 
protein after Ni-NTA 
column purification 
and 2.5 mg cleaved 
FAK after SEC. This 
indicates that, 
although increasing 
the thermal stability of 
the protein, the buffer could not significantly reduce the high losses during SEC. Furthermore, 
SDS-PAGE shows the co-purification of a second protein of approximately 70 kDa (Figure 17), 
which was identified by LC-MS analysis as HSP70. The presence of this chaperone indicates 
that a part of the FAK molecules (~5 %) might not be correctly folded and kept in solution by 
HSP70. Nevertheless, yield and purity of FAK are satisfactory and sufficient for interaction 
studies and complex assembly.  
 Biophysical characterization of recombinant FAK 
Purified recombinant FAK was analyzed by CD spectroscopy to ensure that the protein is 
folded and to determine the distribution of secondary structure elements. Figure 18 shows that 
FAK displays an estimated secondary structure composition of 55.5 % α-helical, 14.3 % β-sheet 
and 16.4 % unordered elements, as well as a clear transition temperature at 53.5 °C when 
thermally unfolded. This transition temperature of FAK purified on Tris buffer (Figure 18B) is in 
good accordance with the Nano-DSF measurements, where the protein was thermally half 
unfolded at 51.8 °C in Tris buffer. DLS measurements showed that FAK is monodisperse (23 % 
Figure 17: Large-scale purification of recombinant FAK produced in HEK293E 
cells. (A) After IMAC, FAK was applied to a preparative Superdex200 column for 
further purification and removal of aggregates and affinity tag (B, right peak). The 
fractions indicated in the chromatogram were visualized by SDS-PAGE, showing 
high purity of FAK and the presence of HSP70 protein. This chaperone appears to 
keep ~5 % of the recombinant FAK in solution and could not be removed by SEC.  
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PD) and that the particles measured have an average hydrodynamic radius of 5.4 nm, which 
corresponds to a globular protein of 174 kDa. Since this is slightly higher than the molecular 
weight of monomeric FAK (119 kDa) but still well below the weight of a dimer (238 kDa), the 
measurements might indicate a slightly elongated shape of the protein.  
 
Figure 18: Biophysical characterization of recombinant FAK. (A) CD measurement revealed a secondary 
structure distribution of 55.5 % α-helical, 14.3 % β-sheet, 13.8 % turn and 16.4 % unordered, RMSD 0.303. (B)  
The transition temperature was determined by measuring CD at 207 nm over a temperature gradient from 10 to 
90 °C. The melting temperature TM is 51.8 °C. (C) DLS measurements showed a monodisperse protein at 5.4 nm 
hydrodynamic radius. (D) Recombinant FAK displays 1-3 phosphorylations at the positions Y-397, Y-576, Y-577 
and Y-925. (E)  Addition of 0.5 mM ATP to the recombinant protein before SEC shifts the elution volume, 
indicating a conformational change. The green trace represents FAK without addition of ATP and the red trace 
shows FAK in the presence of 0.5 mM ATP. The second peak in the red trace at 115 ml elution volume represents 
His-SUMO tag, which was absent in the other sample. Both SEC runs were carried out on a Superdex200 column 
in Buffer C1.  
Analysis of the protein total mass revealed that each molecule carries 1, 2 or 3 
phosphorylations, since peaks for the expected mass plus 80, 160 or 240 Da were detected. 
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Mapping of the phosphorylation sites within the protein (analysis by N. Nagaraj, MPIB Core 
facility) revealed that the most abundant modification was on Tyr-397, followed by Tyr-925, 
Tyr-576 and Tyr-577. Modification of Tyr-397 in the linker region between the FERM domain 
and the kinase domain is achieved by auto-phosphorylation while Tyr-576 and Tyr-577 are 
phosphorylated by Src kinase. All three modifications are necessary for FAK to adopt the 
catalytically fully active, elongated conformation. Therefore, the recombinantly produced FAK 
is expected to be (at least partially) catalytically active.  
Upon addition of ATP to a final concentration of 0.5 mM to recombinant FAK for the SEC 
purification step, a clear shift in the peak elution volume was observed (Figure 18E). FAK without 
additional ATP eluted at 62.9 ml, corresponding to a globular protein of 292 kDa, while FAK 
incubated with 0.5 mM ATP eluted at 67.5 ml or 202 kDa. The second peak in the profile of 
FAK with 0.5 mM ATP corresponds to cleaved His-SUMO tag, which was not removed prior to 
SEC, while in the sample without ATP it was removed by reverse Ni-NTA chromatography. The 
shift in FAK elution volume might hint at a conformational change upon ATP binding or at a 
transition from a dimeric to a monomeric form, resulting in a more compact shape of the 
protein.  
 Interaction with paxillin and THD 
FAK has been reported to directly interact with paxillin and talin via its C-terminal FAT domain. 
In order to determine whether this holds true with the recombinantly produced proteins, pull-
down experiments were conducted as a first attempt (Figure 19). Either His-SUMO-paxillin 
(produced in E. coli) or His-SUMO-FAK were immobilized on Ni-NTA beads and incubated with 
tag-less THD or FAK.  
A control with FAK and THD on empty beads served as an indicator of unspecific interactions. 
Immobilized paxillin binds tag-less FAK at much higher levels than the unspecific interaction 
of FAK with empty beads, confirming interaction and potentially indicating the ability of 
paxillin to bind more than one molecule of FAK. The stoichiometry of FAK-paxillin binding is 
the subject of ongoing investigations. Furthermore, THD appears to bind to immobilized FAK, 
but not at 1:1 stoichiometry, indicating a weaker affinity to FAK than paxillin. Immobilized 
paxillin does not bind THD and it seems that no ternary complex between FAK, paxillin and 
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THD is formed either, since paxillin is able to bind a high amount of FAK but still no THD in the 
presence of FAK. The affinities of FAK towards THD and paxillin have to be determined.  
 
Figure 19: Ni-NTA pull-downs to determine interactions between FAK, paxillin and THD. His-SUMO-paxillin 
(samples 1, 3 and 4) or His-SUMO-FAK (sample 2) were immobilized on Ni-NTA beads and incubated with tag-
less FAK or THD. As a control, empty beads were incubated with the tag-less proteins. The beads were washed 
twice with 50 mM imidazole-containing buffer to reduce unspecific binding and eluted with 500 mM imidazole. 
Sample 1 shows interaction of FAK with paxillin, which is more than 1:1 stoichiometry, while sample 2 indicates 
a sub-stoichiometric interaction with THD. Paxillin does not bind THD directly, nor in a trimeric complex with FAK 
(sample 3 and 4). SN: unbound interaction partner, El: eluate, 500 mM imidazole, B: proteins still on beads after 
elution 
FAK binding to paxillin was further confirmed by AUC measurements with equimolar 
concentration of the two proteins (Figure 20). Both proteins were measured separately and in 
mixture to determine the different sedimentation behaviors. The runs were conducted at  
14 °C in Buffer C1 supplemented with 10 µM ZnCl2, which is required to keep all LIM domains 
in paxillin properly folded. The protein peaks were detected by via light absorption at 280 nm.  
FAK renders two peaks at 2.5 S and 3.0 S, which correspond to HSP70 and FAK. Surprisingly, 
the intensity of the HSP70 peak is significantly higher than the FAK peak (3.0 vs. 0.6 AU), which 
does not represent the ratio observed in SDS-PAGE (Figure 17) or mass spectrometry and is 
likely an artifact, potentially caused by the addition of Zn2+ ions. Paxillin renders one clear peak 
at 1.4 S and a smaller one at 0.5 S, which is likely caused by insufficient removal of the His-
SUMO tag and of no consequence to the analysis. In the sample containing both proteins, the 
intensity of the paxillin peak at 1.4 S is reduced and the FAK peak at 3.0 S is shifted to 3.5 S, 
away from the HSP70 peak, which remains unchanged. This clear shift of the FAK peak 
confirms the interaction with paxillin.  
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Figure 20: AUC analysis confirms FAK-paxillin binding. Recombinant FAK and paxillin were each diluted to a final 
concentration of 4.8 µM in Buffer C1 supplemented with 10 µM ZnCl2 and separated at 14 °C. Sedimentation was 
monitored via A280-measurement. FAK and paxillin were sedimented separately and in equimolar mixture. FAK 
yields a main peak at 3.0 S, while a second peak at 2.5 S is likely due to HSP70 content in the sample. Paxillin 
renders a peak at 1.4 S. When both proteins are present, the FAK peak is shifted to 3.5 S, indicating interaction. 
 Phosphorylation of recombinant paxillin by FAK 
Phosphorylation of paxillin by FAK has been studied in cells and two tyrosine residues (Y-31 
and Y-118), which are predominantly phosphorylated, have been identified (Bellis et al., 
1995). Consequently, kinase activity of FAK could be tested with recombinant paxillin 
produced in E. coli and therefore non-phosphorylated. Furthermore, it can be used to test 
whether other adhesome components such as talin or kindlin are phosphorylated by FAK. For 
each phosphorylation reaction, 100 µg of recombinant paxillin, kindlin-2, THD, full-length talin 
(obtained from Z. Sun, Fässler department), EPLIN or α-parvin were incubated with 1 µM FAK, 
10 mM MgCl2 and 0.5 mM ATP. Phosphorylation was allowed to proceed for 20 min on ice, 
then at room temperature and finally at 37 °C. After each incubation step, samples were taken 
for Western Blot analysis and the phosphorylation stopped by addition of SDS sample buffer. 
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The phosphorylation was monitored using a universal phospho-tyrosine antibody (Figure 21A, 
C). The Western Blots showed clearly that FAK phosphorylates paxillin at low efficiency at 4 °C 
or RT and at high efficiency at 37 °C, confirming the biological activity of the kinase. 
Furthermore, in all samples the intensity of the FAK band, which is also detected due to its Tyr 
phosphorylation, increases after incubation at RT or 37 °C, indicating auto-phosphorylation of 
FAK and probably further increase in activity.  
 
Figure 21: Characterization of paxillin phosphorylation by FAK. (A) Recombinant FAK (1 µM) was incubated with 
100 µg of each potential substrate (paxillin, THD, talin fl,) in Buffer C1 supplemented with 10 mM MgCl2 and 0.5 
mM ATP at first for 20 min on ice (4 °C), then 20 min at 25 °C and finally 20 min at 37 °C. After each incubation 
step, a sample was taken for Western Blot analysis. Only paxillin is clearly phosphorylated by FAK. (B) It was 
further confirmed that no Src is present in the FAK or paxillin samples, which might also account for the 
phosphorylation. (C) Apart from paxillin, no other protein phosphorylation was detected (kindlin-2, EPLIN, α-
parvin). 0 indicates the substrates without FAK addition, Phos indicates FAK addition and 20 min incubation at 
37 °C. Detection with antibodies specific for paxillin phosphorylation at position Y31 (D) or Y118 (E) both detected 
phospho-paxillin but not the non-phosphorylated form, confirming phosphorylation in both positions. (F) Mass 
spectrometric analysis of phospho-paxillin shows the presence of 0, 1 or 2 phosphorylations on the protein. 
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None of the other substrates was phosphorylated by FAK, including THD or the full-length 
variant (forced into the open confirmation with high salt concentration), which seems to 
interact with FAK. It is possible that kindlin becomes phosphorylated by FAK in the presence 
of paxillin, which might act as a “bridge” between the two proteins. Paxillin, however, is 
efficiently phosphorylated in at least two different positions as determined by analysis of the 
protein full mass of the phosphorylated paxillin sample (Figure 21F). About 40 % of paxillin is 
still non-phosphorylated (60811 Da expected), while approximately 50 % of the molecules 
carry one phosphorylation (mass difference of ~80 Da) and 10 % carry two phosphorylations 
(~160 Da mass difference). Western Blot analysis using antibodies directed against phospho-
Tyr31 and phospho-Tyr118 of paxillin both detected the phosphorylated protein, indicating 
that both known sites are phosphorylated (Figure 21D, E). Enzymatic digest of the protein and 
analysis of the fragments by LC-MS confirmed that paxillin is primarily phosphorylated on 
Tyr118 and to a lesser extent on Tyr31. Furthermore, phosphorylation of Tyr40 and Tyr181 
was detected, two residues which have been mentioned in the literature but not as 
extensively studied as Tyr31 and Tyr118.  
The phosphorylations might be induced by co-purified Src from HEK293E cells, since FAK is 
phosphorylated itself at Y-576 and Y-577, which is normally done by Src. However, no Src band 
at ~60 kDa could be detected in either paxillin or FAK samples, indicating that no Src was co-
purified (Figure 21B). FAK, however, is also detected with the Src antibody, indicating that the 
antibody might not be entirely specific. 
In summary, recombinant full-length FAK could be produced and purified in milligram 
amounts and its activity as a scaffolding protein, which binds to paxillin and, potentially, talin 
as well as its kinase activity could be demonstrated.  
 
3.2 EPLIN 
 Purification and characterization of recombinant α-EPLIN 
The coding sequence for full-length murine α-EPLIN was amplified from the vector pET15b-
EPLIN (by E. Karaköse, Fässler department) using the primers PaKa137/138. The PCR product 
and the empty pCoofy17 vector were cut with the restriction endonucleases BamHI and XhoI. 
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The ensuing fragments were purified by gel extraction and ligated, yielding the pCoofy17-
EPLIN expression vector for His-SUMO-tagged, full-length EPLIN. Correct insertion was 
confirmed by sequencing of the entire coding sequence.  
Recombinant His-SUMO-EPLIN was produced in E. coli-Rosetta cells in LB medium 
supplemented with kanamycin and chloramphenicol at 18 °C for 18 h after induction with  
200 mM IPTG. The pellet was resuspended and disrupted in Buffer A1. The recombinant 
protein was isolated from the cleared lysate via IMAC using buffers A1 and A2, where the main 
fraction of EPLIN eluted at 250 mM imidazole concentration. The His-SUMO-tag was removed 
by cleaving with SenP2 protease over night and reverse Ni-NTA chromatography. EPLIN was 
further purified by SEC chromatography using Buffer A3 supplemented with 10 µM ZnCl2, 
which is required for proper folding of the central LIM-domain, as is the case for paxillin.  
 
Figure 22: Characterization of recombinant EPLIN. (A) SDS-PAGE shows SEC-purified, tagless EPLIN at an 
apparent size of 75 kDa, while the actual MW is 66 kDa, confirmed by ESI-TOF mass spectrometry. (B) CD-
spectroscopic analysis of EPLIN purified in Buffer A containing 0 or 10 µM ZnCl2. For the measurements the 
protein was diluted with water to a final concentration of 2.3 µM (+ Zn2+) or 2.5 µM (- Zn2+). The spectra confirm 
the largely unstructured nature of the protein. (C) Size exclusion chromatography using Buffer A containing 0 or 
10 µM ZnCl2 shows a shift of the elution peak, indicating a Zn2+-dependent compaction of the central LIM-
domain. 
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Addition of ZnCl2 already during IMAC causes severe precipitation of His-SUMO-EPLIN, 
potentially due to interaction of Zn2+-ions with the His10-tag. Incorporation of Zn2+-ions into 
the LIM-domain could be shown in analytical SEC runs in the absence or presence of ZnCl2 in 
the buffer. Addition of ZnCl2 causes a clear shift of the elution volume from 11.5 ml to 12.0 ml 
(295 kDa to 213 kDa), indicating a compaction of the molecule and a reduction of the 
hydrodynamic volume, probably caused by a conformational change of the LIM domain (Figure 
22C). The apparent molecular weight of EPLIN is much higher than its actual weight of 66 kDa, 
which indicates a largely unstructured protein, as was to be expected from disorder prediction 
analysis (data not shown). CD spectrometric analysis of EPLIN yielded a secondary structure 
distribution of 6 % α-helix, 33 % β-sheet, 24 % turns and 37 % unordered elements (Figure 22B), 
confirming the predictions. It appears that only the central LIM-domain of EPLIN has a distinct 
structure, while the actin-binding domains at the N- and C-termini are unstructured and 
flexible. Binding to F-actin might cause these domains to adopt a more distinct structure. It is 
notable that on denaturing SDS-PAGE, the apparent size of EPLIN is approximately 80 kDa, 
while analysis of the total protein mass yielded the expected molecular weight of 66132 Da 
(Figure 22A). This shift might therefore be caused by the large amount of disordered structures. 
Addition of ZnCl2 does not significantly change the CD spectrum, indicating that binding of Zn2+ 
leads to the compaction observed in SEC but does not lead to the formation of secondary 
structures.  
 Recombinant EPLIN does not interact with PINCH and paxillin 
EPLIN has been shown to localize to focal adhesions and associate with PINCH and paxillin, 
which might be responsible for its recruitment to the adhesome. However, in pull-down assays 
neither full-length His-SUMO-PINCH nor full-length PINCH in complex with α-parvin and ILK 
bound EPLIN in higher amounts than the negative control.  
Furthermore, recombinantly produced PINCH LIM 2, 3, 4 or 5 domains (produced and purified 
by M. Veelders, Fässler department) failed to bind EPLIN (Figure 23). PINCH LIM 1 domain could 
not be expressed, therefore binding to it was not tested. Similarly, binding to paxillin was 
neither observed in pull-down assays nor in MST measurements (data not shown).  
These findings suggest that the interaction is indirectly or postranslational modifications such 
as phosphorylation of EPLIN might be necessary for interaction with either PINCH or paxillin. 
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It has been reported that in cells, EPLIN is phosphorylated by ERK. This was confirmed by 
incubating recombinant EPLIN with commercial ERK (New England Biolabs) and then analyzing 
the protein total mass (Figure 24).  
 
Figure 23: Interaction studies of EPLIN and PINCH using Ni-NTA pull-downs. His-SUMO-tagged PINCH LIM 
domains 2-5, full-length PINCH or full-length IPP complex (constructs #2, #3 or #3 in complex with kindlin-2 and 
paxillin) were immobilized on Ni-NTA beads and incubated with recombinant tagless EPLIN. Empty beads were 
used as a control for unspecific interactions. SN1 refers to unbound tagged protein, SN2 to unbound EPLIN, W1 
to the first of two washing steps with 50 mM imidazole, E1 to eluate 1 with 500 mM imidazole and B to beads 
with residual protein bound to them. Neither full-length PINCH nor the individual LIM domains showed binding 
to EPLIN. PINCH in complex with parvin and ILK showed no interaction either, even when in complex with kindlin-
2 and paxillin. 
Besides non-phosphorylated EPLIN at 66132 Da, peaks with masses of 66293 Da and 66374 
Da were detected, corresponding to EPLIN with 2 and 3 phosphorylations (~80 Da mass shift 
per phosphate group). However, direct comparison of phospho-EPLIN (pEPLIN) to the non-
phosphorylated form did not yield differences in pull-downs or MST experiments. Therefore, 
no direct interaction between EPLIN and either paxillin or PINCH was observed. However, it 
cannot be fully excluded that modifications on PINCH or paxillin are required for interaction 
or that different phosphorylations on EPLIN from those by ERK are necessary. 
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Figure 24: Phosphorylation of EPLIN by ERK has no effect on binding to PINCH or paxillin. (A) EPLIN was 
phosphorylated by recombinant ERK (NEB) 2 or 3 times, as confirmed by mass spectrometric analysis. Residual 
non-phosphorylated EPLIN at a molecular weight of 66132 Da was observed as well as species which were 160 
or 240 Da heavier, corresponding to 2 or 3 phosphate groups. (B) In Ni-NTA pull-down assays with immobilized 
His-SUMO-PINCH, His-SUMO-paxillin or His-tagged IPP complex, no difference was observed between 
phosphorylated EPLIN (pEPLIN) and the non-phosphorylated form. Empty beads were used as a control for 
unspecific interactions. None of the samples showed increased EPLIN binding compared to the negative control. 
SN refers to unbound EPLIN, W1 to the first of two washing steps with 50 mM imidazole, E1 to eluate 1 with 500 
mM imidazole and B to beads with residual protein bound to them.  
 
3.3 Simultaneous expression of the adhesome core components in the same cell 
using the MultiBAC expression system 
 Cloning and assembly of MultiBAC expression vectors 
For the study of multi-protein complexes it is often advantageous to co-express all 
components simultaneously in a single cell, allowing the complex to assemble on its own in 
native conditions, rather than producing all components separately and then painstakingly 
assembling them in vitro. If a tight complex is formed inside the cell, it can subsequently be 
purified as an entity with all components present in the correct stoichiometry. One expression 
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system optimized for multi-protein complex production in insect cells is the MultiBAC system 
(Bieniossek et al., 2012). It was used for the production of full-length IPP complex by itself or 
in combination with either kindlin-2 or paxillin or GST-integrin β1 or THD together with FAK or 
EPLIN together with RSU-1. 
 
Figure 25: Schematic representation of the MultiBAC expression vector assembly. (A) Each gene to be 
expressed was first inserted into a donor vector (pIDC/pIDK/pIDS) or an acceptor vector (pACEBac1) to provide 
a promoter and a polyA sequence for insect cell expression. (B) The expression cassettes were then cut out with 
restriction enzymes and inserted into another linearized vector carrying another expression cassette (C). (D) This 
allowed for the assembly of donor and acceptor vectors with 2-3 expression cassettes. The donor vectors can 
each be merged with the pACEBac1-IPP acceptor vector separately or simultaneously using Cre-mediated 
recombination at the loxP sites. Correctly fused vectors are selected according to the respective antibiotic 
resistance markers. The acceptor vector or any fusions with donor vectors can be integrated into the baculovirus 
genome via the Tn7L and Tn7R sites. 
The rationale behind this expression strategy was to start with the IPP complex as a stable 
“core” of the multi-protein complex, since ILK, PINCH and α-parvin have been reported to 
form a ternary complex which is pre-assembled in the cytosol prior to recruitment into focal 
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adhesions (Hoffmann et al., 2014). To this “core”, additional components can be added to test 
if a larger complex is formed and stable enough to allow co-purification. Ideally, this would 
have allowed for the isolation of adhesome complexes, which could have been used for 
chemical crosslinking, cryo-EM studies or even crystallization.  
The basic principle of the MultiBAC system is the assembly of all genes to be expressed into 
one vector, pACEBac1 or 2, which contains Tn7R and Tn7L sequences necessary for 
transposition into the baculovirus genome. Therefore, the genes coding for ILK, PINCH and α-
parvin were inserted into the pACEBac1 “acceptor” vector to provide the complex core. The 
other components were inserted into pIDC, pIDS or pIDK “donor” vectors, which do not 
possess Tn7R/L sequences and thus cannot be directly inserted into the virus genome. Instead, 
they each contain one loxP site, which allows for Cre recombinase-mediated fusion of the 
donor vectors with the acceptor vector pACEBac1, which also carries a loxP site. Since all 
vectors carry different antibiotic resistance markers, up to three different donor vectors can 
be fused to an acceptor vector and the desired expression vector can be identified by selection 
using a combination of the respective antibiotics. With this approach, different combinations 
of the adhesome components could be cloned in one single step.  
Prior to assembly of the multi-protein expression constructs, each gene to be expressed had 
to be inserted into the multiple cloning site of pACEBac1, pIDC, pIDK or pIDS in order to 
provide them with a promoter and a polyA sequence compatible with insect cell expression. 
The coding sequences for full-length murine ILK, PINCH-1, α-parvin, kindlin-2, FAK, paxillin, 
integrin β1-CT, EPLIN and RSU-1 were amplified from expression vectors available at the 
Fässler department. α-parvin carried an N-terminal His8-tag, cleavable by PreScission protease 
and PINCH-1 was amplified with primers coding for a C-terminal Strep-tag sequence. In order 
to increase the size of the integrin β1 tail peptide and to allow for affinity purification, the 
coding sequence was first cloned into the pGEX-6P-1 vector, adding an N-terminal GST-tag to 
the tail. The coding sequence for GST- β1 tail was then inserted into the pIDK vector. Apart 
from the above mentioned, no further affinity tags were added to components of the 
complex. The details of the construction of the first set of vectors are indicated in Table 6.  
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Table 6: Overview of MultiBAC donor and acceptor vectors generated. All coding sequences were amplified by 
PCR using the primers indicated and, if not further specified, vector backbone and PCR product were both 
digested with the same restriction enzymes prior to ligation. 
Name Template Primers promoter/polyA/tag Restriction enzymes 
pGEX-6P-1-Beta1 pET15b-TMCyto-b1-wt PaKa182/183 -/-/GST BamHI/XhoI 
pACEBac1-PINCH pCoofy17-PINCH1 PaKa184/185 polH/SV40/Strep SalI/NotI 
pIDK-ILK pCoofy50-mILK PaKa187/188 p10/HSV/- XhoI/NheI 
pIDK-Parvin pCoofy50-mParva PaKa189/190 p10/HSV/His8 XhoI/NheI 
pIDS-K2 pCoofy17-Kindlin2 PaKa191/192 p10/HSV/- XhoI/NheI 
pIDC-Paxillin pCoofy50-Paxillin PaKa193/194 polH/SV40/- StuI/XbaI 
pIDK-IntBeta pGEX-6P-1-Beta1 PaKa203/204 p10/HSV/GST XhoI/NcoI 
pIDK-EPLIN pCoofy17-EPLIN PaKa195/196 p10/HSV/- XhoI/NheI 
pIDK-RSU pCoofy17-RSU PaKa197/198 p10/HSV/- NheI/NsiI 
pIDC-Talin pCoofy17-THD PaKa199/200 polH/SV40/- AfeI/XbaI insert 
StuI/XbaI backbone 
pIDC-FAK pCoofy55-FAK PaKa201/202 polH/SV40/- BamHI/XbaI 
 
After insertion of all coding sequences into donor or acceptor vectors and sequencing of the 
entire genes, vectors with multiple expression cassettes were generated. Restriction enzymes 
were selected which cut the vectors before the promoter and after the polyA sequence. The 
ensuing fragments were blunted when necessary and inserted into a linearized acceptor or 
donor vector carrying a second expression cassette. Likewise, vectors with three expression 
cassettes were created. Table 7 lists the multiple expression vectors generated. Figure 25 shows 
the schematic representation of the cloning steps as well as the final three donor vectors pIDS-
K2-IntBeta-Pax, pIDK-RSU-EPLIN and pIDC-FAK-Talin and the acceptor vector pACEBac1-IPP. 
Table7: Overview of MultiBAC vectors with multiple expression cassettes. Indicated are the vectors out of 
which expression cassettes were cut out (Insert) as well as the vectors into which they were inserted (Backbone) 
and the restriction enzymes used. Whenever the ensuing ends of the fragments did not match, they were blunted 
using T4 DNA polymerase. The vectors highlighted in green are the final donor and acceptor vectors.  
Name Insert from Insert RE Backbone Backbone RE 
pACEBac1-PINCH-ILK pIDK-ILK SpeI/PmeI/HindIII pACEBac1-PINCH SpeI/PmeI 
pACEBac1-IPP pIDK-Parva PmeI/ClaI/PstI pACEBac1-PINCH-ILK PmeI 
pIDS-K2-IntBeta pIDK-IntBeta PI-SceI/BstXI pIDS-K2 BstXI 
pIDS-K2-IntBeta-Pax pIDC-Paxillin PI-SceI/NruI pIDS-K2-IntBeta BstXI 
pIDK-RSU-EPLIN pIDK-EPLIN PI-SceI/BstXI pIDK-RSU PI-SceI 
pIDC-FAK-Talin pIDC-Talin NruI/MscI pIDC-FAK NruI 
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The donor vectors were mixed with the acceptor vector and fused using Cre-mediated 
recombination. After transformation into chemically competent E. coli cells, clones carrying 
correctly fused vectors were selected by testing for the presence of multiple antibiotic 
resistances. Attempts to generate a fusion construct of pACEBac1-IPP with all three donor 
vectors were not successful. It is possible that the ensuing vector fusion construct is too large 
for efficient transformation into chemically competent cells, a problem that might be 
overcome by electroporation. It was decided, however, to try expression of fusions of 
pACEBac1-IPP, pIDS-K2-IntBeta-Pax and pIDC-FAK-Talin or pACEBac1-IPP and pIDK-RSU-EPLIN 
first and upon promising results more efforts could have been made to create a fusion of all 
four vectors. Five different vector fusions or acceptor vectors were integrated into baculovirus 
and used for recombinant protein production. For simplicity, they were given numbers as 
which they are referred to in the following sections.  
IPP#1: pACEBac1-IPP + pIDS-K2-IntBeta-Pax + pIDC-FAK-Talin   
ILK, His8-α-parvin, PINCH fl-Strep, kindlin-2, paxillin, GST-beta 1, THD, FAK 
IPP#2: pACEBac1-IPP + pIDS-K2-IntBeta-Pax   
ILK, His8-α-parvin, PINCH fl-Strep, kindlin-2, paxillin, GST-beta 1 
IPP#3: pACEBac1-IPP + pIDK-RSU-EPLIN  
ILK, His8-α-parvin, PINCH fl-Strep, RSU-1, EPLIN 
IPP#4: pACEBac1-IPP  
ILK, His8-α-parvin, PINCH fl-Strep 
IPP#5: pACEBac1-IPP-dLIM5 (Stop-codon inserted after PINCH LIM4 via mutagenesis)   
ILK, His8-α-parvin, PINCH dLIM5 
 Test expression and purification of IPP#1 and IPP#2 and optimization of expression 
conditions 
IPP constructs 1 and 2 were inserted into baculovirus genomes and virus was produced in SF9 
insect cells. The virus particles were used to infect small culture volumes (10 ml) of SF9 or High 
Five insect cells at dilutions of 1:500, 1:1000 or 1:2000. After 72 h post infection, the cells were 
counted, harvested by centrifugation, flash-frozen in liquid nitrogen and resuspended in PBS 
(100 µl per 10*106 cells). The lysed cells were mixed by vortexing and samples of the whole 
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cell lysates as well as of the cleared supernatants after centrifugation were separated by SDS-
PAGE and analyzed by Western Blot (Figure 26). Detection of the expected adhesome proteins 
using specific antibodies revealed that the IPP complex, kindlin-2, paxillin, FAK and THD were 
successfully produced. Comparison of the whole cell lysates and the soluble fraction revealed 
no large differences for most of the proteins, indicating that the greater part of the 
recombinant proteins is soluble and not aggregated. High Five and SF9 cells displayed 
significant discrepancies in expression levels, especially for α-parvin, PINCH and paxillin. 
Overall, protein amounts were much higher in High Five cells at all dilutions, suggesting these 
cells are best suited for large-scale production. In High Five cells, virus dilutions of 1:500 and 
1:1000 showed no significant differences, while the 1:2000 dilution resulted in slightly 
reduced expression levels. Therefore, production in High Five cells at a virus dilution of 1:1000 
was determined as optimal condition.  
 
Figure 26: Detection of recombinantly produced proteins in insect cells by Western Blot. IPP#1 and #2 
constructs were produced in High Five (H5) and SF9 cells for 72 h and the whole cell lysates (WCL) and soluble 
fractions (SN or not further specified) were analyzed by Western Blot using specific antibodies against the 
proteins produced. Optimal virus dilutions (1:500, 1:1000, 1:2000) were tested as well and compared to non-
infected SF9 or H5 lysates (ctrl). All proteins were produced in the expected samples, except for GST-Integrin β1, 
which might be degraded or not produced at all. Protein levels of all components were higher in High Five cells 
than in SF9 cells and a dilution of 1:1000 yielded optimal expression levels.  
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None of the samples showed a prominent band at 32 kDa in the anti-GST detection, indicating 
that either the GST-Integrin β1 fusion construct is not expressed or is being degraded in insect 
cells. Furthermore, a high amount of unspecific bands indicates that a lot of GST is present in 
the cells, which might be the reason why GST fusion proteins are degraded. Therefore, integrin 
tail peptides from other sources have to be added for complex assembly.  
FAK and THD were only detected in the IPP#1 samples, as expected. The anti-THD antibody 
detects some unspecific bands but shows clearly a band at 46 kDa, which is absent in the IPP#2 
samples. Paxillin and kindlin-2 levels appear to be significantly higher in the IPP#2 samples 
than in IPP#1, which might be due to the fact that in #2, the cells do not have to produce FAK 
and THD and have therefore more capacities for producing the other proteins. However, the 
levels for ILK, PINCH and parvin appear mostly identical in both constructs. Another 
explanation could be the fusion of 2 copies of the pIDS-K2-IntBeta-Pax vector to one 
pACEBac1-IPP vector, resulting in higher expression levels of the two proteins. 
After defining the optimal expression conditions, 500 ml culture volume of construct IPP#2 
was was used to test purification with a 1 ml HisTrap column. Theoretically, if a tight complex 
of ILK, PINCH and parvin and optionally of kindlin-2 and paxillin is formed, all components 
should co-elute if α-parvin is immobilized to the column via its His8-tag. Since the previous 
samples were very viscous, the purification of one quarter of the cell lysate each was carried 
out in Buffer A3 without any additives (1), with 0.1 % NP-40 (2), with 0.1 % Tween-20 (3) or 
with 10 µM ZnCl2 (4) (Figure 27). The addition of ZnCl2 was expected to increase the amounts 
of PINCH and paxillin purified, since both proteins require the presence of Zn2+ in the buffers 
when produced in E. coli. The protein bound to the column was eluted using stepwise increase 
of 50, 125, 250 and 500 mM imidazole.  
Sample (3) showed by far the purest preparation of ILK, PINCH and α-parvin, indicating that 
Tween-20 reduces unspecifically bound contaminating proteins or binding to membrane 
fragments left over from cell lysis. As expected, addition of ZnCl2 to the buffer resulted in a 
more distinct PINCH band. Therefore, supplementing the buffers used for purification with  
0.1 % Tween-20 and 10 µM ZnCl2 appears beneficial. In later purifications, it became evident 
that including 0.1 % Tween-20 in the lysis buffer and 0.05 % in all other buffers yields 
equivalent purity and reduces the effects of the detergent on biophysical methods.  
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Figure 27: Optimization of buffer conditions for purification of the IPP complex. Cell lysate of IPP#2 was purified 
via IMAC in Buffer A3 with either no additives, 0.1 % NP-40, 0.1 % Tween-20 or 10 µM ZnCl2. The fractions of the 
50, 125, 250 and 500 mM imidazole elution steps were concentrated by TCA precipitation and analyzed via SDS-
PAGE. Addition of Tween-20 resulted in the purest preparation of ILK, PINCH and parvin, while addition of ZnCl2 
increased PINCH elution.  
Unfortunately, none of the samples showed clear bands of kindlin-2 or paxillin bound to the 
IPP complex. This indicates that the interactions might not be strong enough to retain a larger 
complex potentially formed inside the insect cells during purification. Therefore, this method 
was used for purification of only the IPP complex without co-expression of other components.  
 Purification of recombinantly produced adhesome complexes using rate-zonal 
centrifugation 
Since all of the desired adhesome components were produced in copious amounts inside the 
same cell, the formation of a larger complex was expected. The reason why no other 
components than ILK, PINCH and parvin could be co-purified in Ni-NTA chromatography might 
be that shearing forces are too high when the complexes pass through the column material 
under constant flow and thus components bound with low affinities or with high koff rates than 
those between the components of the IPP complex are washed away more easily. To avoid 
this situation, the more gentle method of purification by rate-zonal centrifugation was applied 
to cell lysates of IPP#1. Cells were homogenized in Buffer B2 and 300 µl of the centrifuged, 
unfiltered lysate was applied to a 13 ml sucrose gradient (5-20 %). After 16 h of centrifugation, 
the gradient was separated into fractions of 500 µl, beginning from the top of the tube. The 
fractions, especially those representing the first half of the gradient where complexes were 
expected, were analyzed by SDS-PAGE and Western Blot (Figure 28).  
All proteins were present in the cell lysate, as expected. ILK, PINCH and α-parvin were 
detected in fractions 2-12, with lower fraction numbers corresponding to lower density of the 
gradient and lower molecular weight of the particles and higher numbers to more density and 
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heavier particles. Therefore it seems that some IPP complex was formed and could be 
detected at the expected medium-range density, while the majority of IPP was detected as 
single proteins. The remaining proteins FAK, THD, paxillin and kindlin-2 were only detected in 
fractions 2-7 and did not correlate with the IPP complex at higher fractions. Therefore, they 
were not part of a complex, which would have sedimented further than the first few fractions.  
 
Figure 28: SDS-PAGE and Western Blot analysis of the preparation of adhesome complexes by rate-zonal 
centrifugation. Lysate of construct IPP#1 was separated using a 5-20 % sucrose gradient and fractions of 500 ml 
were harvested from the top. 0 indicates the topmost fraction containing the lightest particles, while 24 is the 
bottom fraction of highest density. The location of the expressed adhesome components was determined by 
Western Blot using specific antibodies. It is apparent that ILK, PINCH and α-parvin are spread out over fractions 
2-12, indicating the presence of a complex at higher fraction numbers and individual proteins at lower numbers. 
FAK, THD, paxillin and kindlin-2 are only present up to fraction 7, indicating that none of them forms a complex 
with other proteins. If a large “adhesome” complex had been formed, the individual bands would have been 
enriched in certain higher fractions due to the increased molecular weight of a complex compared to individual 
components. 
This experiment showed that separation of adhesome complexes in a sucrose gradient is not 
a suitable tool for obtaining high-quality protein preparations for structural analysis. If there 
are complexes pre-formed in the cytosol of the High Five cells, they are not stable enough to 
allow purification, potentially because the affinities of individual components towards each 
other are too low. It is also possible that FAK, THD, paxillin or kindlin-2 are post-translationally 
modified (e.g. phosphorylations) by the insect cells in a way that abrogates binding to the IPP 
complex.  
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Production and purification of IPP#3, in which EPLIN and RSU-1 are co-expressed with the IPP 
complex yielded similar results. After purification, only the IPP complex and trace amounts of 
RSU-1 were detected, suggesting that the affinity of RSU-1 to PINCH is not high enough to 
form a tight complex in 1:1:1:1 stoichiometry (data not shown). 
Taken together co-purification by IMAC or on Ni-NTA beads with large pore sizes failed (data 
not shown), suggesting that the initial hypothesis of a stable adhesome complex might have 
to be corrected and that the interactions of the individual components might be more 
transient. 
3.4 The IPP complex 
 Large-scale expression and purification of recombinant full-length IPP complex from 
High Five insect cells 
Since the initial tests showed that no large adhesome complex could be isolated by this 
approach, the main focus was shifted towards the production and purification of recombinant 
full-length IPP complex. Due to instability of the proteins and extremely low expression levels, 
no purification and characterization of a trimeric complex of all three components in full-
length has been reported to date. Since a number of caveats have been observed during 
production and purification of the complex, a detailed protocol is presented here. 
IPP complex can be purified using any of the constructs, but highest yields are obtained for 
IPP#4, which comprises only the pACEBac1-IPP donor vector. Infection of the cells can be 
achieved using a P1 virus preparation, which is the “classical” protocol. Alternatively, an 
appropriate amount of SF9 cells are transfected with the bacmid DNA and the ensuing cleared 
supernatant, which contains virus particles, is used to infect the final expression culture. The 
latter protocol omits the P1 virus amplification to shorten the process. It is however critical 
that the baculovirus used for infection is prepared directly before protein production. The 
virus can theoretically be stored at 4 °C for several weeks and retain its activity, but it has been 
observed that with increased age of the virus IPP yields decrease and at a certain point ILK is 
suddenly no longer produced, while parvin and PINCH are still produced. Therefore, fresh virus 
should be produced for each expression and it is beneficial to produce a large batch (3-5 l 
culture volume) once instead of several smaller batches subsequently.  
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Protein production was maintained for 72 h post infection and yielded copious amounts of IPP 
complex. Therefore, no variation of the duration of protein production was tested although 
the yield might still be further increased. The cells were harvested by centrifugation and the 
pellets flash-frozen in liquid nitrogen. The pellets can be stored for several months at -80 °C 
until needed, causing no reduction in yield or quality of the purified proteins that could be 
observed so far. 
After thawing the cell pellet was resuspended in buffer to a final volume of 10x pellet volume 
to lower the viscosity of the ensuing lysate. Cell lysis was carried out in Buffer B1, which 
contains 0.1 % Tween-20 for efficient removal of membrane fragments. The buffers used for 
purification contained 0.05 % Tween-20. The lysis buffer and all other buffers were 
supplemented with 1 mM TCEP to keep the Cysteine residues of the intracellular proteins 
reduced and to prevent formation of non-physiological disulfide bonds. To prevent proteolytic 
degradation, 1 mM PMSF was added to the lysis buffer. Since no degradation was ever 
observed, PMSF can probably be omitted. Furthermore, all buffers contained 10 mM ZnCl2 to 
allow proper folding and activity of the five PINCH LIM domains. For cell disruption, thawing 
of the flash-frozen cells and treatment with a Dounce homogenizer was sufficient. Although 
Tween and high amounts of DNase were added, the cell lysate after centrifugation was still 
very turbid and probably still contained membrane or other cell fragments. This could not be 
improved by longer centrifugation, therefore the lysate had to be passed through several 0.45 
µm sterile filters (~30 ml per filter before clogging) to remove large particles prior to IMAC.  
The cleared lysate was passed 2-3 times over the column for sample application and elution 
was carried out using a stepwise increase of imidazole concentration (Figure 29). IPP complex 
eluted at 125 mM and 500 mM imidazole, with the majority of the protein in the 500 mM 
fraction. Judging from SDS-PAGE analysis, ILK, PINCH and α-parvin are purified in 
approximately 1:1:1 stoichiometry, indicating that a stable complex is formed. If this were not 
the case, more His8-tagged α-parvin would be isolated and tagless ILK and PINCH would be 
lost. It is noteworthy that despite having lower molecular weight, α-parvin (46 kDa) displays a 
higher apparent molecular weight in SDS-PAGE than ILK (51 kDa). This was verified by Western 
Blot analysis and by cleaving His8-parvin with PreScission protease, which results in a shift of 
only the upper band, while the ILK band remains unchanged (data not shown). The apparent 
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molecular weight of PINCH (38 kDa) in SDS-PAGE is lower than expected (~30 kDa), but mass-
spectrometric analysis of protein full mass showed all three proteins at the expected sizes. 
 
Figure 29: Purification of full-length IPP complex by IMAC and SEC. (A) The cleared lysate from High Five insect 
cells was loaded onto a 5 ml HisTrap column and the chromatography carried out in Buffer B2 and B3. The 
fractions were analyzed by SDS-PAGE. (C) Full-length IPP complex in an apparent stoichiometry of 1:1:1 eluted 
at 125 and 500 mM imidazole. Since only α-parvin carries a His8 tag, the three proteins evidently form a stable 
complex that allows co-purification. (B, D) As a second purification step, the IPP complex was separated from 
aggregates on a Superdex200 column. The peak elution volume of 70 ml corresponds to an apparent molecular 
weight of 165 kDa, only slightly larger than the actual weight of 136 kDa, indicating monomeric complexes. The 
IPP complex could be purified to >90 % purity. 
PINCH carries a C-terminal Strep-tag, therefore immobilization of the complex on StrepTactin 
beads was intended as a second purification step to reduce contaminants in the protein 
sample. However, only very low amounts of IPP complex bound to the beads, indicating that 
the Strep-tag might not be accessible and hidden inside the complex. Therefore, it cannot be 
used for further purification. 
The fractions containing IPP complex were pooled and concentrated using a centrifugal 
concentrator to a final volume of 2.5-3 ml and applied on a Superdex200 size exclusion column 
equilibrated with Buffer B2. The chromatogram showed a clear separation of aggregates near 
the void volume (~40 ml) and the trimeric IPP complex with a peak at 70 ml elution volume, 
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which corresponds to a globular protein of 165 kDa. This is very close to the actual size of the 
complex of 136 kDa, indicating a monomeric form. It is notable, however, that the IPP peak is 
unusually broad, which might be caused by the presence of oligomers at lower elution 
volumes and by disassembled complexes towards higher elution volumes. The presence of 
contaminants, such as HSP70 or other chaperones, can be excluded, as they would have been 
detected either in SDS-PAGE or mass spectrometric analysis. If the presence of Tween-20 
poses a problem for subsequent analyses or assays, SEC can also be performed without the 
detergent in the running buffer. This seems to slightly reduce yield and stability of the proteins 
and results in a more “uneven” chromatogram, indicating the presence of multiple species.  
The final purified IPP complex displays a purity of >90 %, judging from SDS-PAGE, at a yield of 
around 5 mg per 1 l High Five cell culture volume. It can be concentrated up to 10 mg/ml and 
can be flash-frozen in liquid nitrogen without any additives and stored at -80 °C. Upon thawing, 
aggregates need to be removed by centrifugation at 21000 x g for 5 min at 4 °C.  
The main problem when working with the IPP complex is its tendency to form aggregates and 
to precipitate. Considerable amounts of protein are lost when the IPP complex is concentrated 
using a centrifugal concentrator, which is noticeable as white precipitate on the membrane. 
Furthermore, the IPP complex aggregates in a time-dependent manner, resulting in clearly 
visible precipitate after storage over night at 4 °C. This aggregation process can be accelerated 
by increasing the temperature to room temperature. Therefore, whenever assays are 
conducted, aggregates are removed by centrifugation shortly before adding the IPP complex 
to a sample and all samples are constantly kept on ice or at 4 °C.  
 Biophysical characterization of recombinant IPP complex 
For all assays and for the determination of protein concentration, the IPP complex is treated 
as one large fusion protein with a molecular mass of 135878 Da and an extinction coefficient 
of 129260 M-1cm-1.  
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The secondary structure distribution and thermal unfolding of recombinant IPP complex was 
studied by CD spectroscopy (Figure 30A, B). The spectrum reveals that the complex is folded and 
contains 38.4 % α-helical, 13.2 % β-sheet, 18.9 % turn and 29.3 % unordered elements. The 
thermal unfolding curve did not show one clear transition temperature, but rather several 
“smaller” transitions. This might be due to individual unfolding of ILK, PINCH and α-parvin and 
could potentially be further influenced by disassembly of the complex. The main transition 
occurs around 52 °C, while two smaller transitions can be observed around 30 °C and 75 °C. It 
is notable that thermal unfolding seems to begin at 20 °C already, confirming the observation 
of increased 
aggregation at room 
temperature. 
DLS measurements 
were conducted in 
Buffer B2 without 
Tween-20, since the 
detergent micelles 
interfere with the 
detection of particle 
species. The 
measurement 
revealed a 
hydrodynamic 
radius of 5.2 nm, 
which corresponds 
to a globular protein 
of 157 kDa (Figure 
30C). This value is 
very close to the 
actual molecular 
weight of 136 kDa 
and, like SEC 
Figure 30: CD and DLS analysis of recombinant IPP complex. (A) CD measurements of 
55 µM IPP complex, diluted 1:10 in ddH2O revealed a secondary structure distribution 
of 38.4 % α-helical, 13.2 % β-sheet, 18.9 % turn and 29.3 % unordered, RMSD 0.187. 
(B) The melting curve shows a main transition at 52 °C and two smaller transitions at 
30 °C and 75 °C. (C) DLS measurements at 4 °C showed a sharp decay curve which was 
fitted to a hydrodynamic radius of 5.2 nm (157 kDa) at 50 % polydispersity. (D) DLS 
measurements at 20 °C (green curves) showed the presence of large particles and 
aggregation, compared to the same sample at 4 °C (pink curve). (E) Storage at 4 °C 
over night resulted in a defined increase in hydrodynamic radius to 6.5 nm (269 kDa). 
(F) A temperature scan from 4 °C to 25 °C revealed that aggregation of the IPP complex 
begins at a temperature of 17-18 °C, with really large aggregates beyond 25 °C. The 
measurements were carried out in Buffer B2 without Tween-20. 
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measurements, indicates monomeric complexes. The polydispersity of 50 % was rather high, 
indicating that the sample was not perfectly homogeneous. DLS analysis also confirms the 
thermal instability of the IPP complex, since after increasing the temperature to 20 °C the 
sample already contains large aggregates (Figure 30D). Aggregation begins to increase 
significantly at 17-18 °C, leaving only very large particles beyond 25 °C (Figure 30F). Therefore, 
measurements with the IPP complex should be conducted below 17 °C, if possible. Another 
notable change in the DLS decay curves occurs after storage of the IPP complex over night at  
4 °C. Even after centrifugation directly before the measurement, the same sample suddenly 
shows an increase in hydrodynamic radius, from 5.2 nm to 6.5 nm, corresponding to a globular 
protein of 269 kDa (Figure 30E). This might indicate the formation of complex dimers over night, 
but not of large aggregates, since the decay was still very sharp.  
From CD and DLS measurements it can be concluded that the IPP complex is folded and 
monomeric, if freshly purified by SEC. Increasing the temperature to more than 18 °C or 
incubation over night lead to an increase in size and to the formation of aggregates. Therefore, 
for critical analyses the IPP complex should be used directly after SEC and kept at lowest 
possible temperature.  
 Interaction studies of IPP and other adhesome components 
Correct folding and biological activity of the recombinant IPP complex was assessed through 
interaction studies with its reported binding partners. IMAC-purified IPP complex was 
concentrated and mixed with other recombinantly produced and purified adhesome 
components and applied to an analytical SEC650 column. The formation of a quaternary 
complex of IPP and kindlin-2 (78 kDa, produced in E. coli) could be observed by a clear shift of 
the IPP elution peak from 12.3 ml (197 kDa) to 11.7 ml (293 kDa) (Figure 31A). SDS-PAGE of the 
peak fraction shows all four proteins at apparently equal amounts, confirming the formation 
of a quaternary complex (Figure 31D). A second peak at 13.2 ml (109 kDa) contains excess 
kindlin-2 and disassembled IPP components. The elution volume of the second peak is almost 
identical to that of monomeric kindlin-2.  
The same applies for complex formation with paxillin (66 kDa, E. coli), where the IPP peak is 
also shifted to 11.7 ml (Figure 31B). A shoulder of the peak contains paxillin and IPP complex, 
which did not bind each other (Figure 31E). Notably, monomeric paxillin elutes at the same 
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volume as the IPP complex, which is probably due to a high amount of disordered stretches 
within the protein rather than multimer formation.  
THD does not bind to the IPP complex, which results in the formation of two peaks at elution 
volumes identical to monomeric IPP complex and THD (Figure 31C). Unlike kindlin-2 and paxillin, 
addition of THD does not cause a shift of the IPP peak and the four proteins were not found 
within a fraction in SDS-PAGE (Figure 31F). 
 
Figure 31: Detection of complex formation of IPP with kindlin-2, paxillin or THD via SEC. (A) To detect protein-
protein interactions, recombinant, IMAC-purified IPP complex was mixed with recombinant kindlin-2 (A), paxillin 
(B) or THD (C) and applied on an analytical SEC column for separation. To confirm complex formation, all proteins 
were also applied to the column separately and the runs were overlaid to compare peak elution volumes. Arrows 
depict peak fractions and their positions on the SDS gels (D-F). Kindlin-2 and paxillin both form quaternary 
complexes with the IPP complex, causing a distinct shift of the IPP peak. THD does not form an additional 
complex, instead two peaks at the same elution volumes as the monomeric components are observed. The peaks 
at 8-10 ml elution volume contain aggregates of the IPP complex and are not relevant for complex analysis. SEC 
was carried out in Buffer B2 at 4 °C on a 24 ml SEC650 column.  
Kindlin-2 and paxillin both bind to the IPP complex individually, raising the question whether 
their binding is mutually exclusive or whether a pentameric complex can be formed. To answer 
this question, IPP complex was mixed with kindlin-2 and paxillin and applied to an analytical 
SEC column (Figure 32A). The ensuing chromatogram shows a main elution peak at 11.0 ml (466 
kDa), which is clearly shifted from the kindlin-IPP and paxillin-IPP peaks at 11.7 ml, indicating 
further increase in hydrodynamic volume of the particles and thus complex formation with 
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both components. SDS-PAGE confirms the presence of all five proteins in apparently 
equimolar amounts in the peak fraction (Figure 32D).  
Overlay of the IPP-kindlin-paxillin chromatogram with those of IPP alone and of kindlin-paxillin 
show genuine complex formation, since the particles formed are significantly larger than the 
kindlin-paxillin complex (Figure 32A). It is notable that, although they are of almost equal 
molecular weight, the kindlin-paxillin complex (11.9 ml, 144 kDa) displays a significantly larger 
hydrodynamic volume of 257 kDa than the IPP complex (136 kDa actual, 197 kDa apparent). 
This indicates that the IPP complex is more compact and globular than the kindlin-paxillin 
complex, which might display a rather extended conformation, possible due to unstructured 
parts of paxillin.  
 
Figure 32: Detection of a pentameric IPP-kindlin-2-paxillin complex but no interaction with THD on SEC. (A, D) 
Recombinant, IMAC-purified IPP complex was mixed with kindlin-2 and paxillin and separated on an analytical 
SEC column. Formation of a pentameric complex created a peak at 11.0 ml (466 kDa), which is clearly shifted 
from the IPP-kindlin and IPP-paxillin peaks at 11.7 ml (293 kDa). (B) The IPP-kindlin-paxillin peak is also clearly 
shifted from those of the kindlin-paxillin complex (11.9 ml) and the IPP complex (12.3 ml). (C, E) Addition of THD 
does not lead to formation of a hexameric complex, THD found in the same fraction as the other proteins does 
not indicate complex formation but is due to an unspecific effect of THD, leading to a second peak at 13 ml in a 
sample containing only THD (purple arrows, F). The peaks at 8-10 ml elution volume contain aggregates of the 
IPP complex and are not relevant for complex analysis.  SEC was carried out in Buffer B2 at 4 °C on a 24 ml SEC650 
column. 
Considering that IPP can bind kindlin-2 as well as paxillin individually and that kindlin-2 and 
paxillin can form a complex themselves, the binding modalities of these complexes are of 
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particular interest. It is unclear whether in the pentameric complex kindlin and paxillin bind 
to the IPP complex in the same manner as in the two tetrameric complexes and whether they 
interact with each other through the same binding interfaces when bound to IPP as in solution. 
Another scenario is that only paxillin or kindlin can directly bind to IPP and the other protein 
binds only to the attached partner but not to the IPP complex. These questions are subject of 
further studies. 
It was further tested whether addition of THD to IPP, kindlin-2 and paxillin leads to hexameric 
complex formation. Although no interaction of THD with either of the proteins has been 
detected, it might be possible that pentameric complex formation leads to conformational 
changes and the formation of binding sites, which are not present in the monomeric proteins. 
However, no further shift of the IPP-kindlin-paxillin peak was detectable (Figure 32C) and no 
THD appears in the peak fraction when analyzed by SDS-PAGE (Figure 32E). Traces of THD can 
be seen in the fractions at 13 ml elution volume, significantly before the THD elution peak. 
However, this is not caused by THD binding to any of the other proteins but is rather an effect 
of THD itself, since also in the chromatogram of THD alone, a small peak before the main peak 
appears (Figure 32F). Therefore, SEC analysis indicates that THD does neither bind to the IPP 
complex nor to the pentameric IPP-kindlin-paxillin complex. 
 Determination of binding affinity between IPP and paxillin by MST 
The paxillin-IPP interaction was further characterized through MST measurements, which 
allowed determination of the binding affinity and stoichiometry. Recombinant paxillin was 
labeled with the NT-647 dye (Nanotemper) and diluted to a final concentration of 30 nM in 
each capillary. IMAC- and SEC-purified IPP complex was concentrated to ~50 µM for each 
measurement and a 1:1 titration series was pipetted for each measurement. The fluorescence 
values for all capillaries were similar, within 100 fluorescence units variation caused by 
pipetting errors. Since the deviations did not follow a defined pattern, fluorescence quench 
or loss of fluorescent molecules could be excluded as causes.  
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Figure 33: MST measurements of paxillin versus IPP complex. Paxillin-NT-647 was used at 30 nM final 
concentration, IPP was concentrated to a maximum of 50 µM and diluted in a 1:1 ratio to create a dilution series 
of 16 concentrations. The normalized fluorescence Fnorm from thermophoresis and T-jump was plotted against 
the IPP concentration and a binding curve was fitted through the data points. Reproducibility of the experiment 
was tested in four independent measurements (Run 1-4). Missing data points were obvious outliers (distorted 
MST traces) and were removed from the analysis so they would not interfere with the data fitting. The different 
Fnorm values of the four experiments at identical fluorophore concentrations are probably due to variations in the 
IPP sample preparation or in the buffer composition, yet have no effect on the KD values determined. The 
measurements were carried out in Buffer B2 at 25 °C, using premium coated capillaries.  
For determination of the KD value the normalized change in fluorescence intensity of 
thermophoresis and temperature jump were plotted against the IPP concentration and a 
binding curve was fitted into the data points. From this, the KD value of paxillin binding to the 
IPP complex was determined as 535 nM (Table 8). This value represents the average KD from 
four independent experiments (Figure 33).  
Table 8: Summary of MST measurements to determine the binding constant of paxillin and the IPP complex. 
The table summarizes four individual experiments conducted at identical settings with slightly varying maximum 
IPP concentrations.  
Run # KD [nM] c (pax-647) [nM] Std. Error of Regression Excitation Power MST Power 
1 510.56 30 1.919240761 20% 40% 
2 502.85 30 2.769171762 20% 40% 
3 544.24 30 1.759375874 20% 40% 
4 582.32 30 2.232124671 20% 40% 
 ø 535.0     
 
 Interaction of IPP and kindlin-2 
Unlike paxillin, determination of the binding affinity of kindlin-2 and the IPP complex turned 
out to be more difficult. MST measurements conducted with the same setup as for paxillin-
IPP with kindlin-2 labeled with NT-647 dye resulted in apparently good-looking binding curves 
in MST and temperature jumps (Figure 34A). However, a constant increase in fluorescence 
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intensity was detected with increasing concentration of IPP complex in the capillary scan 
(Figure 34B) and the fluorescence detected during measurements (Figure 34C). Since this might 
either indicate a fluorescence enhancement by the IPP complex or be an artifact caused by 
loss of fluorescent material, an SD-test recommended by the manufacturer was carried out 
on the remaining samples not loaded into the capillaries. The samples with the three highest 
and the three lowest IPP concentrations were denatured by addition of SDS and heating, and 
then their fluorescence values compared to the non-denatured condition. If the change in 
fluorescence was caused by binding of increasing amounts of IPP to kindlin-NT-647, it should 
vanish after denaturing of the proteins. However, the denatured samples still showed the 
same difference in fluorescence between capillaries with high and low amounts of IPP 
complex, indicating that the measurements are flawed by loss of fluorescent kindlin-2.  
This might be due to unspecific interactions of kindlin-NT-647 with pipet tips or plastic tubes 
in which the samples are mixed. High amounts of IPP complex (50 µM) might “saturate” the 
surfaces and reduce the probability of kindlin-NT647 (47 nM) interacting with them. This 
hypothesis was tested by adding 1 mg/ml BSA to the fluorescently labeled kindlin-2 before 
mixing it with the dilution series of the IPP complex, resulting in a final concentration of  
0.5 mg/ml BSA. This should theoretically not interfere with the binding of kindlin-NT-647 to 
IPP and “saturate” the surfaces to the same amount in all samples.  
As expected, BSA reduced the differences in fluorescence intensity to normal levels of  
± 50 units without any clear trend of the data points (Figure 34E). However, the resulting binding 
curve of kindlin-2 towards IPP fluctuates strongly and the fit is not satisfying (Figure 34D, F). This 
might be because either BSA does unexpectedly interfere with the binding or kindlin-2 stability 
might be reduced, either by labeling with the NT-647 dye or by using Buffer B2 containing 10 
µM ZnCl2, which might lead to aggregation of the protein. Destabilization seems more likely 
since unlabeled kindlin-2 used in other MST measurements displayed some “stickiness”, but 
to a far less amount which could be countered by using premium coated hydrophilic 
capillaries. The MST experiment was repeated with unlabeled kindlin-2 and IPP complex 
labeled with Alexa-647, but no binding could be detected to kindlin-2 in this setup either. This 
might however be due to problems with the labeled IPP complex, since binding to paxillin 
could not be detected either. 
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Figure 34: MST measurements to determine the binding affinity of kindlin-2 to the IPP complex. (A) A dilution 
series of IPP complex (50 µM) with kindlin-2-NT-647 (47 nM) yielded an apparent binding curve in temperature 
jump and thermophoresis, but also an increase in fluorescence intensity towards high IPP concentrations (B, C). 
(E) This increase is an artifact caused by loss of kindlin-NT-647, since addition of 1 mg/ml BSA to the fluorescent 
protein sample removed this difference. (D, F) Addition of BSA also resulted in strong fluctuation of the data 
points and no clear binding curve. The measurements were carried out in Buffer B2 at 25 °C, using premium 
coated capillaries. 
Conclusively, MST measurements are not suitable for measuring the affinity of kindlin-2 
towards the IPP complex. This might instead be achieved by ITC measurements or by ELISA. 
SPR measurements are also an option. However, in past experiments kindlin-2 displayed a 
high affinity towards dextrane or polycarboxylate hydrogel surfaces of the SPR chips, 
interfering with the protein-protein interactions to be detected. Therefore, a passivation of 
the chip using PEG or PLL-PEG would be necessary. 
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 The IPP complex does not bind directly to integrin tails 
Early studies on ILK reported direct interaction of ILK with β1 and β3 integrin tails as well as 
its ability to phosphorylate the tails (Hannigan et al., 1996). The alleged kinase activity of ILK 
has since been refuted in several studies and was probably due to co-purification of active 
kinases together with ILK (Wickstrom et al., 2010). Binding to β1 and β3 integrin tails has been 
confirmed by GST pull-down assays with recombinant ILK-PKD/α-parvin-CH2 complex, which 
was used for crystallization (Fukuda et al., 2009). To test whether this holds true for full-length 
IPP complex and, if possible, to measure binding affinities, MST, AUC and pull-down 
experiments were conducted. However, none of the assays showed interaction of IPP with 
fluorescently labeled or GST-conjugated integrin β1 or β3 tails.  
 
Figure 35: Test for interaction of the IPP complex and integrin β1 or β3 tails by MST, AUC and pull-down 
experiments. (A, B) In MST measurements with Atto-488-labeled tail peptides (210 nM) versus IPP complex of a 
concentration up to 50 µM, no interaction could be detected.. The MST measurements were carried out in Buffer 
B2 at 25 °C, using premium coated capillaries. (C, D) AUC measurements with 10 µM IPP complex and 35/38 µM 
Atto-488-β1/3 peptide in Buffer B2 were conducted at 14 °C for 16 h and absorption at 503 nm was measured 
to detect the integrin tail monomers (< 1 S) and a potentially formed complex with IPP. However, no second peak 
apart from monomeric tail was detected. (E) Pull-down experiments with GST-β1 or –β3 immobilized on GST-
beads and IMAC-purified IPP complex also failed to show interactions. SN: unbound proteins, E: eluate 
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For MST measurements, Atto-488 conjugated β1 tail peptide was dissolved in Buffer B2 and 
used at a final concentration of 210 nM and added to a 1:1 IPP titration series with a maximum 
concentration of 50 µM. The fluorescence distribution within the capillaries was within ±50 
units without indication of a fluorescence quench or other effect. The MST traces showed no 
indication of binding, neither in thermophoresis nor in temperature jump analysis (Figure 35A, 
B). This indicates either no interaction or a KD value in the very high µM to mM range.  
Analytical ultracentrifugation was conducted with Atto-488 conjugated β1 or β3 tail peptide 
at 35 or 38 µM concentrations in Buffer B2 against 10 µM IPP complex. The samples were 
adjusted to 400 µl final volume and A503 nm values of 1.2. The measurements were carried out 
at 14 °C and detection at 503 nm, ensuring that only the labeled tail peptides are visible in any 
complexes they might form. Unlabeled peptides are too small (< 5kDa) to cause a detectable 
shift of the IPP peak, therefore they must be labeled. Like MST, AUC failed to detect any 
interaction between IPP and either tail peptide (Figure 35C,D). Both AUC traces show only one 
peak < 1S, representing monomeric unbound tail peptides. Binding of a tail peptide to IPP 
would have resulted in the detection of a second peak at a much higher sedimentation 
coefficient. Considering the 3.5-fold excess of integrin tail to IPP complex, even at very low 
affinity at least a small peak should have been detected (~6 % bound β1 fraction at 500 µM 
KD). Therefore, no interaction of IPP and tail peptides could be detected. 
In order to reproduce the GST-pull-down assay which was used to show binding by Fukuda et 
al., GST-β1 and GST-β3 fusion proteins were produced in E. coli and purified using GST-beads 
and SEC. Functionality of these fusion proteins was tested by MST measurements with NT-
647-labeled GST-β1/3 and unlabeled kindlin-2. The KD values measured matched those 
determined with integrin tail peptides (~10 µM range, data not shown). Furthermore, GST-
β1/3 immobilized on GST-beads pulled down kindlin-2, confirming its binding activity. 
However, IPP complex failed to bind to GST-β1/3 on beads (Figure 35E), once more confirming 
that no interaction takes place between the integrin tails and the IPP complex.  
These results contradict the published pull-down experiments with ILK-PKD/parvin CH2. It is 
possible that in full-length IPP complex, a potential binding site for integrin tails is hidden by 
parts of α-parvin or PINCH, which were not present in the published setup. Should this be the 
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case, ILK would have to be separated from one or both of its binding partners to be able to 
interact with integrin tails.  
 Optimization of buffer conditions to reduce aggregation and increase stability of the 
IPP complex 
Considering the thermal instability of the IPP complex and its tendency to form aggregates, 
which prevents the generation of good samples for cryoEM analysis, an extensive buffer 
screen was conducted to find conditions, which improve its stability. The screen used was 
optimized for cryoEM applications and contains 11 different buffer substances at 8 different 
pH values each (Chari et al., 2015). The buffers were formulated as 10x stock solutions, 
therefore the protein was diluted in a 10:1 ratio, more or less retaining the salt concentration 
of the original buffer. Thermal stability in the 88 different buffers was assessed by Thermofluor 
assay, which yielded very noisy data and no clear thermal transitions and was therefore 
inconclusive. Additionally, thermal unfolding was determined using NanoDSF measurements, 
which rendered more reliable transitions (Figure 36B, C). 
While the reference sample in the normal purification Buffer B2 and most other buffer sets 
showed a more or less constant increase in Trp/Tyr fluorescence without a pronounced 
transition from folded to unfolded, two sets of buffers (Citrate and ADA) showed 
comparatively clear inflection points. Buffers containing 100 mM ADA (N-(2-
Acetamido)iminodiacetic acid) rendered the most pronounced thermal transitions around 52 
°C, resulting in the highest final fluorescence values of all samples. This effect was observed 
for all ADA samples, from pH 6.0 to 7.4, with the highest and sharpest peaks at pH 6.0 and 6.2. 
However, The ADA samples at pH 6.4 and 6.6 displayed a later onset of thermal unfolding than 
the other samples, with potentially a second transition around 40 °C. This might indicate more 
overall stability than just higher final fluorescence values, which could be caused by the ADA 
itself.  
The buffer set containing 100 mM Citrate from pH 5.5 to 7.25 also rendered clear transitions 
around 50 °C, with the best curves at pH 5.75 and 6.0. In these two conditions, the initial 
fluorescence values are slightly lower than the reference and stay lower until the first 
transition point is reached, indicating less unfolding at temperatures below the inflection 
point. A second transition around 70 °C can be detected in the pH 6.0 and 6.25 samples.  
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Figure 36: Determination of the influence of different buffer substances and pH values on thermal stability and 
aggregation of the IPP complex. (A) 11 different buffer substances at 8 different pH values each were added as 
10x stock solutions to the sample, retaining the sample’s initial salt concentration. SPG 10x: 0.125 M Succinic 
acid, 0.5 M NaH2PO4, 0.375 M Glycine; MMT 10x: 0.2 M DL-Malic acid, 0.4 M MES, 0.4 M Tris; PCB 10x: 0.4 M 
Sodium Propionate, 0.2 M Sodium cacodylate trihydrate, 0.4 M Bis-Tris Propane; ADA 10x: 1 M N-(2-Acetamido) 
iminodiacetic acid. (B, C) NanoDSF measurements were carried out with IPP complex diluted in the respective 
buffers at a final concentration of 0.1 mg/ml, same as for the DLS measurements. The melting curves for Citrate 
Buffer pH 5.5-6.25 (B) and ADA buffer pH 6.0-6.6 (C) gave the best results in NanoDSF. Buffer B2, used for 
purification, is included in the analyses as an orange curve for reference. (D) DLS measurements also identified 
the Citrate Buffer series as most promising, since it yields nicely defined decays and smaller particles than the 
reference. (E) The ADA buffer samples all contained very large inhomogeneous particles, which indicate that it is 
not suited for cryoEM and other sensitive applications. 
The limiting factor when working with recombinant IPP is its tendency to form aggregates. 
Therefore, all samples were additionally analyzed by dynamic light scattering to test how large 
the IPP particles are in the different buffers. Most buffers tested yielded decay curves that 
were very similar to the Buffer B2 reference and thus indicated no improvement. Surprisingly, 
the samples containing ADA which seemed to improve thermal stability all rendered curves 
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indicating very large particles and high polydispersity, if the curves could be determined at all 
due to sample inhomogeneity (Figure 36E) 
The samples containing Citrate buffer, however, yielded very good decay curves, which 
indicated smaller particles than the reference in Buffer B2. The best pH conditions are pH 6.0 
and 6.25, in accordance with the NanoDSF measurements.  
The results from this screen indicate that using citrate as a buffer substance at pH 6.0 or 6.25 
might increase thermal stability of the IPP complex as well as reduce aggregation. This has to 
be tested further and samples purified in citrate buffer analyzed by negative staining to see if 
they lead to a more homogeneous particle distribution. 
ADA seemed to improve thermal properties of the IPP complex but dramatically increases the 
polydispersity of the sample. Furthermore, it is not an optimal buffer substance for the 
intended purposes since it chelates divalent metal ions like Zn2+, absorbs light at wavelengths 
<260 nm and its solubility in H2O at 4 °C is only 90 mM, which might have caused aggregates 
of the 100 mM buffer in the DLS samples that are unrelated to the protein.  
 Chemical crosslinking of focal adhesion complexes 
In addition to cryoEM studies and crystallization trials, complexes of IPP, kindlin-2 and paxillin 
were assembled, crosslinked with the NHS-reactive, isotopically light and heavy labeled BS3 
crosslinker, enzymatically digested and analyzed via LC-MS. This approach allows for the 
identification of protein surfaces which are sterically in close proximity within the complex, so 
that one Lys residue on each surface can interact with either side of the bifunctional 
crosslinker. The crosslinks stay intact through enzymatic digest and keep formerly close 
peptides linked until mass spectrometric analysis. There, the crosslinked peptides are 
identified and a crosslinking network can be established to represent all protein surfaces 
within the complex, which are in close proximity. It has to be noted that a crosslink does not 
necessarily have to indicate the exact interaction surface of two proteins. In many cases, 
binding of the proteins makes lysines within the binding surface inaccessible or there are 
simply no lysines involved in the binding. It is more likely that surfaces next to the binding 
interfaces become crosslinked, where lysines are readily accessible on the protein surface.  
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Figure 37: Crosslinking of adhesome complexes with BS3. (A) Ni-NTA immobilized IPP#4 was incubated with 
kindlin-2, paxillin, THD and integrin β1 tail peptide and eluted with 500 mM imidazole. The eluate was crosslinked 
with increasing concentrations of BS3, resulting in inefficient crosslinking. (B) Another sample, which was passed 
through a desalting column prior to crosslinking to reduce the imidazole concentration displayed heavy 
crosslinking even at the lowest BS3 concentration. (C) The final samples used for digest and LC-MS analysis were 
crosslinked with 53 and 107 µM BS3. (D) The crosslinks identified in three independent experiments are displayed 
in a schematic representation of the individual components. Pink lines represent intra-protein crosslinks, green 
lines are inter-protein crosslinks . (E) No crosslinks between the integrin tail and THD or kindlin were detected, 
although the THD-β1 complex has several accessible lysines on the surface (marked by black arrows). Depicted 
is the complex of talin-F2F3 (grey) and integrin β1D tail peptide (red) (PDB: 3G9W). Lysine residues accessible on 
the surface of the proteins are highlighted in green. 
In initial crosslinking trials, recombinant IPP#4 was immobilized on Ni-NTA beads and 
incubated with excess kindlin-2, paxillin, THD and integrin β1 tail peptide in order to assemble 
a large complex. After washing with Buffer B4 to remove unbound proteins, the complex was 
eluted with Buffer B5 and applied on a desalting column to remove most of the imidazole, 
which reacts with the BS3 crosslinker at high concentrations (Figure 37A, B). In order to obtain 
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a reasonable amount of inter-protein links but to prevent unspecific crosslinking caused by 
too high amounts of BS3, for each experiment a titration series was performed on small 
amounts of the sample prior to the actual crosslinking reaction. Then, the two best 
concentrations were chosen for the actual sample preparation (Figure 37C).  
The samples were denatured and digested with Trypsin and LysC and the crosslinked peptides 
enriched and analyzed via LC-MS by The PhD student Mia Potočnjak of the Franz Herzog group 
(LMU Gene Center). For better visualization, the detected crosslinks were displayed in a 
schematic network (Figure 37D). The crosslinks represent three individual experiments with two 
different crosslinker concentrations each. A large number of crosslinks have been detected 
between the components of the IPP complex, as was to be expected since it was used as basis 
for complex assembly. The most heavily crosslinked region of the entire complex is the PINCH-
LIM5 domain (AA 262-325), with many links to ILK and α-parvin and some to kindlin-2 and 
paxillin. This is surprising, since the LIM5 domain has not been shown to be required for the 
formation of the IPP complex. The “minimal” IPP complex is comprised of parvin CH2 domain, 
ILK and PINCH-LIM1 domain and sufficiently stable to be purified (Stiegler et al., 2013). 
Furthermore, LIM5 appears to be in close proximity to so many surfaces of different proteins 
that it would have to be at the very center of the complex with all other proteins arranged 
around it. Another potential explanation is that LIM5 is mostly unstructured and highly flexible 
and therefore can “reach” many different protein domains without binding to them. 
None of the experiments yielded any crosslinks of an adhesome protein to the integrin β1 tail 
peptide, although the tail was present after the pull-downs and intramolecular crosslinks 
within the tail were observed. It is possible that the intra links were established in tail peptides, 
which have become unbound from kindlin or talin due to fast off-kinetics. If there had been a 
sufficient amount of bound tail in the complex, crosslinks should have formed, as becomes 
clear from the crystal structure of the THD-integrin tail complex which has several accessible 
lysine residues on the surface near the binding interface (Figure 37E). To test whether PINCH-
LIM5 has a central position in the IPP complex as well as in the IPP-kindlin-paxillin complex or 
whether it is unstructured and flexible, a mutant IPP complex (IPP#5) lacking the LIM5 domain 
was produced. If the LIM5 domain were indeed interacting with all proteins the crosslinks 
imply, its deletion should have consequences on stability of the IPP complex and on complex 
assembly.  
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Figure 38: Purification and complex formation of IPP#4 and IPP#5. (A) IPP#4 and #5 were expressed and purified 
in parallel and their behavior was compared. SEC profiles of both constructs were identical, with a small shift of 
IPP#5 from 73 to 74 ml elution volume, due to its smaller size (136 kDa vs. 126 kDa). (B) The purity of the SEC 
fractions was also identical, as well as the yields (~5 mg both). (C) The ability to bind paxillin and kindlin-2 was 
assessed in pull-down assays with IPP#4 and #5 immobilized on Ni-NTA beads. Both constructs seem to bind 
equal amounts of kindlin and paxillin and more than is bound unspecifically to the beads. Additionally, the ability 
of either construct to bind GST-integrin β1 was assessed, but only the same amount of protein as on empty beads 
was bound.  
pACEBac1-IPP-dLIM5 was generated by introducing a stop-codon after the PINCH-LIM4 
domain via site-directed mutagenesis using primers PaKa242/243 and the pACEBac1-IPP 
vector as template. The correct insertion of the desired mutation and the absence of 
unwanted mutations were confirmed by sequencing the entire coding sequences of ILK, α-
parvin and PINCH.  
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In order to directly compare IPP#4 and #5 they were expressed and purified in parallel, using 
one liter of insect cell culture each. After performing Ni-NTA purification on beads, both 
samples were applied on a Superdex200 SEC column (Figure 38A, B). Purity and yield was almost 
identical for both constructs (~5 mg each), the SEC elution profiles were identical except for a 
small shift of IPP#5 to higher elution volumes due to the slight reduction in size (10 kDa). This 
indicates that deletion of LIM5 does not de-stabilize the IPP complex, reduce its solubility or 
increase losses due to aggregation.  
In Ni-NTA pull-down assays the ability of both constructs to bind kindlin-2 and paxillin was 
tested (Figure 38C). IPP#4 and #5 were immobilized on Ni-NTA beads and incubated with excess 
tag-less kindlin and paxillin. Both constructs appear to bind similar amounts of the proteins, 
which are higher than the amounts of unspecifically bound proteins on the beads. This 
indicates that deletion of the LIM5 domain does not reduce the complex formation with 
kindlin-2 and paxillin, which would be expected if the domain was truly interacting with both 
proteins. Furthermore, pull-downs with GST-tagged integrin β1 tail showed no interaction 
with either construct. There is some protein bound in both samples, but the amounts are 
identical to that bound to the empty beads control, indicating some stickiness of the GST-β1 
but no bona fide binding. 
Finally, both constructs were crosslinked with paxillin, kindlin-2, integrin β1 and THD and the 
crosslinking patterns were compared. For this experiment, the complexes were not eluted 
from the Ni-NTA beads but instead crosslinked while still bound. Denaturing and enzymatic 
digest then released the proteins from the beads, which do not interfere with any of the 
processing steps. Optimal crosslinker concentrations were determined through a titration 
series performed on small aliquots of the bead-immobilized complexes (Figure 38A).  
In the absence of the PINCH-LIM5 domain, previously unobserved inter-protein crosslinks 
between ILK and α-parvin, paxillin and α-parvin and ILK and paxillin were detected. The intra-
protein crosslinks are mostly unchanged, indicating that the conformation of the adhesome 
proteins is not dramatically changed upon removal of LIM5. Taken together, all experiments 
with the IPP#5 construct indicate that LIM5 is not the central element holding the complex 
together but rather an unstructured domain with high flexibility that happens to be in close 
proximity to several components of the complex. It is possible that the LIM5 domain adopts a 
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less flexible conformation when it is bound to RSU-1 and then mediates a biological function 
in adhesome assembly.  
 Structural information on the IPP-kindlin-paxillin complex gained by crosslinking 
The intra-protein crosslinks show that in α-parvin, three regions are mainly crosslinked, the 
potentially unstructured N-terminus, the central part of the CH1-domain and the N-terminal 
part of the CH2 domain. The lysine residues in all these regions are crosslinked, suggesting 
that they face towards each other and possibly form a binding interface. The same residues 
were also crosslinked to ILK, PINCH and paxillin and thus probably face towards the center of 
the complex.  
The N-terminal residues K56 and K57 were linked to the ILK pseudokinase domain (PKD, K209, 
K223, K364), as well as to the ANK5 domain. The CH1 domain of parvin (K163) was linked to 
ILK ANK3 (K85) and the N-terminus of the CH2 domain (K292, 298, 306) was linked to ILK ANK3 
(K85) and ANK5 (K154, 165). All three regions in parvin were also linked to PINCH LIM2 (K111) 
and LIM3 (K132). Furthermore, the CH2 domain showed one crosslink to the C-terminus of 
paxillin LD4 domain. In the NMR structure of parvin-CH2 in complex with paxillin LD4 (PDB: 
2VZI), the crosslinked K277 in paxillin is not included but is only three residues away from the 
C-terminus of the LD4 peptide and thus in range of K292 in parvin. Therefore, the detected 
crosslink is in good accordance with the known parvin-paxillin LD4 structure.  
Since the PINCH LIM5 domain has been shown to be flexible and probably does not contribute 
to the stability of the complex, the crosslinks to LIM5 are omitted from the analysis to avoid 
drawing false conclusions. The intra-protein crosslinks in ILK indicate that ANK3 (K85), ANK5 
(K165/170), the linker between ANK5 and PKD (K184) and the central part of the PKD 
(K209/220) are in close proximity. While ANK3 is linked to α-parvin, ANK5, linker region and 
PKD are all crosslinked to PINCH LIM2 domain (K84/111) and the linker between LIM2 and 
LIM3 (K132). The same residues in ILK and in PINCH are involved in binding to parvin CH1 
domain and to the N-terminus of the CH2 domain, suggesting a central binding interface 
within the IPP complex formed by the α-parvin N-terminus, the center of the CH1 domain and 
the N-terminus of the CH2 domain, the N-/C-terminus and center of the PKD, ANK3 and ANK5 
of ILK and PINCH LIM2.  
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Figure 39: Crosslinking networks of IPP#4 and IPP#5 in complex with kindlin-2, paxillin and THD. (A) Titration 
series indicated that 2x/1.7x molar excess of BS3 crosslinker for IPP#4/#5 immobilized on Ni-NTA beads and 
complexed with kindlin-2, paxillin, THD and integrin β1 peptide yielded optimal amounts of linkage between the 
proteins. (C, D) Direct comparison of the resulting crosslink distributions indicates that the presence of the LIM5 
domain in IPP#4 prevents many crosslinks between ILK and parvin or paxillin and parvin, which are observed in 
IPP#5. This confirms the hypothesis that LIM5 is very flexible and not essential for complex formation. (B) The 
crosslinks between kindlin-2 and paxillin can be compared to those observed in an experiment with only kindlin 
and paxillin (data by M. Veelders, P. Rombaut and M. Potočnjak). Crosslinking was carried out on Ni-Sepharose 
beads in Buffer B4.  
The intra-protein crosslinks in paxillin match exactly those observed in crosslinking studies 
with kindlin-2 and paxillin alone (experiment carried out by M. Veelders and analyzed by P. 
Rombaut and M. Potočnjak, Figure 39B). This indicates that in the pentameric complex with IPP 
and kindlin-2, paxillin does not adopt a significantly different conformation from that in 
complex with kindlin-2 alone. The same holds true for the intra-protein links in kindlin-2.  
In paxillin, the residues involved in inter-protein crosslinks are limited to K123 at the N-
terminus of the LD2 motif, K199/203 between LD2 and LD3, and K506 at the C-terminus of the 
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LIM3 domain. This indicates that the same areas in paxillin are involved in protein-protein 
interactions when it is bound to kindlin-2 alone or additionally to the IPP complex. 
The inter-protein crosslinks between kindlin F0 domain (K51/55) and paxillin LIM3 domain 
(K506/518) are identical in the dimeric and in the pentameric complex, indicating that these 
protein domains interact in the same manner in both complexes. 
 However, the crosslinks between 
paxillin K199 and K506 and the kindlin 
PH domain, which represent a second 
binding site of the two proteins 
observed in the kindlin-paxillin 
complex, are absent in the pentameric 
complex. Instead, K123 is heavily 
crosslinked to the C-terminus of ANK5 
and the N-terminus of the pseudokinase 
domain of ILK. In kindlin-2, K476 is 
crosslinked to K223 in ILK PKD, the same 
residue that is crosslinked to paxillin 
K123, putting all three residues spatially 
close together. This explains the absence 
of the paxillin-K123-kindlin-K476 link, 
which is replaced by two crosslinks to 
ILK. A similar observation can be made 
for paxillin-K123, ILK-K438/448 and 
kindlin-K285, where the former crosslink 
between kindlin and paxillin is replaced 
by two crosslinks to ILK. This indicates 
that in the pentameric complex, kindlin 
and paxillin are still attached via the 
same surfaces as in the dimeric complex 
but are now both additionally interacting with the N- and C-terminus of ILK PKD. The ILK-
Protein Domain Residues Actual residues wt/iso 
ILK ANK1 2-30  
 ANK2 31-63  
 ANK3 64-96  
 ANK4 97-129  
 ANK5 130-174  
 PKD 193-446  
α-parvin CH1 127-233 95-201 
 CH2 294-401 262-369 
PINCH LIM1 10-62  
 LIM2 71-121  
 LIM3 135-184  
 LIM4 193-243  
 LIM5 252-303  
Kindlin-2 F0 0-96  
 F1 97-276  
 F2-N 277-326  
 PH 380-476  
 F2-C 496-568  
 F3 569-653  
Paxillin LD1 3-15 3-15 
 LD2 144-156 144-156 
 LD3 216-228 216-228 
 LD4 265-276 265-276 
 LD5 299-311 333-345 
 LIM1 322-381 356-415 
 LIM2 382-439 416-473 
 LIM3 440-499 474-533 
 LIM4 500-557 534-591 
Talin F0 1-85  
 F1 86-202  
 F2 203-309  
 F3 310-400  
Table 9: Overview of adhesome protein domains. All 
domain boundaries were obtained from the UniProt website. 
The α-parvin used in this study contains an N-terminal His8-
tag and a PreScission site, adding 32 residues to the protein. 
The paxillin used is isoform α, however the domain 
boundaries given at UniProt correspond to the longer, 
alternatively spliced isoform β and had to be adjusted for 
correct localization of the crosslinks. 
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binding interface in 
kindlin-2 has been 
mapped to a 38 AA 
linker sequence 
between F2-N and the 
PH domain (Huet-
Calderwood et al., 
2014), which fits to the 
crosslinked residues 
K476 and K285 in 
kindlin, which are 
attached to ILK PKD. In 
summary, the crosslinks 
suggest that the  
kindlin-2 and paxillin 
interactions are 
identical in the dimeric 
and in the pentameric 
complex and that both 
proteins bind to ILK PKD 
at the same time.  
 
The intra-protein crosslinks observed for THD fit perfectly into the crystal structure (PDB: 
3IVF), indicating that the protein adopts the same conformation as in the crystal. However, it 
is not clear whether the observed inter-protein links to α-parvin, kindlin-2, paxillin and PINCH 
are genuine or an artifact caused by unspecific binding of THD to the beads used for complex 
assembly. Each inter-protein crosslink involving THD was found only once in several 
independent experiments, while almost all other inter-links were detected at least twice. 
Furthermore, since the adhesome proteins studied are all rich in lysines, most inter-crosslinks 
are “multiplied”, for neighboring lysines tend to be crosslinked with the same partner when 
Figure 40: SEC analyses of THD with kindlin-2 and paxillin to test for complex 
formation. (A) Recombinant THD, kindlin-2 and paxillin were applied on an 
analytical gel filtration column separately and in combination and the 
chromatograms were overlaid to detect interactions. Neither kindlin-2 (A) nor 
paxillin (C) form a complex with THD, which would result in a shift of the elution 
peak towards lower elution volumes. (B) The interaction of kindlin-2 and paxillin, 
however, is clearly detectable by a slight shift of the paxillin peak. The reason 
why the shift is not more pronounced is that paxillin becomes compacted upon 
binding to kindlin-2. (D) THD cannot bind to the kindlin-2-paxillin complex either, 
ruling out the possibility that upon complex formation a new binding interface 
is created by conformational changes. The SEC runs were performed using a 
SEC650 column in Buffer A3 at 4 °C.  
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they both are in the vicinity. This is not the case for THD, although it displays a lot of intra-
protein crosslinks and thus readily accessible lysines. 
Another indication that THD might be only non-specifically linked to the other proteins is that 
in SEC and AUC analyses, no interaction of THD with any of the other components was 
detected (Figure 31C, Figure 32C). Therefore, the THD inter-crosslinks might derive from THD 
sticking to the beads and being in close vicinity to the other proteins without actually binding 
to any of them. This also explains why there are single, non-reproducible crosslinks to four of 
the proteins. Another explanation might be that the THD association with the other adhesome 
components is only very transient and that THD is not included in a tight complex but is 
constantly dissociating and re-binding to the complex, making its fixation via crosslinks 
difficult and preventing the co-elution with other proteins on SEC or AUC.  
 Model of the IPP complex based on existing structural information 
The crosslinks identified in the IPP-kindlin-paxillin complex can be displayed in existing NMR 
or crystal structures using the Xlink Analyzer plug-in for UCSF Chimera (Kosinski et al., 2015). 
This program inserts crosslinks between specified lysine residues within the same protein or 
in different components of a multi-protein complex. Depending on the spatial restrictions 
given by the chemical crosslinker, the crosslinks are displayed in blue if the distance between 
the lysine residues matches the restriction or in red if this is not the case. The length of one 
BS3 molecule and two lysine side chains is ~30 Å, therefore the spatial restriction between the 
backbones of two linked proteins was set to 30 Å.  
Of particular interest are the crosslinks found between ILK ANK and ILK PKD, as they might 
give an indication of how the two halves of ILK are oriented towards each other. To approach 
this objective, the crystal structures of ILK PKD in complex with α-parvin CH2 domain (PDB: 
3KMU) and of ILK ANK in complex with PINCH LIM1 domain (PDB: 4HI8) were merged into one 
structure. Then the crosslinks were listed in .csv files including the chain names and the 
absolute positions of the crosslinked lysines (see appendix) and loaded into the Xlink analyzer 
dialog. The plug-in then displays the crosslinks and facilitates “interactive docking”, where 
domains can be moved and rotated while the crosslinks are retained and change color from 
red to blue when the spatial restrictions are met. This allows the rough positioning of ILK 
PKD/parvin CH2 and ILK ANK/PINCH LIM1 towards each other.  
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Figure 41: Display of the intra-protein crosslinks of ILK in existing crystal structures of ILK PKD/parvin CH2 (PDB: 
3KMU) and ILK ANK/PINCH LIM1 (PDB: 4HI8). The two structures were merged, placed randomly at first and the 
crosslinks were displayed, with a distance limit of 30 Å. The crosslinks are colored in red (violating the distance 
restriction) and blue (below restriction). Within ILK PKD, some red crosslinks span the whole domain, indicating 
that they are not within one molecule but between two neighboring ILK PKD molecules. ILK ANK residues K165 
and K170 are heavily crosslinked to a multitude of residues, indicating non-specific links. These links were 
omitted in further analyses. Grey: PINCH LIM1 domain, blue: ILK Ankyrin repeat domain, green: ILK pseudokinase 
domain, red: parvin CH2 domain 
Of course, this is only a very crude approach to gain structural information on the complex 
and should by no way be treated as a precise model from which structural insight can be 
deduced. It can only serve as a tool to roughly positon the domains and to exclude certain 
orientations which are not supported by the crosslinks. Furthermore, the two separate crystal 
structures of ILK PKD and ANK do not necessarily have to represent the conformations of the 
two domains in the full-length IPP complex. 
Initially, all intra-protein crosslinks of ILK were displayed in the structures (Figure 41). Especially 
within the ILK PKD the crosslinks matched the crystal structure very well. However, some 
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crosslinks spanned the whole domain from one lysine located on the outside of the domain to 
another. These links are far too long to correspond to genuine crosslinks within the domain 
but rather appear to have formed between two PKD molecules that were in close proximity. 
Therefore, these crosslinks were omitted from the analysis, since they do not contribute to 
the correct positioning of the domains. Furthermore, a multitude of crosslinks from K165 and 
K170 in ILK ANK to different residues in the PKD and to α-parvin CH2 were observed. These 
crosslinks appear to be too unspecific to represent genuine spatial proximity of rigid 
structures. Instead, it seems that the linker region between ANK and PKD where the two 
residues are located is very flexible and becomes crosslinked to a lot of different residues. 
Furthermore, the ANK structure ends with a part of this flexible linker, which is not attached 
to any part of the folded domains and therefore unlikely to be in the exact same conformation 
as in full-length ILK. For this reason, these crosslinks are likely to lead to a false positioning of 
ANK and PKD and were omitted from further analyses.  
 
Figure 42: Model of ILK ANK, PKD, α-parvin CH2 and PINCH LIM1 complex based on crosslinking. The two crystal 
structures 3KMU and 4HI8 were moved and rotated until all distance restrictions of the crosslinks were satisfied. 
The resulting model was tested for clashes of the domain surfaces and appears to fit quite well. In this model, 
the four domains form a compacted complex rather than an elongated one. Grey: PINCH LIM1 domain, blue: ILK 
Ankyrin repeat domain, green: ILK pseudokinase domain, red: parvin CH2 domain 
After removing the crosslinks likely to be non-specific, ILK ANK/LIM1 and ILK PKD/CH2 were 
moved towards each other and rotated until all intra-molecular ILK crosslinks and the two ILK-
CH2 inter-links were satisfied and turned blue (Figure 42). For the result of this docking 
procedure, the surfaces of the four domains were displayed and analyzed for clashes. It 
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appears that the surfaces fit together quite well and that no domains overlap. The resulting 
model puts the four domains into a compact shape, with the CH2 domain close to ILK ANK. It 
has to be emphasized again that this is not a reliable structure but only a crosslink-based 
approach of gaining an idea of how the domains are oriented within the complex.  
 Display of all detected crosslinks in crystal structures of individual domains 
With the exception of kindlin-2, only partial structures of the crosslinked adhesome 
components are available, making it difficult to gain structural information only through the 
crosslinks. Apart from the previously described “minimal” IPP complex of ILK ANK/PKD, parvin 
CH2 and PINCH LIM1, NMR structures of kindlin-2 PH domain (PDB: 4F7H) and PINCH LIM2-4 
(PDB: 2D8X, 2COR, 1NYP) are available, as well as the crystal structure of kindlin-2, in which 
the flexible loop in the F1 domain and the entire PH domain have been deleted (PDB: 5XPY, 
5XPZ, 5XQ0, 5XQZ). The structures of the PINCH LIM domains and the kindlin-2 PH domain 
have been added to the model of the IPP complex displayed in Figure 42 and the crosslinks to 
the new domains have been added. Beforehand, all crosslinks involving residues that are 
either not part of the structures or are located in flexible linker regions at the N- or C-termini 
of the domains had been omitted from the analysis.  
Again, the docking of the LIM2-4 domains and the kindlin-2 PH domain according to the 
crosslinks is a very crude approach to determine the approximate positions of these domains 
within the complex. Kindlin-2 PH is located close to ILK PKD, but since only two crosslinks to 
the same lysine in PH were identified it is impossible to deduce the orientation of this domain 
towards ILK PKD. For the PINCH LIM domains, more crosslinks have been obtained, which are 
positioned along the interface between ILK ANK and ILK PKD. The most likely orientations of 
LIM2 and LIM3 are in a parallel or antiparallel manner to LIM1. For LIM2, it cannot be predicted 
if the domain is oriented in an antiparallel (Figure 43A) or in a parallel (Figure 43B) manner to 
LIM1, since both orientations satisfy the crosslinks. It is, however, more likely that the 
orientation of LIM2 is antiparallel, since the C-terminus of LIM1 and the N-terminus of LIM2 
point in the same direction in this configuration. Were it otherwise, the domains would have 
to be connected by a linker stretching over the distance that is between the two domains. It 
appears that LIM4 is not positioned in line with the other three LIM domains but has to be 
located next to LIM2 and LIM3 to satisfy the detected crosslinks. This might indicate that 
PINCH in complex with ILK and parvin is not completely elongated but folded back on itself. It 
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might however be the case that the crosslinks are misleading or that the entire model is based 
on a false positioning of ILK ANK and PKD and therefore other possibilities of positioning the 
LIM domains have not been considered.  
 
Figure 43: Model of ILK ANK/PINCH LIM1, ILK PKD/parvin CH2, kindlin-2 PH and PINCH LIM2, 3 and 4 based on 
the detected crosslinks. (A) All components were merged into a single file and the crosslinks displayed by the 
Xlink analyzer tool (dark blue). Only those crosslinks not involving lysines in flexible loops or between lysines on 
opposite surfaces of a domain were selected and used for docking of kindlin-2 PH domain and PINCH LIM2-4. 
The domains were arranged in a manner that satisfies all crosslinks. For LIM2 there are two orientations that 
satisfy all distance restrictions, one where the domain is arranged antiparallel to LIM1 and where C- and N-
termini are close to each other (A) and one where the domain is tilted by 180° so that the domains are parallel 
but the C- and N-termini on opposing sides (B). The lower pictures show only the LIM domains and the crosslinks 
for better visualization.  Light blue: ILK Ankyrin repeat domain, light green: ILK pseudokinase domain, red: parvin 
CH2 domain Grey: PINCH LIM1 domain, dark green: PINCH LIM2 domain, pink: PINCH LIM3 domain, purple: 
PINCH LIM4 domain 
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Attempts were made to include the kindlin-2 crystal structure into the model of the IPP 
complex, however only one crosslink between the kindlin-2 “backbone” (F0-F3, without the 
PH domain and the F1 loop) and ILK PKD was observed, which does not provide enough 
information for the positioning of kindlin towards the IPP complex. The number of crosslinks 
between the kindlin-2 “backbone” and the PH domain was also insufficient for creating a 
model of the entire kindlin molecule. Furthermore, no conformation could be found in which 
all length restrictions provided by the crosslinks were satisfied. This is mainly due to the 
missing linker sequences connecting the PH and the F2 domains, which are probably highly 
flexible and have not been resolved in either structure (PDB: 4F7H, 5XPY). In the structure of 
the kindlin-2 “backbone”, the entire PH-domain insertion, including the flexible linkers, has 
been deleted, thus directly connecting the N- and C-terminal halves of the F2 domain (Li et al., 
2017a). In the full-length protein, which was used for the crosslinking experiments, the F2 
domain is separated by the linkers and PH domain, which might lead to a slightly different 
arrangement of the F2 domain than was resolved in the crystal structure. This slight distortion 
might be enough to interfere with the proper positioning of the crosslinks and prevent a 
correct alignment of the PH domain towards the “backbone”.  
Conclusive structural information on the IPP-kindlin-paxillin complex can only be gained by 
crystallization or EM studies, but the crosslinks can serve as additional information on the 
overall arrangement of the domains or on conformational changes.  
 
3.5 Study of kindlin-2 and THD interactions with integrin tails in a native lipid 
environment 
 Binding of kindlin-2 and THD to integrin tails with low affinity 
In order to assemble native adhesome complexes it is most straightforward to begin with 
immobilized integrin β tails and successively add other proteins. The major prerequisite for 
this approach is the formation of stable complexes with the integrin tail that allow for washing 
steps to remove non-specifically bound proteins. However, it became clear in MST and AUC 
experiments that kindlin-2 and THD, the two proteins that bind directly to the integrin tail and 
therefore the first components that probably trigger the assembly of adhesome complexes, 
display surprisingly low affinities towards integrin tail peptides. For kindlin-2 binding to the β1 
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cytoplasmic tail peptide, the KD determined by MST measurements and confirmed by AUC 
experiments is 7 µM, for β3 it is 12 µM. The affinity of THD towards integrin β1 or β3 tail 
peptide has been placed in the range of 168 µM. Although these values are not as exact as 
those for kindlin-2 due to problems obtaining high enough THD concentrations to reach 
saturation of the tail binding reaction. The very low THD affinities are in accordance with those 
obtained from NMR studies (Anthis et al., 2009).  
The very low affinities of the two major integrin activators towards the integrin tails are 
unexpected and incompatible with the hypothesis that for integrin activation, talin and kindlin 
are recruited from the cytoplasm to the cytoplasmic tails and initiate the formation of the 
adhesome complex. This would require the formation of a high affine bond between talin or 
kindlin and the integrin tail that is stably retained for a given time. Yet, obviously the 
interaction must be favored by factors within the cell that help overcome the low affinities. 
One possible explanation might be that the affinities of kindlin and talin are indeed as low as 
measured, but once they are bound to an integrin tail, the interaction is stabilized by the 
recruitment of other focal adhesion components. This would mean that although initial 
binding is limited by the low affinity, once kindlin and talin are at the focal adhesion, other 
proteins prevent their dissociation. Another potential reason for the high KD values measured 
is that inside the cell, talin, kindlin and/or the integrin tail are modified by modifications such 
as phosphorylation that does not occu in proteins recombinantly produced in E. coli. A third 
explanation is that inside the cell, the integrin tails are inserted into the plasma membrane, 
which was not done in the solution-based measurements. The lipids might increase the affinity 
of talin and kindlin to the integrin tail either by ensuring correct orientation of the proteins 
through a second interaction surface. It is also possible that kindlin and talin are recruited to 
the membrane through interaction with PIP2 before attaching to the integrin tail, which leads 
to a high local concentration and thus increases the number of molecules bound to the tail by 
reaching concentrations close to the KD.  
To better understand the events at integrin cytoplasmic tails in their native environment and 
to test the hypothesis that the plasma membrane might be crucial for talin/kindlin-tail 
interactions, constructs consisting of the integrin transmembrane and cytoplasmic domain 
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(TMCyto) were embedded into Nanodiscs (lipid bilayers encompassed by scaffolding proteins) 
and used for interaction studies.  
 Production and purification of TMCyto constructs and assembly into Nanodiscs 
Fusion constructs of the integrin cytoplasmic tail, the integrin transmembrane domain, a 
Fos/Jun dimerization domain and an N-terminal His6-tag were expressed in E. coli Rosetta cells 
at 18 °C for 16 h using the expression vectors pET15b-TMCyto-b1-wt and pET15b-TMCyto-a5-
wt (obtained from H. Tseng, Fässler department). The constructs were expressed separately, 
rendering α5 or β1 integrin tails with their native transmembrane helix and a dimerization 
domain as a means to bring both subunits together if desired. Due to the hydrophobicity of 
the transmembrane domains, these constructs are insoluble when produced intracellularly 
and are deposited in inclusion bodies. These can be isolated by centrifugation, washed with 
Triton X-100 to remove cell debris and membrane fractions and finally be solubilized over 
night in 3 % EMPIGEN (Buffer D1).  
 
Figure 44: Purification of TMCyto β1 wt by IMAC and cation exchange chromatography. (A)TMCyto β1 wt was 
produced in E. coli in inclusion bodies, solubilized in 3 % EMPIGEN and purified by IMAC on a 1 ml HisTrap FF 
column using Buffers D3/D4. (B) The 250 mM (250) and 500 mM (500) imidazole fractions were diluted in Buffer 
D5 and applied on a 1 ml HiTrap SP HP column and purified using Buffers D5/D6. The 500 mM and 1 M eluates 
were pooled and flash-frozen. (C) The fractions were analyzed by SDS-PAGE after TCA precipitation to remove 
the EMPIGEN. P: pellet before solubilization, containing the insoluble TMCyto construct. FT: flow-through IMAC.  
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The solubilized TMCyto constructs can then be purified by IMAC and CIEX chromatography 
(Figure 44), as long as the EMPIGEN concentration in the buffers is kept at 1.5 % or higher. The 
fractions obtained from CIEX chromatography were pooled and flash-frozen in liquid nitrogen 
without any additives and stored at -80 °C. 
The constructs produced were TMCyto β1 for interaction studies and α5 as a negative control, 
to which talin and kindlin-2 should not bind. As negative controls, mutant β1-NPIY>A and β1-
NPKA-TT>AA constructs were also expressed and purified. In TMCyto β1-NPIA, the membrane-
proximal NPIY motif essential for talin binding is mutated and should therefore only bind 
kindlin in interaction studies. Likewise, in TMCyto β1-NPKA-TTAA the membrane-distal NPKY 
motif is mutated, which should dramatically reduce kindlin binding.  
However, MST studies with mutant tail peptides have shown that the NPKA mutation alone is 
not sufficient to abolish binding but only reduces the KD tenfold, bringing the affinity to the 
same range as for talin-integrin tail peptide (personal communication by M. Veelders). 
Therefore, two Thr residues at the N-terminus of the NPKY motif were additionally mutated 
to alanines, which should addiotionally lower the affinity. Both binding deficient constructs 
were generated by site-directed mutagenesis using pET15b-TMCyto-b1-wt as a template and 
primers PaKa225/226 for generation of pET15b-TMCyto-b1-NPIA and primers PaKa227/228 
and, in a second round of mutagenesis, primers PaKa229/230 for generation of pET15b-
TMCyto-β1-NPKA-TTAA. All constructs were sequenced to ensure the correctness of the entire 
coding sequence.  
For detection in fluorescence microscopy, the TMCyto constructs were labeled with Alexa-647 
dye via maleimide coupling. Since each TMCyto constructs contains a single cysteine at the N-
terminus, they can be selectively labeled with one fluorophore per tail. Labeling was carried 
out by adding the Alexa-647 dye directly to the EMPIGEN solubilized TMCyto constructs 
(diluted to 0.5 % EMPIGEN) and afterwards removing the excess dye by immobilizing the 
TMCyto construct on Ni-NTA beads. The eluate was then used for Nanodisc assembly. 
Unfortunately, the labeling efficiency, determined by LC-MS, could not be raised to more than 
50 % and attempts to separate labeled from unlabeled integrin tails failed.  
The purified TMCyto constructs were inserted into Nanodiscs by mixing them with cholate-
solubilized lipids and commercially available MSP2N2 scaffold protein and then slowly 
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removing the detergents by dialysis. With decreasing detergent concentrations, the 
hydrophobic lipids and transmembrane domains become exposed to the hydrophilic solvent 
and start interacting with each other and with the inside of the membrane scaffold protein. 
Eventually, stable Nanodiscs are formed with one molecule MSP2N2 enveloping ~330 lipid 
molecules and one or more TMCyto molecules (Figure 45C). The assembled Nanodiscs were 
separated from excess MSP2N2 and TMCyto by SEC, which produced two clearly separated 
peaks. A peak simultaneously in A280 and in A650 indicates assembled Nanodiscs with Alexa-
647-labeled TMCyto incorporated (Figure 45A, B).  
 
Figure 45: Assembly of MSP2N2 Nanodiscs with incorporated TMCyto constructs. (A) MSP2N2 was mixed with 
cholate-solubilized lipids and EMPIGEN-solubilized, Alexa-647-labeled TMCyto constructs, dialyzed to remove 
the detergents and applied on an analytical SEC650 column to separate assembled Nanodiscs from excess 
MSP2N2 and TMCyto. The green trace shows A280, the brown trace A650 to detect labeled TMCyto constructs.. (B) 
The fractions from the first peak containing assembled Nanodiscs were analyzed by SDS-PAGE  and show that 
both MSP2N2 and TMCyto are present, indicating successful incorporation. Due to low protein amounts, the 
bands were visualized by Silver Staining, which reveals previously unobserved contaminants at 25 kDa, probably 
from the commercial MSP2N2. (C) Schematic representation of the final Nanodisc, with MSP2N2 in purple 
encompassing the lipid surface composed of 90 % uncharged lipids (DMPC) and 10 % charged lipids (DMPG or 
PIP2) and the TMCyto construct consisting of the cytoplasmic tail, the transmembrane domain, a FOs/Jun 
dimerization domain (blue), a single cysteine (red) and a His6-tag for immobilization.  
In order to study interactions of THD and kindlin-2 with the integrin tail, TMCyto constructs 
α5, β1 wt, β1 NPIA and β1 NPKA TTAA were incorporated into MSP2N2 Nanodiscs. 
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Furthermore, to 
determine the effect of 
different lipid 
compositions within the 
Nanodiscs on THD and 
kindlin-2 binding, 
Nanodiscs with only 
uncharged DMPC lipids 
were compared to discs 
containing 10 % 
negatively charged lipids, 
which should have higher 
affinity towards the two 
proteins. At first, a 
mixture of DMPC with 10 
% DMPG was used for 
establishing purification 
and assay set-up, while 
later a mixture of DMPC 
and 10 % PIP2 was used.  
This phosphatidyl-
inositide is the natural 
ligand for THD and 
kindlin-2 within the 
plasma membrane. The 
exact ratio of charged 
and uncharged lipids at 
focal adhesions is 
unknown, therefore 10 % 
was used as a starting value. Potentially, higher or lower ratios can have an influence on the 
binding behavior and needs to be tested in the future. 
Figure 46: Detection of THD and kindlin-2 binding to empty and TMCyto β1 
wt incorporated Nanodiscs. (A) MSP2N2 Nanodiscs have a diameter of ~17 
nm, which in theory allows kindlin-2 and THD to bind simultaneously to the 
same integrin tail located in the middle of the disc.  (B) Empty or TMCyto β1-
incorporated Nanodiscs with 10 % DMPG were immobilized on Ni-NTA beads 
(GE) and incubated with THD and/or kindlin-2. After washing twice with 50 
mM imidazole, the bound discs were eluted and analyzed by SDS-PAGE and 
silver staining. For empty Nanodiscs, His-MSP2N2 was used, while for TMCyto 
containing discs the His6-tag was cleaved to ensure that only discs containing 
a tail were immobilized. (C) To check for non-specific binding, empty beads 
were incubated with THD and kindlin-2 and furthermore the beads after 
elution were analyzed. The pull-downs were performed in Nanodisc buffer. 
Since the positions of THD and His-MSP2N2 on the gel overlap, THD and 
kindlin-2 were detected by Western Blot. Both proteins were present in 
seemingly equal amounts in all samples. 
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 Detection of THD and kindlin-2 binding to Nanodisc-embedded TMCyto constructs 
The functionality of the TMCyto-Nanodiscs, i.e. the ability to bind kindlin-2 and talin, was first 
assessed in pull-down experiments. “Empty” Nanodiscs consisting only of His6-MSP2N2 and 
lipids were used as a control for interaction of kindlin and talin with the membrane lipids. Prior 
to assembly of the TMCyto-incorporated discs MSP2N2 was cleaved with TEV protease to 
ensure that discs immobilized on Ni-NTA surfaces only attach via the His6-tag in the TMCyto 
construct and therefore no empty discs are included. Empty beads, empty Nanodiscs and 
TMCyto β1 wt-incorporated Nanodiscs immobilized on Ni-NTA beads were incubated with 
THD, or kindlin-2 or both proteins, washed twice and then eluted. The eluates were compared 
by SDS-PAGE and silver staining and by Western Blot analysis with antibodies against kindlin-
2 or THD (Figure 46).  
Both proteins interact with empty and β1 wt Nanodiscs but not or to a lesser extent with 
empty beads. Since the band representing THD overlaps with that of His6-MSP2N2, THD had 
to be additionally visualized by Western Blot. It appears that both THD and kindlin-2 are bound 
in similar amounts in all samples, regardless of the presence or absence of integrin tails. It has 
to be noted, however, that the amount of empty discs seems to exceed that of β1 wt 
Nanodiscs, judged by the strength of the MSP2N2 (cleaved/ uncleaved) bands. Therefore, no 
reliable quantitative information can be derived from Figure 46B. Instead, it serves as proof that 
THD and kindlin-2 bind to Nanodiscs with incorporated TMCyto β1 wt as well as to empty 
Nanodiscs. Therefore, Nanodiscs provide a suitable platform for studying the binding behavior 
of the two proteins with the integrin β1 tail in a lipid environment of one’s choosing. 
 Studies on complex formation between THD, kindlin-2 and integrin tail peptides  
Having established a platform for studying THD and kindlin-2 behavior towards integrin tails 
and lipid surfaces it can be used to shed light on the unresolved question whether both 
proteins can bind to the same cytoplasmic tail. Although the two NPxY motifs are very close 
together, sterically binding of both proteins might be possible, even in light of the recently 
published structure of kindlin-2. Attempts to resolve the binding issue using integrin tail 
peptides and THD and kindlin-2 in solution rendered conflicting results. Analytical 
ultracentrifugation with Atto-488-labeled β1 tail and unlabeled THD and kindlin-2 or both 
showed complex formation between THD and β1-488 and kindlin and β1-488, however, no 
ternary complex of one tail peptide with both proteins (Figure 47A, Data by M. Veelders). 
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As an orthogonal 
method, MST 
measurements were 
conducted with THD 
and Atto-488-β1 tail 
peptide, yielding a KD of 
168 µM. In a second 
experiment, the β1-
Atto-488 tail was mixed 
with kindlin-2, yielding 
a final concentration of 
105 nM tail peptide 
and 28 µM kindlin-2. 
Theoretically, at a KD of 
7 µM, the tail peptides 
are saturated to 80 % 
with kindlin-2 in this 
configuration. 
Therefore, if THD 
cannot bind 
simultaneously to the 
same tail as kindlin-2, 
titration of the same 
THD concentrations 
should yield a different 
curve shape than in the absence of kindlin-2. Due to the much lower affinity of THD the binding 
curve should start to decay at higher concentrations in the presence than in the absence of 
kindlin-2.  
However, the curve measured for THD against kindlin-saturated β1 tail peptide hardly differed 
from that for THD versus “free” tail peptide (Figure 47B). The KD was determined at 188 µM, 
almost identical to that of the interaction without kindlin. At the highest THD concentration 
Figure 47: AUC and MST analysis of kindlin-2 and THD interactions with Atto488-
labeled integrin β1 tail peptide. (A) Recombinant THD and kindlin-2 were mixed 
with β1-488 tail peptide and sedimented in Buffer A3. Detection of the labeled 
tail peptide at 501 nm showed complex formation with both kindlin-2 and THD 
individually, but no ternary complex with both proteins on the same tail. This 
would have resulted in the detection of a new peak at a higher sedimentation 
coefficient (A). (B) MST measurement with THD and β1-488 yielded a KD of 168 
µM, while measurements of THD versus 105 nM β1-488 mixed with 28 µM kindlin-
2 yielded almost the same KD value (188 µM). At 28 µM, the tail peptides are 
saturated to 80 % with kindlin-2, which was expected to change the binding 
behavior of THD if both proteins are incapable of binding simultaneously. 
However, neither the shape of the binding curve nor the KD changed dramatically. 
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of 1189 µM and a KD of 168 µM, the tail peptide (105 nM) is saturated to 88 %, while at the 
same time theoretically being saturated to 80 % with kindlin-2. This strongly indicates that 
both proteins can bind simultaneously to one tail peptide, which is in stark contrast to the 
results of the AUC measurements. 
A possible explanation for these conflicting observations is that THD somehow displaces 
kindlin-2 effectively from the integrin tail, potentially due to the different kon and koff values, 
resulting in an unchanged KD in MST measurements with only THD attached to a single tail 
molecule. Another possibility is that the interaction of THD with a kindlin-tail complex is very 
transient with a fast koff rate, resulting in no observable trimeric complex in AUC. A third 
possible explanation is that in the AUC measurements an excess of unbound integrin tail was 
present, resulting in the formation of dimeric THD-tail and kindlin-tail complexes but no 
trimeric complexes.  
Due to the low affinities of both proteins and unspecific interactions with surfaces, biophysical 
methods with both proteins are difficult to set up, therefore the question whether both 
proteins can bind to the same tail remains unresolved with the solution-based measurements. 
Since it is possible that the plasma membrane contributes to the binding of both proteins to 
the integrin tail, the focus was shifted to the Nanodisc-based approach rather than solution-
based methods.  
 Single-molecule microscopy to analyze binding of kindlin-2 and THD to integrin tails 
in a lipid environment 
One problem of most biophysical methods is that in a system such as the Nanodisc-embedded 
TMCyto constructs, where THD and kindlin-2 can bind to the integrin tail as well as to the lipid 
bilayer, it is difficult to distinguish both binding events since they take place at the same time 
as the binding sites are in close proximity and it is not known to which degree they influence 
each other. Therefore, a novel approach was developed together with Armin Lambacher 
(Fässler Department) that allows for the direct observation of all proteins involved as well as 
their locations and interactions at a single molecule level. Alexa-647-labeled and His-tagged 
TMCyto constructs incorporated into MSP2N2 Nanodiscs were immobilized on NiNTA-tagged 
PEG-coated glass slides to yield a density of approximately 100 fluorescent molecules per 
section and mixed with 1 µM Alexa-488-labeled kindlin-2 and 1 µM Atto-565-labeled THD. The 
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fluorophores were excited with laser light of their respective excitation wavelengths and the 
fluorescence was detected using corresponding filter sets in a TIRF microscope. The intensity 
of the laser light was adjusted to a level that caused stepwise bleaching of the single 
fluorophores, which were detected during a time-lapse movie. Three channels for the three 
different fluorophores were measured simultaneously and then overlaid. For a correct 
alignment of the three channels, their respective offsets were determined using a separate 
sample containing beads with immobilized antibodies labeled with the different fluorophores. 
Furthermore, background correction was performed on all channels. The final, corrected time-
lapse movies show spots in three different colors representing the three proteins present in 
the sample (Figure 48A). Each spot can then be analyzed individually and the fluorescence 
intensity traces over the recorded time can be displayed (Figure 48A, zoom-in). Red spots and 
traces represent the 647-labeled integrin TMCyto constructs, green ones THD-565 and blue 
ones kindlin-2-488, according to the laser light needed for their excitation.  
The traces show distinct “steps” in fluorescence intensity, indicating the inactivation of one 
fluorophore. This inactivation is in some cases reversible, causing a fluorophore in one spot to 
re-appear and disappear again over the time trace (“blinking”). In some traces, two defined 
steps are visible, indicating the presence of two fluorescent molecules in the same spot. For 
the TMCyto constructs, each molecule can only carry one fluorophore since they only contain 
one cysteine residue, while THD and kindlin-2 were labeled via NHS-chemistry to a degree of 
labeling of ~1.0, which means that most molecules carry one fluorophore and only a few 
molecules carry two or no fluorophores. However, for analysis and statistics it has to be kept 
in mind that the labeling efficiency of the TMCyto constructs is only 50 % as determined by 
LC-MS and it cannot be judged if the ratio of labeled and unlabeled integrin tails after 
incorporation into Nanodiscs is still unchanged.  
To ensure that the presence of steps in two different channels in one spot really indicates 
interaction of the two proteins control measurements with a fusion protein containing two 
fluorescent protein domains were performed. These measurements yield a typical distance in 
the set-up in which two truly interacting fluorophores are positioned towards each other. This 
distance was used as a restriction for distinguishing true protein-protein interactions from 
coincidental co-localization. Using this restriction, several different interactions were 
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identified. Predominantly, spots with a single integrin tail inactivation step and either one THD 
or one kindlin-2 step are observed (Figure 48A). Additionally, there are spots in which two 
integrin steps correlate with one kindlin and one THD step, indicating a cluster of two TMCyto 
constructs bound to the two proteins (Figure 48B). Some spots show only one integrin step and 
one THD and one kindlin step each, indicating either simultaneous binding of the two proteins 
to the same tail or the binding to two tails of which only one is detected due to a maximum of 
50 % labeling efficiency of the TMCyto constructs. Additionally, a lot of spots show only THD 
or kindlin-2 steps without integrin tails, indicating either binding of the proteins to unlabeled 
TMCyto tails or interaction with the lipid surface of the Nanodiscs.  
 
Figure 48: Examples of three-channel single-molecule microscopy to study kindlin-2 and THD interaction with 
integrin tails in a lipid environment. Alexa-647-labeled TMCyto β1 wt incorporated into DMPC/PIP2 Nanodiscs 
(red) were immobilized on PLL-PEG/NTA-passivated glass slides and incubated with 1 µM kindlin-2-Alexa-488 
(blue) and 1 µM THD-Atto-565 (green). The three channels were overlaid and for each spot the time-traces of 
the three fluorophores were analyzed (zoom-in windows). Distinct steps in fluorescence intensity indicate the 
inactivation of single fluorophores and allow “counting” of the molecules in one spot. Many THD and kindlin-2 
molecules are found in spots where there is no integrin tail present, indicating interactions of the two proteins 
with the lipid surface independent of tail peptides. In other spots, one kindlin-2 or THD step and one integrin 
step correlate, indicating 1:1 interactions. Spots with two integrin steps and one kindlin and one talin step, 
indicating a cluster of two integrins with both proteins bound either to one tail each or both to the same tail.  
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It had been expected that both talin and kindlin attach to the lipid surface, since for both 
proteins non-specific interactions with a multitude of different surfaces had been observed. 
For this reason, the glass coverslips used for the single-molecule microscopy have to be 
passivated with PLL-PEG to create a layer to which non-specific attachment of kindlin and talin 
is reduced to a minimum. To allow immobilization of the TMCyto-Nanodiscs to the surface 
some PLL derivatized with NTA groups was mixed with the PLL-PEG. After loading the NTA 
groups with Ni2+ the N-terminal His6-tag of the TMCyto constructs could bind and ensure a 
correct orientation of the discs. For immobilization of the empty Nanodisc control the His6-tag 
of the Alexa-647-labeled scaffold protein was retained, while it was cleaved off in the TMCyto- 
samples. Due to the passivation of the glass surface the spots containing only talin or kindlin 
and no integrin step indicate interactions with the lipids rather than the glass surface. 
As control experiments to estimate how many of the binding events are actually due to the 
integrin β1 tail and to what extent the lipid surface enhances talin and kindlin recruitment 
Nanodiscs with incorporated Alexa-647-TMCyto α5 as well as empty Nanodiscs were used 
(Figure 49). The α5 measurements show that kindlin-2 and THD also co-localize with the α-
subunit, indicating either unspecific interactions or an enhancement of (in solution) very weak 
interactions by the lipid surface. The experiments with empty Nanodiscs confirm that both 
proteins interact with the lipid surface alone, independent of the presence of an integrin tail.  
These initial experiments demonstrate that the set-up is working and that it can be used to 
study the events of THD and kindlin-2 binding to integrin tails in a lipid environment as well as 
to the lipid surface alone. In order to draw conclusions about the ratio of bound THD and 
kindlin-2 and whether a statistically relevant number of events involving only one tail and both 
proteins can be found to prove that a ternary complex is formed, the measurements will have 
to be repeated several times and evaluated, which will be the subject of further studies. 
Furthermore, it is highly interesting to study different lipid compositions within the Nanodiscs, 
like only uncharged DMPC molecules to test whether the charged head groups of the 10 % 
PIP2 included in the first discs increase binding of talin and kindlin to the lipid surface or to the 
tails. Having established the measurements, the negatively charged lipid will be changed from 
PIP2 to PIP3, which is the component within the plasma membrane with the highest affinity 
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towards kindlin and which should provide a lipid surface very close to the conditions within 
the cell. 
 
Figure 49: Control measurements with α5-TMCyto-incorporated or empty Nanodiscs in three-channel single-
molecule microscopy. (A) Alexa-647-labeled TMCyto α5 incorporated into DMPC/PIP2 Nanodiscs or empty 
Nanodiscs with Alexa-647-labeled MSP2N2 (B) were immobilized on PLL-PEG/NTA-passivated glass slides and 
incubated with 1 µM kindlin-2-Alexa-488 (blue) and 1 µM THD-Atto-565 (green) as negative/lipid-only controls 
for the β1 interaction. The α5 measurements show that kindlin-2 and THD also co-localize with the α-subunit, to 
which they do not bind in solution. Furthermore, both proteins co-localize with the scaffold protein of empty 
Nanodiscs due to interactions with the lipid surface (B).  
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Another factor that has to be taken into consideration for determining the number of THD 
and kindlin molecules bound to integrin tails are the labeling efficiencies. For THD and kindlin 
the labeling reactions could be optimized in order to obtain a degree of labeling of around 1.0, 
thus placing on average one dye molecule on each protein. For the TMCyto constructs, 
however, the labeling reaction could not be optimized further and therefore a maximum DOL 
of 0.5 was achieved. Since there is only one Cys residue in each TMCyto protein, 50 % of the 
molecules carry one fluorophore and 50 % are unlabeled. Therefore, when counting the 
bleaching steps for the TMCyto constructs, one has to bear in mind that only 50 % of the 
molecules give a signal. So when, for example, a TMCyto dimer is observed, it will display two 
bleaching steps with a probability of 25 %, one bleaching step with a probability of 50 % and 
no step with a probability of 25 %. These statistical considerations will be included in the data 
analysis once enough measurements have been performed to provide reliable data.  
In the future, the TMCyto-Nanodisc platform can be used to study the behavior of other 
adhesome components as well, for example paxillin and whether it is recruited to the integrin 
tail via kindlin-2. Furthermore, FAK can be added as a scaffolding protein or to study its role 
as a kinase and the effects of its phosphorylation on adhesome components. The potential 
recruitment of the IPP complex to integrin tails via kindlin or paxillin is another objective that 
can be studied using this platform. The only limitation is the number of proteins that can be 
studied simultaneously, since the current set-up only allows for three channels and thus the 
observation of three proteins labeled with different fluorophores. A fourth channel could be 
established but requires a lot of effort in hardware and software.  
 
3.6 Study of THD-integrin interactions under force 
The surprisingly low affinities of THD to the β1 and β3 integrin tail raise the question how talin 
is able to transduce actomyosin-mediated forces to the integrin-extracellular matrix bonds 
with such low affinities for the tail. As discussed before, one possible explanation is a 
strengthening occurs through the interaction with the plasma membrane, which provides 
additional binding sites for anchoring talin to focal adhesions. Another hypothesis, which has 
so far never been tested, is a catch-bond behavior of talin with the integrin tail – a protein-
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protein interaction, which increases in strength as force is applied. An example for a catch-
bond is the interaction of the a5b1 integrin ectodomain with fibronectin.THD 
In order to test the catch-bond hypothesis and to study the kinetics of the talin-F3-integrin 
interaction, fusion constructs of talin F3 domains connected to the integrin β1 cytoplasmic tail 
via an unstructured flexible linker was designed and purified by M. Veelders. Since talin1 and 
integrin β1A are the variants expressed in most cells, they were chosen for this and for other 
interaction studies. Due to the extremely low affinity of talin1 to integrin β1A (KD 168 µM) , 
problems with the detection of binding events were anticipated. Therefore, in addition to a 
talin1-F3-β1A fusion construct, a talin2-F3-β1D fusion was studied, since this combination has 
been shown to display the highest affinity of all talin-integrin pairs (Anthis et al., 2009).  
The F3 domains of talin1 and 2 used in the fusion proteins were mutated in order to remove 
all cysteine residues. Instead, two Cys residues were introduced at the N-terminus of the F3 
domain and between the end pf the C-terminus of the linker and before the β1 integrin tail. 
These cysteines are used for the site-directed attachment of maleimide-functionalized 
oligonucleotides to opposing sides of the fusion protein. These oligonucleotides allow for the 
attachment to silica beads functionalized with complementary “DNA handles”. The silica 
beads can then be trapped in a dual-beam optical tweezer-setup, which allows for the 
stretching of the fusion protein between the beams and thus for the defined application of 
force on the molecule (Figure 50B). The attachment of the DNA handles, the optical trap 
measurements and their analysis are carried out by Marco Grison and Mihai Bodescu in 
Matthias Rief’s group at the TUM.  
 The talin1-β1A and talin2-β1D constructs with short linkers show no defined two-
state behavior  
The first measurements were carried out with talin1-F3-β1A and talin2-F3-β1D constructs with 
27 AA linker sequences (designed and purified by M. Veelders). Talin2-β1D showed an 
unexpected behavior upon application of increasing force on the construct. From 1-5 pN the 
construct was slowly extended but remained in the closed conformation, while at 4 pN a shift 
was observed, indicating unbinding of the integrin tail peptide from the F3 domain. At 13 pN, 
a drastic extension represents the unfolding of the entire F3 domain (Figure 50C).  
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Figure 50: Basic principle of the molecular tweezer set-up and force-dependent elongation traces of talin1-F3-
β1A and talin2-F3-β1D (images by M. Grison). (A) The interaction of talin1-F3 domain with integrin β1A as well 
as the much higher affine interaction of talin2-F3 with β1D were studied using molecular tweezers. (B) Fusion 
proteins of talin F3 and the integrin tail, connected by a linker sequence were attached to silica beads via DNA 
handles attached at two cysteine residues at the N-termini of F3 and of the integrin tail. (C) Moving the two laser 
traps apart creates an increasing force across the molecule, resulting first in unbinding of the integrin tail 
(purple/green transition) and later in unfolding of the F3 domain (green/red transition) for talin2-β1D. (D) For 
talin1-β1A no transition indicating unbinding of the integrin tail was observed. (E) Simulatioin of a classical two-
step binding curve. In a classical two-step binding, the binding and unbinding rates increase linearly in correlation 
with the force applied to the molecule. (F) Simulation of a catch-bond binding curve. A catch-bond would 
manifest itself in a decrease in unbinding events in a certain force range, indicating a force-dependent 
strengthening of the bond. (G) Actual curve determined for the talin2-β1D construct with short linker. For the 
talin2-β1D construct with the short 27 AA linker, the observed curve could be fitted to neither model, indicating 
problems with the linker length.  
Therefore, if the construct is maintained at a constant force of around 5 pN a constant binding 
and unbinding of the integrin tail to the F3 domain can be observed. Surprisingly, the talin1-
β1A construct did not display a transition force, only one shift indicating complete unfolding 
at 20 pN (Figure 50D). Therefore, β1A tail binds with an incredible fast off-rate, which allows 
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only transient interactions that are detected by the fluctuations observed in a force regime up 
to 20 pN.  
The talin2-β1D construct displays binding and unbinding events in the force range from 5-15 
pN. The rates at which this binding and unbinding occurs were determined at different forces 
and plotted against the applied force (Figure 50E). In a classical two-step system, the unbinding 
rates should increase linearly with increasing force (simulated curve displayed in Figure 50E). In 
a system involving a catch-bond, one would expect at first an increase in unbinding rates, 
followed by a decrease at the force where the catch-bond is formed (simulated curve 
displayed in Figure 50F). The decrease in unbinding rates corresponds to a strengthening of the 
bond through the formation of a catch-bond. 
At higher forces the unbinding rate increases again (Figure 50F). The curve obtained for the 
talin2-β1D fusion protein, however, cannot be fitted to any of the two models (Figure 50G). One 
possible explanation for this could be that the talin-tail interaction does not follow a classical 
two-step binding model but instead there is an additional binding site in the membrane-
proximal region of the integrin tail. This, however could be excluded through a fusion 
construct in which the membrane-proximal region was replaced by Ser and Gly residues and 
which still showed the same behavior. Another reason might be that the 27 AA linker between 
F3 and the integrin tail is too short and therefore induces force on the bond already before it 
is applied externally. In order to test this hypothesis, talin1-F3-β1A and talin2-F3-β1D 
constructs with longer linker sequences were produced.  
 Production and purification of talin-integrin fusion constructs with longer linkers 
An expression vector containing the coding sequence for a 72-AA flexible linker containing 
mainly glycines interspersed with Ser, Thr and Glu residues was obtained from Prof. Dr. 
Hermann Gaub’s group (TUM). The linker sequence was amplified using primers PaKa231/232, 
while the vector backbone of pCoofy17-Talin2H_7SGGG_b1D_C-link (M. Veelders) was 
amplified using primers PaKa233/234. The two PCR products were combined by SLIC cloning, 
creating vector pCoofy17-Talin1-F3-b1A_long_link. Similarly, the backbone of pCoofy17-
THD_7SGGG_b1_ dF0F1F2-CYS-C336S-linkerCys was amplified using primers PaKa233/235 
and merged with the linker to vector pCoofy17-Talin2-F3-b1D_long_link. The correct insertion 
of the linker into both constructs was confirmed by sequencing. The cysteine residues at the 
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N-terminus of the F3 domain and at the C-terminus of the linker region used for attachment 
of the DNA handles were retained in the same positions.The fusion constructs with longer 
linkers were produced in E. coli with N-terminal His10-SUMO tags and purified via IMAC using 
Buffer A1 and A2. After removal 
of the tag with SenP2 protease 
and reverse Ni-NTA 
chromatography, the proteins 
were applied onto a Superdex200 
column as a finalizing purification 
step in Buffer A3 (Figure 51A, B). 
Both proteins were purified to ≥ 
95 % purity and showed identical 
behavior. DLS measurements 
showed that both constructs are 
monodisperse and have a 
hydrodynamic radius of 3.0 nm, 
which is slightly larger than that of 
the constructs with shorter linker 
sequences (2.7 nm). This is due to 
the more voluminous longer 
unstructured linker and hence 
was expected.  
As with the construct with the 
shorter linker, there was no 
binding and unbinding signal 
detected for talin1-β1A-long, indicating that the interaction is indeed too weak or transient to 
be detected and that the shorter linker did not destabilize the bond. For talin2-β1D, a similar 
elongation, unbinding and unfolding behavior was observed as for the construct with shorter 
linker. However, the unbinding rates at increasing pN values now match the linear increase 
expected for a two-state system (Figure 52E). The previously observed effect that distorted the 
curve is not present in this construct, indicating that it was caused by the shorter linker. 
Figure 51: SEC purification and DLS measurements on the talin2-F3-
β1D fusion protein with 72 AA linker sequence. The SEC elution 
profile (A) as well as SDS-PAGE of the fractions (B) show high purity 
of the talin2-β1D construct with a longer linker region. DLS analysis 
shows that the protein is monodisperse and displays a radius of 3.0 
nm (C), which is slightly larger than the analogous construct with a 
shorter linker (2.7 nm). SEC was performed on a HiLoad 16/600 
Superdex200 pg column at 4 °C using Buffer A3.   
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Apparently, this linker applied force on the bond by itself, compromising the measurements. 
This measurement also rules out the possibility that talin2-F3 forms a catch bond with the 
integrin β1D tail. All further experiments were carried out with the talin2-F3-β1D construct 
with the longer linker. 
 Determination of binding affinities and kinetics of the talin2-F3 interaction with 
different integrin tail peptides in competition assays 
When the talin2-β1D fusion construct is maintained at a constant force between 5-9 pN, the 
integrin tail is constantly unbinding and binding which is reflected in an oscillation in the signal 
between the bound state, which is less extended, and the more extended unbound state.  
 
Figure 52: Example of a competition assay between an integrin tail peptide in solution and the talin2-F3-β1D 
fusion protein (Images from (Grison, 2017)). When maintained at a constant force between 5-9 pN, the integrin 
tail fused to the F3 domain constantly unbinds and re-binds, causing oscillation of the signal (A). Passages colored 
in purple indicate the “closed” state, in which the fused integrin tail is bound to F3. Green marks the “open” 
state, in which the fused tail is unbound from F3 and cyan marks the passages in which a competing tail peptide 
in solution is bound to F3, abolishing the return to the closed state (B). A zoom-in of A shows the difference 
between open and closed conformation and the missing assumption of the closed state when a competing 
peptide is bound (C). The fusion constructs with the longer linker sequence show binding and unbinding 
behaviors as expected for a two-state system, indicating that the previously measured curves were distorted by 
intrinsic force on the fusion protein, generated by the short linker (D, E).  
In this state, integrin tail peptides in solution can be added to the set-up for competition 
assays. When the integrin tail fused to talin F3 dissociates, it can afterwards re-bind, or one of 
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the peptides in solution can attach to F3 instead (Figure 52B). The bound peptide causes a 
decrease in the oscillation for a certain time, equal to the lifetime of the F3-peptide bond 
(Figure 52A). From competition assays with free β1D integrin tail peptide a KD of 9 µM was 
determined, three times lower than the KD determined by NMR. 
Furthermore, the on-rate for the binding of free β1D to F3 was estimated at 7 µM-1 s-1, the 
off-rate at 100 s-1. This off-rate indicates an extremely short-lived interaction, independent of 
the applied force. Further experiments with different tail peptides will show the influence of 
point mutations on KD and on-rates. 
 Production and purification of full-length THD constructs with ybbR-tags for DNA-
handle attachment 
Since the experiments with the talin2-F3-β1D fusion construct showed no indication for a 
catch-bond behavior, it is possible that a strengthening of the talin-integrin bond is achieved 
through the interplay with the other domains of THD or through interactions with the plasma 
membrane. In order to study this, a construct of full-length THD fused to the integrin tail is 
required, which can be introduced into the molecular tweezer set-up as well. Since THD 
contains 6 cysteines, it would take a lot of mutagenesis steps to remove all of them and 
introduce two new cysteines at the desired positions, while increasing the risk of destabilizing 
the protein. Therefore, another approach using ybbR tags was chosen for attachment of the 
DNA handles. The ybbR tag is an 11 AA sequence originating from B. subtilis, which is 
recognized by Sfp phosphopantetheinyl transferase, an enzyme that attaches small molecules 
via a coenzyme A modification to the target sequence. By introducing two ybbR tags at the 
end of the linker sequence and at the N-terminus of THD it is possible to apply force onto the 
entire head domain.  
The N-terminal ybbR tag was inserted into the talin2H sequence on pCoofy17-Talin2-Head by 
restriction digest with AgeI and insertion of hybridized complementary primers PaKa236/237 
carrying the ybbR sequence. The second ybbR tag was inserted into the vector pC17-Talin2-
F3-b1D_long by restriction digest with MscI and insertion of the hybridized primers 
PaKa238/239. The entire linker and tail sequence was then amplified using primers 
PaKa235/240 and merged with the backbone of the ybbR-talin2H construct amplified with 
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primers PaKa233/234 by SLIC cloning. The resulting vector was termed pCoofy17-Talin2-Head-
b1D-2ybbR-N-link.  
 
Figure 53: Purification and characterization talin2-head-β1D constructs with ybbR tag on the F0 or F3 domains. 
Both constructs were purified by IMAC, cleaved and finalized by SEC to ≥ 90 % purity (A, B). DLS measurements 
show that the construct with the ybbR tag inserted between F2 and F3 is larger than that with the ybbR tag at 
the F0 domain (4.8 vs. 4.2 nm, C). This indicates a potential disruption of the THD fold by the ybbR tag at the F3 
domain, which also results in changes in the CD profile (D). Therefore, the F0 construct should be used for force 
measurements, since it is properly folded. 
An analogous construct for talin1H-β1A was cloned following the same protocol. Additionally, 
in case the attachment of the ybbR tag to the N-terminus of F0 leads to the unfolding of 
domains before the integrin-F3 bond is disturbed, another construct was cloned which 
includes the ybbR tag at the N-terminus of the F3 domain. The three constructs talin1-head-
F0-β1A, talin2-head-F0-β1D and talin2-head-F3-β1D were produced and purified analogously 
to the F3 constructs with longer linkers (Figure 53A, B).  
The purified proteins were analyzed by DLS, which showed that all three proteins are 
monodisperse and that the two constructs with the ybbR tag at the N-terminus of the F0 
domain display a hydrodynamic radius of 4.2 nm. The fusion protein with the ybbR tag 
between the F2 and F3 domains, however, displays a larger hydrodynamic radius of 4.8 nm 
(Figure 53C). Since all proteins are of the same size and composed of the same domains, this 
increase in size indicates that the ybbR tag might interfere with proper folding of talin2H by 
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separating F2 and F3 from each other. The ensuing change in secondary structure distribution 
was observed in CD spectroscopy (Figure 53D). Conclusively, the construct with the internal 
ybbR tag at the F3 domain should be used very carefully in optical tweezer experiments, 
keeping in mind that its stability might be reduced by the inserted tag. 
Table 10: Overview of all talin-integrin fusion proteins produced and cloned  
Construct #/vector Talin Attachment Location Status Producer 
#239-pC17-Talin1-F3-
b1A_short_linker 
1-F3 Cys N-term F3 
C-term linker 
measured M. Veelders 
#247-pC17-Talin2-F3-
b1D_short_linker 
2-F3 Cys N-term F3 
C-term linker 
measured M. Veelders 
#249-1-pC17-Talin2H_ 
7SGGG_b1D_C-link-helix-
replaced 
2-F3 Cys N-term F3 
C-term linker 
Mutated MP region 
measured M. Veelders 
#258-pC17-Talin2-F3-
b1D_sh_C-term_Cys 
2-F3 Cys N-term F3 
C-term tail 
measured M. Veelders/ 
P. Kammerer 
#259-pC17-Talin1-F3-
b1A_long_linker 
1-F3 Cys N-term F3 
C-term linker 
measured P. Kammerer 
#260-pC17-Talin2-F3-
b1D_long_linker 
2-F3 Cys N-term F3 
C-term linker 
measured P. Kammerer 
#266-pC17-Talin1-Head-b1A-
2ybbR-N-link 
1-F0, F1, 
F2, F3 
ybbR N-term F0 
C-term linker 
purified P. Kammerer 
#268- pC17-Talin2-Head-b1D-
2ybbR-N-link 
2-F0, F1, 
F2, F3 
ybbR N-term F0 
C-term linker 
measured P. Kammerer 
#269-pC17-Talin1-Head-b1A-
2ybbR-F3-link 
1-F0, F1, 
F2, F3 
ybbR N-term F3 
C-term linker 
purified P. Kammerer 
#271-pC17-Talin2-Head-b1D-
2ybbR-F3-link 
2-F0, F1, 
F2, F3 
ybbR N-term F3 
C-term linker 
produced P. Kammerer 
#267-pC17-Talin1-F2F3-b1A-
2ybbR-N-link 
1-F2, F3 ybbR N-term F2 
C-term linker 
cloned P. Kammerer 
#270-pC17-Talin1-F2F3-b1A-
2ybbR-F3-link 
1-F2, F3 ybbR N-term F3 
C-term linker 
cloned P. Kammerer 
#272-pC17-Talin2-F2F3-b1D-
2ybbR-F3-link 
2-F2, F3 ybbR N-term F3 
C-term linker 
cloned P. Kammerer 
#273-pC17-Talin2-F2F3-b1D-
2ybbR-N-link 
2-F2, F3 ybbR N-term F2 
C-term linker 
cloned P. Kammerer 
#274-pC17-Talin1-F3-
b1A_long_TM 
1-F3 Cys N-term F3 
C-term linker 
+ part of TM helix 
cloned P. Kammerer 
#275-pC17-Talin2-F3-
b1D_long_TM 
2-F3 Cys N-term F3 
C-term linker 
+ part of TM helix 
produced P. Kammerer 
 
Should it be the case that the full-length THD is not suited for the intended experiments, 
constructs consisting of the talin F2 and F3 domains have been cloned and can be purified. 
The F2 domain provides a surface for interaction with lipids and might therefore be sufficient 
to attach the construct to the membrane. An overview of all talin-integrin fusion constructs, 
including those that have not been purified yet, is presented in Table 10. 
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 Potential use of the talin-integrin fusion constructs for studies on kindlin-2 and the 
influence of lipids 
The purified and characterized full-length talin head fusion proteins will be tested in the 
molecular tweezer set-up to see whether the binding and unbinding of the integrin tail as well 
as the unfolding of single domains can be observed. This is especially interesting for talin1-
β1A, since for this combination, no binding was detectable so far. Like with the F3 domain 
constructs, it will be studied whether the full-length head domain shows a catch-bond 
behavior towards the integrin tail. Furthermore, kindlin-2 will be added to the experiments in 
order to test whether it competes with talin for the integrin tail or changes the binding 
behavior. It is also possible that kindlin binds to the fused tail peptide at the same time as 
talin, stabilizing the complex.  
Furthermore, Nanodisc-embedded TMCyto constructs will be added to the fusion proteins, on 
the one hand in competition assays to measure binding affinities in the same way as it was 
done for tail peptides in solution. On the other hand, empty Nanodiscs and kindlin-2 can be 
added to the protein to test whether both proteins need the lipid surface to attach to the 
same tail. In order to be able to perform measurements with Nanodiscs, the silica beads used 
for the optical tweezers have to be passivated to avoid non-specific binding of the lipid 
surface, which interferes with the measurements. A similar passivation approach as for the 
glass slides used for single-molecule microscopy, using PLL-PEG, could be beneficial. 
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4 Discussion 
The main objective of this thesis was the establishment of a molecular toolkit, which can be 
used to study the process of adhesome complex assembly in vitro. The integrin adhesome is 
composed of a multitude of proteins linked via an intricate network of protein-protein 
interactions. Therefore, it is difficult to determine the individual steps that lead to the 
formation of complexes around integrin tails or the composition of these assemblies in a 
cellular context, where there might be certain unidentified components or modifications 
present, which are crucial for adhesome assembly.  
For this reason, an approach solely based on recombinant proteins is desirable, in which all 
components are well characterized and can be modified if necessary, for example by in vitro 
phosphorylation, point mutations, deletion of domains or the introduction of fluorescent 
labels for visualization. Not only does it allow the detection and quantification of individual 
protein-protein interactions but also the step-by-step assembly of large complexes. The latter 
provides insights into the sequence of proteins binding to one another, their stoichiometry 
and the stability of the complexes formed. Furthermore, structural studies using cryo-EM or 
crystallography can be conducted on stably assembled adhesome components and provide 
new insights into the architecture of focal adhesions. 
In order to perform the assembly of adhesome complexes in a cell-like, yet controlled 
environment, an adaptable system that simulates the lipid environment around integrin tails 
was established. By changing the size and composition of the lipid surface provided by the 
Nanodiscs as well as the sequence of the integrin TMCyto constructs, the influence of the 
individual components on complex assembly can be studied. Furthermore, this system is 
suitable for analyzing, on a single-molecule level, how talin and kindlin behave at integrin tails 
– whether they can bind to the same cytoplasmic tail or whether their binding is mutually 
exclusive, which influence the presence of paxillin has on talin or kindlin recruitment and how 
much the complex assembly differs between β1 and β3 integrin tails. 
Lastly, the establishment of a system, which can be used to exert force on talin-integrin fusion 
constructs, introduces a novel parameter to the in vitro studies of adhesome proteins. 
Traction force, especially across talin, is the one parameter that usually has to be omitted in 
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solution-based studies, leaving some degree of uncertainty whether a critical factor is missing 
in the analysis. The optical tweezer-based method allows for the addition of different proteins 
or peptides, which might compete with the integrin tail binding to talin F3 domain or 
strengthen the interaction.  
Conclusively, a toolkit of recombinant proteins, membrane platforms and biophysical analysis 
methods has been established and characterized and enables novel in vitro approaches to 
elucidate what is happening around integrin cytoplasmic tails in focal adhesions.  
 
4.1 Focal adhesion kinase and its dual functions in adhesome complexes 
 Production of recombinant FAK and confirmation of scaffolding function 
As one of the key components in integrin signalling and adhesome assembly, functional FAK 
was considered vital for the intended experiments. An expression system was established 
which allows for the production and purification of recombinant full-length murine FAK in 
milligram amounts from HEK293E cells. The His-SUMO tag was found to be beneficial to both 
yield and stability of the recombinant protein, since earlier constructs with N-terminal His- or 
Strep-tags were produced as well, yet at lower levels. The thermal stability of FAK could be 
enhanced by changing the buffers used for purification, however this did not reduce the 
affinity of the protein towards SEC columns, where a considerable part of each preparation 
was lost. Furthermore, some HSP70 was co-purifed, indicating some folding problems. 
However, the final, purified protein is monodisperse and properly folded.  
Interestingly, the hydrodynamic volume of FAK observed in SEC seems to decrease upon 
supplementation with ATP. Furthermore, addition of ATP and incubation at 37 °C leads to 
increased auto-phosphorylation. It has been shown that in the inactive form, the FAK FERM 
domain forms dimers (Brami-Cherrier et al., 2014). Therefore, it can be speculated that in a 
dimer, both FAK molecules phosphorylate each other in trans upon additon of ATP and then 
dissociate, resulting in monomeric, active FAK. It is also possible that binding of ATP leads to 
a compaction of FAK by binding of the FAT domain to the FERM domain, resulting in a smaller 
apparent size.  
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Expectedly, interaction studies have shown that recombinant FAK can bind paxillin as well as 
THD (Lawson et al., 2012, Hoellerer et al., 2003). Therefore, it can be used as a scaffolding 
protein in adhesome complex assembly in the absence of ATP, where it associates with 
paxillin, talin or both. If stable complexes are formed, structural studies using cryo-EM or 
chemical crosslinking on FAK, paxillin and THD can be conducted. Furthermore, since it has 
been shown that FAK specifically phosphorylates recombinant paxillin, the effect of these 
phosphorylations on paxillin binding to kindlin and the IPP complex can be studied.  
 In vitro phosphorylation of paxillin by FAK facilitates study of these modifications on 
adhesome complex assembly 
It could be shown that recombinant full-length FAK phosphorylates paxillin in vitro after the 
addition of ATP and incubation at 37 °C. This indicates that the purified protein is 
phosphorylated in the HEK293E cells during production, especially at positions Y-397, Y-576 
and Y-577, which are crucial for full activation of FAK. The activating phosphorylations were 
confirmed by mass spectrometric analysis. Apparently, the phosphorylation of Y-397 is not yet 
present in all FAK molecules after purification, since the level of tyrosine phosphorylation of 
the FAK band in Western Blot analysis increases after addition of ATP and incubation at 37 °C, 
indicating auto-phosphorylation.  
Paxillin phosphorylation at the well-described positions Y-31 and Y-118 was confirmed by 
Western Blot and mass spectrometric analysis, the latter revealing additional phosphorylation 
of Y-40, Y-181, two residues which had been reported as phosphorylation sites in paxillin but 
not extensively studied. The phosphorylations are entirely accomplished by FAK, since no co-
purified Src could be detected in the recombinant protein sample. Interestingly, 
phosphorylation by FAK is specifically limited to paxillin, as no modification of kindlin-2, THD, 
full-length talin, EPLIN or α-parvin was observed. Since the phosphorylation of paxillin is 
accomplished quite fast and can be optimized to ensure quantitative addition of two or more 
phosphate groups to the molecule, it is possible to generate sizeable amounts of phospho-
paxillin for interaction studies. Either by SEC or by using His-SUMO-tagged FAK in the reaction, 
which can later be easily removed using Ni-NTA beads, phospho-paxillin can be separated 
again from FAK prior to its use in experiments.  
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The mechanism by which FAK phosphorylates paxillin is of interest as well, since paxillin binds 
to the FAT domain of FAK but must come into close proximity of the kinase domain as well to 
be phosphorylated. Therefore, there has to be either a second paxillin-binding site in the 
kinase domain or the FAT domain associates with the kinase domain and thus brings paxillin 
near the catalytic center. The latter would imply that without the FAT domain, paxillin is not 
phosphorylated by FAK, a hypothesis that can be tested using a FAK construct in which the 
FAT domain is deleted. If this construct, however, is still able to phosphorylate paxillin it would 
be interesting to identify the location of the second binding site at the catalytic domain and 
to determine whether two paxillin molecules can bind to one FAK molecule via the two 
separate binding sites. Even co-crystallization of FAK and paxillin bound to the catalytic 
domain, immobilized by an ATP-analogue, could be attempted.  
Due to the additional complexity of including FAK in adhesome complex assembly, it was 
omitted so far. The primary goal was to characterize the IPP complex and its direct interaction 
partners kindlin and paxillin to better understand the binding modalities of this pentameric 
complex. The next level of analysis will be to include FAK, with and without the addition of 
ATP, to test whether it binds to paxillin and creates a stable hexameric complex. It is also 
possible that FAK binding to or phosphorylation of paxillin results in its dissociation from the 
IPP complex or in altered binding behavior towards other proteins. Successfully assembled 
hexameric complexes can be analyzed by chemical crosslinking or cryo-EM to gain structural 
information.  
It is also unclear if the FAK FERM domain, which has been shown to interact with PIP2 in the 
plasma membrane (Brami-Cherrier et al., 2014), can stabilize the adhesome complex by 
strengthening its attachment to the membrane. The localization of FAK to the plasma 
membrane and the co-localization with THD or paxillin there can be studied using the single-
molecule microscopy approach on Nanodisc-embedded TMCyto constructs. In the same set-
up, the effect of FAK phosphorylating paxillin and a potential change in behavior towards 
kindlin or THD thereupon can be tested.  
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4.2 Recombinant unmodified or ERK-phosphorylated EPLIN does not directly 
interact with recombinant PINCH or paxillin 
Recombinant α-EPLIN was produced and purified under the assumption that it binds to both 
PINCH and paxillin and thus could have a stabilizing effect on the IPP complex or on the IPP-
paxillin interaction. It had been shown previously that EPLIN co-localizes with PINCH as well 
as paxillin inside the cell (Karakose et al., 2015, Tsurumi et al., 2014), therefore a direct 
interaction that leads to the localization of EPLIN to focal adhesions was suspected. Since 
these interactions had not been shown in vitro and the binding interfaces not identified, 
recombinant, bacterially produced EPLIN, PINCH and paxillin were intended for this purpose. 
However, no interaction of unmodified EPLIN with either full-length paxillin, full-length PINCH, 
individual PINCH LIM-domains or PINCH bound to ILK and parvin in the IPP complex were 
detected.  
Since it has been shown that ERK phosphorylates EPLIN, which leads to a detachment of EPLIN 
from actin fibers (Han et al., 2007), it was hypothesized that the same phosphorylation might 
lead to the localozation of EPLIN to focal adhesions. Therefore, EPLIN was phosphorylated by 
recombinant ERK and used in interaction studies with PINCH and paxillin. However, no 
interactions of the phospho-protein with either partner could be detected, indicating that ERK 
phosphorylation is not the “missing link”.  
It is possible that EPLIN can be phosphorylated by another kinase and that these different 
modifications modulate interaction with PINCH or paxillin, or that the interaction partners 
themselves have to be modified. Since EPLIN is largely unstructured except for the central LIM 
domain, it is highly probable that interaction with the LIM-domain proteins paxillin and PINCH 
is mediated via this exact domain. The LIM domain might be inacessible in native EPLIN which 
is not attached to actin, preventing interactions. This can be tested in interaction studies using 
only recombinant EPLIN LIM domain. Furthermore, it is possible that EPLIN does not directly 
interact with PINCH or paxillin but is localized to focal adhesions via a different, unidentified 
protein and thus brought into close proximity of the two proteins.  
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4.3 The MultiBAC system is ideal for expression of recombinant IPP complex but 
does not allow isolation of a fully assembled adhesome complex 
Expression of ILK, PINCH and α-parvin from one expression vector in High Five insect cells 
proved to be the approach that finally led to the production and purification of full-length IPP 
complex in 1:1:1 stoichiometry. All three components are correctly folded and pre-assemble 
into the stable IPP complex inside the insect cells. Purification is achieved by IMAC via only 
one His-tag on α-parvin, which leads to the co-elution of ILK and PINCH, showing that the 
complex is stable. It also passes SEC with only little dissociation of the components. It is, 
however, not possible to co-purify any other adhesome components together with the IPP 
complex, neither by IMAC on column or on beads, nor by a less harsh method like rate-zonal 
centrifugation.  
It appears that the affinities of the other components like kindlin, paxillin or RSU-1 are too low 
or their off-rates too fast to allow the formation of complexes with lifetimes high enough to 
withstand purification and dilution. It is possible to form complexes of IPP, paxillin and kindlin 
on SEC, but for this, kindlin and paxillin have to be used in excess to “force” them to associate 
with IPP. When the peak fraction obtained from SEC is used for negative staining, it appears 
that a considerable amount of complexes are dissociating upon dilution, confirming the failed 
co-purification and complicating cryo-EM analysis.  
The fact that, although all adhesome components expressed on the same vector were 
produced in sufficient quantity, they did not form stable complexes inside the insect cells 
raises suspicions as to whether there is really a tight adhesome complex around integrin tails 
which grows over time through the association of additional components. It is possible that 
focal adhesions are more dynamic than expected and that adhesome components attach for 
a certain period of time to each other and then some of them dissociate again.  
Another possible explanation is that for the proteins to form a stable complex, the integrin tail 
and the plasma membrane have to be present to localize talin and kindlin as the central 
proteins and then all other proteins can attach to them. Or a “critical” number of adhesome 
proteins has to be assembled which form multiple protein-protein interactions and thus 
stabilize a large complex. Possibly, an approach with Nanodisc-embedded TMCyto constructs 
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and all recombinantly produced proteins in high concentrations might yield sizeable 
complexes. This has to be tested in the future. 
 
4.4 Recombinant full-length IPP complex for interaction studies and structural 
analysis 
 Interaction of IPP with kindlin-2 and paxillin and pentameric complex formation 
The fact that recombinant, full-length IPP complex can be purified and forms a stable complex 
is in good accordance with published data stating that the three proteins pre-assemble in the 
cytoplasm and are recruited together to focal adhesions (Hoffmann et al., 2014). This stable 
trimeric complex is of particular value for structural studies, since no structure of the full-
length proteins is available to-date and little is known about the binding modalities of paxillin 
and kindlin to the IPP complex and to each other in a pentameric complex.  
Once purified, the IPP complex has the tendency to aggregate, especially at temperatures 
beyond 15 °C. Unfortunately, this interferes with many biophysical measurements and with 
attempts to resolve the structure of the complex by crystallization or cryo-EM. Buffer screens 
have been conducted in an attempt to find conditions that reduce aggregation and stabilize 
the complex. However, the interpretation of these measurements was complicated by the fact 
that the three proteins unfold at different temperatures and the aggregation seems to 
interfere with the signal as well, resulting in melting curves with no sharp transitions but 
rather a constant increase in fluorescence. The most promising conditions were in citrate 
buffer, which will be further tested in aggregation studies and in negative staining.  
It could be shown that paxillin and kindlin bind individually to IPP, forming tetrameric 
complexes, and that their binding is not mutually exclusive. Instead, a pentameric complex is 
formed when both proteins are added to the IPP complex. Paxillin and kindlin also interact 
with each other and, judging from the crosslinking data, it appears that they adopt a similar 
conformation towards each other when bound to IPP, since crosslinks in the same positions 
as in the sample without IPP were observed. This observation has to be verified by orthogonal 
methods and by cryo-EM in the best case. 
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Although it was found in pull-down experiments and consequently also in crosslinking studies, 
THD does not directly interact with IPP, kindlin, paxillin or the pentameric complex of these 
proteins. The interaction with Ni-NTA beads is unspecific and can be observed in almost all 
pull-down experiments and in the controls with empty beads. Therefore it remains speculative 
if IPP, kindlin and paxillin do not interact with talin at all inside the cell, forming an 
independent complex or if the interaction is mediated by the integrin tail and the plasma 
membrane. It is also imaginable that FAK functions as an adapter molecule between talin and 
paxillin in focal adhesions. This can be tested by the stepwise assembly of complexes on 
Nanodisc-embedded TMCyto constructs.   
 Full-length IPP complex does not interact with integrin tail peptides 
Contrary to published data on the ILK-PKD/parvin-CH2 complex (Fukuda et al., 2009), full-
length IPP complex does not interact with integrin tail peptides. Three orthogonal methods, 
including pull-downs with recombinant GST-β1 and GST-β3 fusion proteins, which is the only 
method used by Fukuda et al. to demonstrate interaction with ILK-PKD/parvin-CH2, failed to 
indicate any interactions. It is possible that in the GST pull-down experiments very low 
amounts of IPP were bound but not detected by Coomassie staining. Potentially, Western Blot 
analysis would have shown an ILK band pointing to an interaction with extremely low affinity.  
However, it seems more likely that the integrin-binding site in ILK, which has been mapped to 
residues 293-451 in the pseudokinase domain, is not accessible in the full-length IPP complex. 
It might be hidden by the parvin CH1 domain or PINCH LIM domains and hence requiring either 
a conformational change or a dissociation of ILK from its binding partners to allow binding to 
the integrin tail. The latter, however, seems unlikely since ILK by itself is not very stable and it 
also has been shown that the IPP complex is pre-assembled in the cytoplasm before being 
recruited to focal adhesions (Hoffmann et al., 2014). The complex would then have to be 
disassembled first, allow ILK binding, and re-assemble. It seems more likely that the published 
data contains an artifact or represents a different structure from that observed in the full-
length construct, since binding was demonstrated in only one assay and no affinities were 
determined.  
It is also possible that the ternary IPP complex is recruited to FAs through kindlin-2, which 
attaches directly to the integrin tail. Being in close proximity to the integrin tail, a 
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conformational change in ILK might occur that leads to the dissociation of PINCH or parvin, 
exposing the integrin-binding site in ILK. Kindlin, bound to the integrin tail, might stabilize ILK 
and facilitate its binding to the tail. This can be tested by assembling kindlin-2 on the surface 
of Nanodisc-embedded TMCyto constructs and addition of IPP complex. If indeed ILK binds to 
kindlin-2 and the integrin tail by displacing PINCH or parvin, they should be absent or reduced 
after washing of the sample.  
 The PINCH LIM5 domain is flexible and non-essential for IPP function 
Initial crosslinking studies on full-length IPP complex with kindlin and paxillin showed that 
PINCH LIM5 domain becomes heavily crosslinked to lysine residues in several different regions 
of ILK and parvin. This high number of crosslinks can be derived from high flexibility and the 
lack of defined structural elements of the LIM5 domain, allowing it to change its position often 
and reach different surfaces of the complex. Another possible explanation is that LIM5 plays 
a central role within IPP, re-enforcing the link between ILK and α-parvin by attaching to both 
of them, and thus is expected to have a high impact on complex integrity.  
Therefore, deletion of LIM5 should result in reduced complex stability and yield as well as 
alterations in biophysical properties and interaction with kindlin and paxillin. Parallel 
purification of full-length and dLIM5 complex, however, showed almost identical elution 
profiles and final yield of the two constructs. Furthermore, the tendency to form aggregates 
is present to the same extent and IPP-dLIM5 is properly folded and monodisperse. The shorter 
complex also shows no discernible difference in kindlin and paxillin binding compared to the 
full-length version, in Ni-NTA pull-down experiments as well as in SEC analyses. Crosslinking 
experiments with IPP-dLIM5 yielded the same crosslinks as full-length IPP, apart from those 
involving the LIM5 domain, indicating that the overall structure of the complex is identical and 
not disrupted by the absence of a central link. Instead, several previously unobserved 
crosslinks were detected, indicating that they were prevented by the presence of LIM5.  
All this strongly indicates that PINCH LIM5 domain adopts a very flexible, probably largely 
unstructured conformation. It is located near the ILK-parvin interface, allowing for the 
establishment of the numerous crosslinks, but has no apparent structural effect. Another 
indication that PINCH LIM5 domain is unstructured is the fact that for PINCH LIM1-4 there are 
NMR structures available (PDB: 1G47, 2D8X, 2COR, 1NYP), while there is no structure 
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deposited for LIM5. It seems unlikely that LIM5 was omitted from the structural studies when 
all other LIM domains were analyzed and yielded structures. Therefore, it seems likely that no 
NMR structure for LIM5 could be obtained, due to its high flexibility. It is possible that PINCH 
LIM5 domain adopts a more defined and less flexible conformation upon binding of RSU-1 
(Dougherty et al., 2005). This can be verified by adding recombinant RSU-1 to the IPP complex 
and analyzing the crosslinks obtained or by trying to co-crystallize RSU-1 and LIM5.  
Conclusively, for structure determination by cryo-EM or crystallization IPP-dLIM5 should be 
used, since it includes less unstructured elements which are detrimental to the resolution that 
can be achieved or prevent crystallization or the identification of class averages altogether.  
 Chemical crosslinking and modelling of substructures 
The mass spectrometric analysis of chemically crosslinked complexes is especially suited for 
proteins of which full or partial structures have already been solved and where the exact 
orientation of certain domains towards each other needs to be determined. Furthermore, 
conformational changes occurring upon binding to other proteins in the complex can be 
detected and mapped. In this case, however, no entire structures of any of the proteins are 
available, making it exceedingly difficult to gain reliable structural information from 
crosslinking data. Instead, only a very rough positioning of the single domains is possible and 
the correctness of this modeling cannot be claimed with any certainty. Therefore, the model 
depicted in Figure 42 represents by no means a definitive structure of the “minimal” IPP 
complex but only a suggestion of how the domains might be oriented towards each other 
satisfiying all valid crosslinks between these proteins.  
The obtained crosslinks were inserted into the partial structures of ILK-PKD/parvin-CH2 and 
ILK-ANK/PINCH-LIM1 solved by x-ray crystallography (Fukuda et al., 2009, Chiswell et al., 
2008). Since these structures were solved separately and it is unclear how they are oriented 
towards each other, Stiegler et al. presented an electron density profile for the “minimal” IPP 
complex consisting of full-length ILK, parvin-CH2 domain and PINCH LIM1 domain, determined 
by SAXS (Stiegler et al., 2013). This electron density displays a roughly triangular shape, into 
which the authors positioned the two partial structures, connected by an unstructured linker 
sequence between ILK ANK and PKD domains which is not present in any of the structures 
(Figure 54C).  
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Figure 54: Comparison of published SAXS data of the “minimal” IPP complex (Stiegler et al., 2013) and the 
model obtained by chemical crosslinking proteomics. The model presented in Figure 42 (A, B), which was 
generated by interactive docking to satisfy all inter-domain crosslinks in ILK-PKD, ILK-ANK, α-parvin CH2 and 
PINCH LIM1 domain differs from the model obtained by Stiegler et al. (C). The latter was derived from the 
insertion of the ILK-ANK/PINCH-LIM1 and ILK-PKD/parvin-CH2 crystal structures (PDB: 3KMU, 4HI8) into the 
electron density map obtained through SAXS analysis. An unstructured linker between ILK-ANK and ILK-PKD 
(purple) was inserted (yellow), through which the two domains are shifted away from each other. The resulting 
model neither fits well into the electron density map, nor would it satisfy the crosslinks obtained for the full-
length IPP complex, which indicate that the two ILK domains are much closer together. The model obtained 
through the crosslinking data does not fit exactly into the electron density either, which might be due to the use 
of full-length IPP complex for crosslinking and the “minimal” version for SAXS analysis. 
It can be claimed with certainty that the crosslinks detected in the full-length IPP complex do 
not support this model, since the arbitrarily positioned linker separates ILK-PKD and ILK-ANK 
too far from each other as that the crosslinks could be satisfied. Furthermore, the crosslinks 
suggest a stronger “tilt” of the two separate structures towards each other, positioning ILK-
ANK and parvin-CH2 close enough to be crosslinked, which is not possible in the model 
presented by Stiegler et al.  
When looking closely at the model shown in Figure 54C, it becomes obvious that the positioning 
of the two structures does not fit very well into the measured electron density map, indicating 
that the orientation of ILK-PKD and ILK-ANK must be different. The most misleading part of 
the model is probably the linker sequence, which the authors chose to model in an elongated 
way, with a large distance between ILK-PKD and ILK-ANK. Judging by the observed crosslinks, 
it seems more likely that the linker is not extended but rather compacted, which brings the 
two domains closer together. 
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The model generated from the crosslinking data does not fit exactly into the electron density 
map of the “minimal” IPP complex either. A potential explanation for this is the fact that the 
crosslinks were obtained using the full-length IPP complex, whereas the SAXS data was derived 
from the shortened version. It could be imagined that the presence of parvin CH1 domain as 
well as PINCH LIM2-4 slightly changes the conformation of ILK, leading to a more compact 
shape than in the “minimal” complex. Furthermore, it is not entirely certain that the structures 
of the ILK-PKD/parvin-CH2 and ILK-ANK/PINCH-LIM1 sub-complexes determined by x-ray 
crystallization represent the structures these domains adopt in the full-length form of the IPP 
complex. Therefore, in order to determine the exact structure of the IPP complex, cryo-EM or 
x-ray crystallography will have to be used. 
Analogous to the model of the “minimal” IPP complex, the positioning of the PINCH LIM1-4 
domains relative to each other and to ILK-PKD and ILK-ANK based on the crosslinking data is 
very crude and can only serve as an indication of the approximate locations of the LIM 
domains. It appears that PINCH is not elongated with all LIM domains positioned in a row but 
rather compacted with the LIM2, 3 and 4 domains forming a cloverleaf-like arrangement. This 
would bring an unstructured, flexible LIM5 domain to the center of the IPP complex, explaining 
the multitude of observed crosslinks to this domain. However, this arrangement is also solely 
based on crosslinking data and might be false due to an incorrect arrangement of ILK-PKD and 
ILK-ANK.  
It is extremely difficult to gain structural information on the IPP-kindlin-paxillin complex from 
the crosslinking data, since only very small stretches of both proteins have been structurally 
characterized. Only few crosslinks have been observed involving the kindlin “backbone”, the 
kindlin-PH domain and the single LD-motifs of paxillin, of which NMR structures are available, 
therefore a correct positioning of these domains is not possible. In order to gain more 
structural information on the IPP-kindlin-paxillin interactions, cryo-EM seems the method of 
choice, if stable complexes can be assembled which do not dissociate upon dilution.  
When studying the crosslinks between kindlin-2 and paxillin, it appears that the two proteins 
interact with each other via the same interfaces as in the absence of the IPP complex. The 
intramolecular as well as the intermolecular crosslinks indicate no large conformational 
changes. Therefore, if no pentameric complex stable enough for cryo-EM studies can be 
established, the dimeric kindlin-paxillin complex could be studied separately. Together, the 
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two proteins form a complex of approximately 140 kDa, which brings it into the size range 
observable in negative staining and cryo-EM.  
 Outlook and future plans for structural studies on full-length IPP complex 
As mentioned before, no structural information on full-length IPP complex is available to date. 
Therefore, it was attempted to gain structural data by x-ray crystallography and cryo-EM 
studies. Crystallization trials on the full-length IPP#4 construct so far yielded only very thin 
needle-shaped crystalline particles, which could not be improved by optimization of the buffer 
conditions. Neither did a seeding approach, for which the needle-like crystals were ground 
into very small shards and then used for inoculation of a second round of crystallization 
conditions lead to large, regularly-shaped crystals. However, some conditions appeared to 
contain a microcrystalline background, which could be analyzed and potentially be used for 
structure analysis.  
Furthermore, crystallization studies on the shortened IPP-dLIM5 construct could lead to better 
results, since the unstructured PINCH LIM5 domain has been removed in that construct, 
reducing flexibility. Additionally, considering the results of the buffer optimization screen, 
purification of the IPP complex in citrate buffer might lead to increased stability or to a slightly 
different behavior than in Buffer B2, which had been used for previous crystallization trials. 
The combination of both the shortened IPP-dLIM5 complex and a more stabilizing buffer 
might lead to an alteration of the crystalline particle shapes and sizes, yielding crystals suitable 
for x-ray analysis. Furthermore, once stabilizing buffer conditions have been identified, 
diverse additive screens can be performed. The presence of needle-shaped crystals in 
numerous conditions in the initial trials indicates that the IPP complex has a tendency to 
crystallize which, under the right buffer and additive conditions, could lead to crystals with 
the desired properties. 
In parallel to the crystallization trials, the IPP complex was analyzed by negative staining on 
carbon grids to find optimal purification techniques, dilutions and buffer conditions for the 
preparation of cryo-EM samples. So far, it is possible to detect single particles in negative 
staining which represent the IPP complex but, apart from these particles, aggregates are often 
detected. Since aggregation of the IPP complex is time- and temperature-dependent, the 
process for generating samples for negative staining so far was to perform SEC, collect the 
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desired peak fraction as soon as possible, keep the fraction permanently on ice and perform 
negative staining on ice. However, despite all these precautions, some degree of aggregation 
could not be prevented.  
Another aspect, which complicates the analysis of the IPP complex by negative staining is its 
relatively small size of 135 kDa (IPP#4, full-length). The recent advances in cryo-EM technology 
allow for the analysis of particles even smaller than 100 kDa, however the smaller the size of 
the complex, the more important it becomes that the proteins analyzed form extremely 
homogeneous and well-defined particles. In order to increase the size of the particles 
analyzed, attempts were made to visualize the pentameric IPP-kindlin-paxillin complex, at a 
molecular weight of approximately 270 kDa. As for the IPP complex alone, all five proteins 
were applied onto an SEC column and the peak fraction containing the pentameric complex 
was collected and directly used for negative staining on ice.  
However, the resulting images indicated that most of the particles detected were too small to 
be IPP-kindlin-paxillin complexes, raising the concern that the pentameric complex 
disassembles easily upon dilution. In one sample so far, large, roundish particles were 
detected which could represent intact pentameric complexes. This will have to be reproduced 
and subjected to further analysis. One method for stabilizing protein complexes for electron 
microscopy analysis is the so-called GraFix approach (Kastner et al., 2008). It combines rate-
zonal centrifugation in a sucrose density gradient with chemical crosslinking, mostly by a 
gradient of glutaraldehyde. The aim of this method is the isolation of intact complexes from 
disassembled single components while at the same time fixating the complex in its assembled 
state through crosslinks. The GraFix approach has been applied to the IPP-kindlin-paxillin 
complex using a 5-20 % sucrose gradient with 0-0.1 % glutaraldehyde. However, in the 
fractions analyzed by SDS-PAGE and silver staining IPP, kindlin and paxillin were detected only 
separately but not as a defined crosslinked band at 270 kDa. As discussed for the isolation of 
adhesome complexes by rate-zonal centrifugation, this method seems not suitable for the IPP 
complex in combination with other proteins as the complexes always seem to disassemble. 
Therefore, the GraFix approach has been discontinued, but if no other approach is found to 
stabilize the complex, attempts can be made to optimize the sucrose gradient, the 
glutaraldehyde concentration or the kind of chemical crosslinker used.  
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A number of measures will be employed in future preparations to improve the sample quality 
in negative staining. On the one hand, the IPP-dLIM5 construct will be used for further 
analysis, since the reduced flexibility might yield more uniform particles. Additionally, 
purification of the IPP complex and SEC will be performed in citrate buffer, since this might 
increase its stability and prevent disassembly. In all approaches so far, 0.05% tween-20 was 
added to the buffer used for purification, as it seems to improve purity and yield of the IPP 
complex. However, the tween-20 used previously was not of ultra-pure quality and therefore 
might contain contaminations, which do not interfere with purification of biophysical analyses 
but are visible in electron microscopy. Therefore, the SEC runs for sample preparation for 
negative staining will be performed using buffer supplemented with ultra-pure tween-20. 
Furthermore, the addition of 5-10 % glycerol to the SEC buffer might prove beneficial for 
complex stability and will be assessed. The sample homogeneity of the IPP preparations might 
further be improved by performing additional ion exchange or hydrophobic interaction 
chromatography steps, as possible contaminations or disassembled proteins might be 
removed better than in SEC alone. 
Conclusively, analysis of the IPP complex and the pentameric IPP-kindlin-paxillin complex 
using cryo-EM seems promising but will require considerable optimization efforts before high-
quality structural information can be obtained in order to gain novel insights into the yet 
unresolved full-length structures and binding modes of the five proteins.  
 
4.5 Establishment of a system to directly visualize adhesome complex formation at 
integrin tails in a lipid environment 
 The influence of the plasma membrane on talin and kindlin binding to integrin 
cytoplasmic domains 
It is obvious that the binding modalities of talin and kindlin toward the integrin tail are unusual 
and in many aspects unexpected. The binding affinities of both proteins towards integrin β1 
and β3 tail peptides in solution are extremely low, with 7 µM for kindlin-2 versus integrin β1 
being the highest. For proteins, which are the key activators of such important and time-
critical processes as integrin activation one would typically expect much higher affinities. 
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However, the low affinities of talin F3 domain towards integrin tails of 160 – 300 µM had been 
first characterized by NMR and have been confirmed by MST and AUC measurements (Anthis 
et al., 2010).  
Furthermore, there is the element of traction force, which is conveyed from the extracellular 
matrix over the integrin and talin to the actin cytoskeleton. In this function, one talin molecule 
bears 7-10 pN of force (Austen et al., 2015). If the talin F3-integrin cytoplasmic tail interaction 
were the only binding interface and thus had to bear the entire force it is difficult to imagine 
how this is possible based on such low affinity. One potential mechanism for reinforcement 
of the talin F3-integrin bond is the formation of a catch-bond upon force application onto the 
two molecules, which, however, should have been observable in the optical tweezer 
measurements.  
Another factor, which potentially increases the affinity of talin and kindlin towards integrin 
tails is the plasma membrane and phosphatidylinositides incorporated therein. Talin binds via 
its F2 and F3 domains preferentially to PIP2, but also to other negatively charged 
(phospho)lipids with slightly lower affinity, suggesting that the charge might be the pivotal 
factor (Martel et al., 2001, Anthis et al., 2009, Moore et al., 2012). Kindlin binds via its PH 
domain to PIP3 with slightly higher affinity than to PIP2, indicating a similar mechanism for 
both proteins, which can be fine-tuned by the prevailing phosphatidylinositides (Liu et al., 
2011).  
There are three mechanisms imaginable for the positive influence of the plasma membrane 
on the talin/kindlin-integrin interaction. One is a conformational change of talin or kindlin 
upon phosphoinositide binding, which seems rather unlikely and can be ruled out for kindlin-
2 and integrin β1A, since pre-saturation of kindlin-2 with IP4, a soluble PIP3 analogue used for 
obtaining the crystal structure of kindlin-2 PH domain (Liu et al., 2012), did not change the 
affinity of kindlin-2 towards an integrin β1A tail peptide in MST measurements (data not 
shown).  
Therefore, a second, more likely explanation is that PIP2 or PIP3, when located in the plasma 
membrane in close proximity to an integrin tail, offers a second binding site for talin or kindlin 
besides those on the cytoplasmic tail, strengthening the interaction. For talin F3 domain, this 
has been demonstrated by NMR measurements using integrin β1 and β3 transmembrane and 
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cytosolic domains incorporated into bicelles (Lu et al., 2016). However, binding to PIP2 in the 
plasma membrane does not seem likely to anchor talin more strongly to integrin tails and to 
help bear the tension forces.  
A third hypothesis is that phosphatidylinositides assist in localizing kindlin and talin to the 
plasma membrane, leading to drastically increased local concentrations in the vicinity of 
integrin cytoplasmic domains which are high enough to overcome the high KD values, resulting 
in a sufficient amount of talin or kindlin bound to integrins to induce and regulate cell 
adhesion. 
Since none of these hypotheses offer an explanation of how talin can bear such high forces at 
such low affinities, it seems likely that the strengthening effect is derived from additional 
adhesome proteins binding to the complex, slowing the off-rate of talin binding to integrin 
tails.  
 Studies on potential trimeric THD-kindlin-integrin tail complexes in solution yield 
controversial results 
The question whether talin and kindlin, both essential proteins for integrin activation that bind 
directly to the integrin cytoplasmic domain, can bind to one integrin tail molecule to form a 
trimeric complex, or whether their binding is mutually exclusive, has been controversially 
discussed for many years. Due to the low affinities, especially of THD, biophysical assays are 
often problematic when they require concentrations that allow saturation of the interaction. 
Bledzka et al. presented SPR measurements on integrin tails immobilized on a gold surface 
with dextrane coating, which seemed to show binding of THD to a surface of tail peptides 
saturated with kindlin-2 (Bledzka et al., 2012). However, these measurements should not be 
given too much credit, as the authors fail to present important information and control 
measurements. For instance, they do not document the strong unspecific interactions of THD 
and kindlin-2 with the dextrane surface, which was observed in attempts to reproduce the 
measurements. This makes all the sensorgrams invalid, as it is impossible to tell how much of 
the signal is derived from non-specific interactions. Furthermore, the authors fail to 
demonstrate that they can reach saturation of the surface with 2.8 µM THD, upon which they 
injected kindlin-2, claiming that the resulting binding curve can only be derived from kindlin 
binding to the talin-saturated integrin tails. Therefore, the results from the study presented 
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by Bledzka et al. should not be taken into consideration when discussing the topic of 
simultaneous THD and kindlin-2 binding to integrin tails.  
The assays presented in Figure 47 render conflicting results, with the AUC measurements 
clearly showing no formation of a trimeric complex of THD, kindlin-2 and the fluorescently 
labeled integrin tail peptide. Yet the MST measurements seem to indicate that, while the tail 
peptide is theoretically saturated to 80% with kindlin-2, the THD titration curve is unchanged 
compared to “empty” tail peptide, reaching a concentration at which theoretically 88% of the 
tail is saturated with THD. This indicates either that THD can bind to an integrin tail to which 
already one kindlin molecule is bound with equal affinity as to a “free” tail peptide or that THD 
is able to displace kindlin-2 from an integrin tail peptide with extremely high efficiency. 
Analysis of THD and kindlin-2 binding to integrin cytoplasmic domains in lipid environment by 
single-molecule microscopy will shed more light on this controversial topic by providing a tool 
to directly observe events at integrin tails.  
 Advantages and caveats of the Nanodisc-embedded TMCyto constructs 
The newly established Nanodisc-based system for microscopic visualization of single integrin 
TMCyto molecules opens up a novel approach for studying the assembly of adhesome 
complexes. The system allows the incorporation of different TMCyto constructs, for example 
integrin β1 and β3, which makes it possible to test for differences in complex assembly based 
on integrin type, or α-integrin constructs, on the one hand as a “negative control”, for THD 
and kindlin-2 should not bind to α-tails, and on the other hand for studying α/β-heterodimers. 
Furthermore, the effect of point mutations within the integrin cytoplasmic sequence on 
complex assembly can be studied, most prominently the disruption of the two NPxY motifs 
essential for talin and kindlin binding. Labeling the TMCyto constructs at one defined Cys 
residue makes it possible to count the bleaching steps in one specific area and deduce how 
many molecules are present there.  
The Nanodiscs have a defined diameter of approximately 17 nm, determined by the 
membrane scaffold protein used. If desired, smaller Nanodiscs can be produced by employing 
a different scaffold protein. The discs can be immobilized on a passivated glass surface in a 
specific orientation using the His6-tag on either the N-terminus of the TMCyto construct or on 
the MSP2N2 protein. Furthermore, the lipid composition within the Nanodiscs can be 
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controlled, for studies on the effect of uncharged or charged lipids on THD and kindlin binding 
and for determining the influence and concentration dependence of PIP2 or PIP3 on the 
number of proteins bound to the Nanodiscs.  
After characterizing the binding modalities of THD and kindlin-2 to Nanodisc-embedded 
TMCyto constructs, an increasing number of adhesome components can be added to the 
system, either labeled or unlabeled. This allows for example the study of kindlin recruitment 
to the integrin tail by paxillin, as proposed by Theodosiou et al., by testing whether more 
kindlin is found to co-localize with integrins in the presence of paxillin (Theodosiou et al., 
2016). Furthermore, the effect of paxillin phosphorylation by FAK can be directly observed by 
adding fluorescently labeled paxillin and unlabeled FAK in the presence or absence of ATP to 
the system.  
A few caveats of the Nanodisc-embedded TMCyto constructs have to be taken into 
consideration when setting up experiments. First, the preparation process is time-consuming 
and reproducibility depends on the correct adjustment of a number of parameters, such as 
the volume ratio of EMPIGEN-solubilized TMCyto constructs to that of the lipid and scaffold 
protein components or the assembly time and temperature during dialysis. In the assembly 
process, incorporation efficiency of the TMCyto constructs varies with the construct used, and 
there is always a certain amount of precipitation of the TMCyto constructs, making it difficult 
to determine their labeling efficiency within the final Nanodiscs. It has to be assumed that 
equal amounts of labeled and unlabeled TMCyto molecules precipitate, retaining the DOL 
determined prior to Nanodisc assembly. Furthermore, the yield of one Nanodisc preparation 
is very limited and depends on the concentration of the TMCyto constructs, which cannot be 
increased by centrifugal concentrators, as this also increases the EMPIGEN concentration and 
leads to unpredictable assembly behavior. Therefore, the amount of Nanodiscs obtained from 
one preparation is more than sufficient for several microscopy sessions or three to four pull-
down samples, but barely allows the use of orthogonal biophysical methods. This limitation 
has to be overcome by preparing multiple samples and combining the Nanodiscs obtained.  
Conclusively, the single-molecule approach to observe directly what transpires at integrin tails 
embedded into lipid bilayers is very promising and has been set up methodically to allow a 
multitude of different measurements. It will have to be tested how well a measurement can 
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be reproduced by repeating the Nanodisc preparations and interaction studies with THD and 
kindlin-2 several times, rendering statistically sound data on the different TMCyto constructs. 
This will eventually lead to new insights into focal adhesion assembly. 
 
4.6 Production of talin-integrin fusion proteins for force-dependent interaction 
studies  
The application of an optical tweezer set-up to study the effect of traction force on the talin-
F3-integrin cytoplasmic tail bond is a novel approach to elucidate the binding modalities of 
this unusual protein-protein interaction. In all other biophysical methods applied so far to 
study the talin-integrin interaction, traction force was absent due to solution-based 
measurements or to complications when using full-length talin and F-actin in the analyses. The 
new approach facilitates the study of how the talin-integrin interaction changes under force, 
setting the focus on the talin head domain, while most analyses so far used full-length talin or 
the rod domain (del Rio et al., 2009, Austen et al., 2015). While initial measurements seemed 
to indicate an interaction type different from the expected two-step behavior, raising the 
hypothesis of a catch-bond. The constructs with longer linker sequences between talin-F3 and 
the integrin tail peptide, however, helped rule out a catch-bond behavior and identifying the 
effect seen in the initial measurements as an artifact due to the short linker sequence, which 
itself applied force onto the construct. It is theoretically possible that the entire talin head 
domain is required for catch-bond formation, but it seems unlikely. Measurements with THD-
integrin fusion constructs will provide final evidence for or against a catch-bond behavior. 
It is surprising that only the talin2-integrin β1D fusion construct yields detectable interactions, 
albeit at low affinity and strong fluctuations. The application of traction force onto the talin 
F3-integrin bond does not increase binding affinity or reduce off-rates. It turned out to be 
impossible to detect a force range of constant binding and unbinding of the fused integrin tail 
peptide for any of the talin1 constructs (in fusion with either β1A or β1D). Therefore, either 
the tails do not bind to the talin1 F3 domain in these constructs at all or the interaction is too 
transient to be detected, which again raises the question of how this interaction can then bear 
traction force.  
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It will be interesting to test whether kindlin-2 can compete with the talin interaction with the 
fused integrin tail. If this is the case, there should be phases detectable in which there is no 
un-binding and re-binding, since kindlin is bound to the tail peptide - similar to the competition 
assays with integrin tail peptides. Furthermore, competition assays with Nanodisc-embedded 
TMCyto constructs might lead to novel insights into the increase in affinity mediated by the 
lipid surface as compared to “free” integrin tail peptides. This depends on the passivation of 
the silica beads used in the optical tweezers to prevent non-specific interaction of the 
Nanodiscs with the glass surface, which would distort the force measurements.  
Conclusively, the novel optical tweezer approach for studying the talin-integrin bond under 
force adds additional insights, which, combined with the conclusions of the other approaches, 
will contribute to a more accurate and versatile understanding of this interaction which is so 
vital for integrin activation and adhesome assembly.   
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5  Summary 
The integrin-proximal adhesome complex is composed of a multitude of proteins which are 
recruited to the short cytoplasmic tail domain of integrin β-subunits, facilitating diverse signal-
transducing and scaffolding functions necessary for the formation of focal adhesion and thus 
the control of integrin-mediated cell adhesion and motility. Among the innermost 
components of focal adhesions are talin and kindlin, which directly bind to the integrin tail, as 
well as paxillin, FAK, the ILK-PINCH-parvin (IPP) complex and EPLIN. All these proteins are 
essential for integrin function and numerous interactions between them have been identified, 
however the exact way in which they interact and assemble into a complex has not yet been 
determined.  
In order to observe the formation of adhesome complexes in vitro, in a well-defined 
environment devoid of any unidentified interfering components, the central aim of this study 
was the establishment of a molecular “toolkit” composed of recombinantly produced and 
purified proteins. Furthermore, in order to mimic the actual conditions inside the cell as 
closely as possible, integrin transmembrane and cytoplasmic domains were incorporated into 
Nanodiscs, which provide an adaptable lipid surface around the integrin tails.  
Focal adhesion kinase, as a pivotal factor due to its dual role as a kinase as well as a scaffolding 
protein, was produced and purified in milligram quantities from HEK293E cells. FAK specifically 
phosphorylates paxillin at positions Y-31 and Y-118, but not talin or kindlin. Furthermore, 
binding of FAK to paxillin and THD in the absence of ATP was confirmed. Therefore, 
recombinant FAK can be used for studying its role in adhesome complex assembly as well as 
the effect of paxillin phosphorylation by FAK on protein-protein interactions. 
The full-length trimeric IPP complex was produced in milligram quantities from High Five 
insect cells using the MultiBAC system. Obtaining the complex of all three proteins in full-
length and in 1:1:1 stoichiometry has never been achieved so far and allows the 
characterization of protein-protein interactions with other focal adhesion proteins such as 
kindlin, paxillin and talin. The IPP complex does not bind THD, and, contrary to the literature, 
no direct interaction with the integrin β1 or β3 cytoplasmic domain could be detected either. 
Instead, the IPP complex forms a pentameric complex with kindlin and paxillin. The orientation 
of the proteins within this pentameric complex was studied by chemical crosslinking and mass 
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spectrometric analysis. Furthermore, the IPP complex will be used for structural studies by 
cryo-EM and x-ray crystallography. 
The interactions of THD and kindlin-2 with integrin cytoplasmic domains, which provide the 
basis for adhesome complex assembly, were studied in solution, yielding very low affinities 
and conflicting results on the question whether talin and kindlin can bind the integrin tail 
simultaneously. In order to elucidate this topic, a novel single-molecule microscopy approach 
for studying talin/kindlin interactions with integrin tails in lipid environment was established. 
Integrin transmembrane and cytoplasmic domains incorporated into Nanodiscs, THD and 
kindlin-2 were fluorescently labeled and studied under single-molecule TIRF conditions. The 
number of fluorophore bleaching steps at a certain position indicate co-localization of THD 
and kindlin with the integrin tail. Like this, the binding behavior of these molecules can be 
studied in the native environment, the effect of point mutations and lipid composition can be 
assessed and even assembly of adhesome complexes on Nanodiscs can be attempted. 
Additionally, fusion proteins of talin head and integrin cytoplasmic domains were produced, 
which allow the study of this interaction under force, an element which is usually absent in 
solution-based biophysical studies. The application of optical tweezers to apply traction force 
onto the bond revealed no catch-bond behavior and low affinities also under force. 
Furthermore, the bond appears to be very transient, with a high rate of binding and unbinding 
of the integrin tail to talin F3 domain.  
Conclusively, this work demonstrates how to produce elusive protein components for 
structural studies on integrin adhesome complexes in solution or surface-based in a native 
lipid environment and a novel approach to study these complexes on the single-molecule 
level. 
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